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Examination of egg white proteins and effects of high pressure  
on select physical and functional properties 
Andrew Hoppe, M.S. 
University of Nebraska, 2010 
Advisor: Michael G. Zeece 
Egg white proteins have become an important and desirable ingredient to the food 
industry due to their functional properties which include gelling, foaming, and 
emulsification.  Egg white is also well recognized as an excellent source of nutrition.  
The goal of this work was to determine the effects of high pressure (HP) treatment on egg 
white proteins.  Specifically, experiments were conducted using Raman spectroscopy and 
pepsin digestibility to investigate structural changes.  Pressure treatment at 400 to 800 
MPa (5 minutes at 4°C) resulted in increased pepsin digestibility of egg white proteins 
ovalbumin, ovotransferrin, and lysozyme compared to heat-treated (85 to 95°C) and 
untreated controls. Increased digestibility was also evident at pressures that did not result 
in gelation.  Raman spectroscopy analysis of protein secondary structural changes 
resulting from HP-treatment showed an increase in β-sheet/α-helix ratio at these pressure 
ranges.  ACE inhibitor peptide YAEERYPIL (origin ovalbumin) was identified from 800 
MPa pepsin digestion sample via Liquid Chromatography/mass spectrometry/mass 
spectrometry (LC/MS/MS).   HP-induced changes in egg white functionality were 
evaluated by determining foaming and gelation properties with and without prior pressure 
treatment.  Gels were formed at pressures of 600 to 800 MPa and with heat treatment of 
85°C to 95°C.  HP gels were softer and more elastic than heat treated gels.  Lowering the 
pH to 6 with tartaric acid improved overall gel appearance.  With respect to foaming 
 
 
properties, HP increased foam capacity while decreasing stability.  Overall, HPP 
improved egg white functional properties and has the potential to improve egg white 
nutritional value through increased digestibility.       
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Literature Review 
Introduction 
      Egg white is a well recognized functional and nutritional food ingredient.  The 
recent development of non-thermal technology employing high hydrostatic pressure 
processing (HPP) has shown promise to further enhance those properties.  It has also has 
shown promise in reduction of microorganisms and increasing product shelf life without 
the use of preservatives.  This is in line with consumer demands for safe and preservative 
free or natural, minimally processed foods (Rastogi, N.K et al 2007).  Thus, it is essential 
to study the effects of HPP on egg white protein and evaluate the impact it has on egg 
white as a functional food ingredient. 
 It is also important to determine the effects of HPP on whole egg white 
digestibility.  Egg white is well recognized as an excellent nutrition source and it is likely 
that pressure induced denaturation will increase digestibility without the side effects of 
thermal processing.    This study was focused on expanding the understanding of the 
effect of HPP on egg white proteins.  The following literature review specifically 
discusses the composition of egg white, HPP technology, protein structure and 
digestibility, and potential nutritional effects with respect to allergenicity and bioactive 
peptides.  The factors affecting egg white functional properties of foaming and gelation 
are also discussed.  
Objectives 
The following outlined objectives were used to test the hypothesis that high 
pressure (HP) treatment will result in protein denaturation and increased pepsin 
digestibility.  Secondly, HP treatment should result in the formation of gels without heat 
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and a shift in protein secondary structure from α-helix to β-sheet.  Thirdly, HP treatment 
should increase the foaming ability of egg white.  Finally, the nutritional value of egg 
white may be increased due to protein denaturation and release of potentially bioactive 
peptides.  The goal of this work was to examine the effects of HPP on whole egg white 
protein functionality and digestibility, in greater detail.  Specifically, the objectives of 
this work were to investigate: 
1. HP-induced changes in egg white protein secondary structure using Raman 
spectroscopy 
2. The effects of HP treatment on egg white protein pepsin digestibility  
3. The peptide products of pepsin digested HP-treated egg white and identify 
bioactive peptides based on sequence identity  
4. Effects of HP treatment on gelation, texture, foaming, and color of egg white  
Egg Composition 
The egg has long been known for its exceptional nutritional value.  It consists of a 
porous carbonate shell, yolk, and albumen commonly known as egg white.  The yolk 
makes up 1/3 of the egg and contains most of the vitamins including A, D, E, K, and B-
complex vitamins.  The yolk also contains essentially all of the lipids, ¾ of the calories, 
and is a good source of antioxidant carotenoids.  In contrast, egg white contains over half 
of the proteins in egg and is a source of the vitamin riboflavin (Mine, Y. et al 2006).  Egg 
whites are low in lipids at 0.01% (Mine, Y. et al 1995), making egg white a healthy 
source of protein and other nutrients. 
     Egg white is composed of ~9.7-10.6% protein by weight.  Over 24 different 
proteins have been identified and isolated from egg white (Mine,Y. et al 2006).  Some of 
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the major proteins include ovalbumin (54%), ovotransferrin (12%), ovomucoid (11%), 
ovomucin (3.5%), and lysozyme (3.4%) (Mine,Y. et al 1995).  The following table lists 
selected properties of the major egg white proteins (Table 1).   
Table 1: Major egg white proteins and selected properties (Mine, Y. et al 1995) 
Protein %  protein in 
egg white 
Molecular Weight 
(kDa) 
pI Denaturation 
Temperature (°C) 
Ovalbumin 54 44.5 4.5 84.0 
Ovotransferrin 12 77.7 6.1 61.0 
Ovomucoid 11 28.0 4.1 77.0 
Ovomucin 3.5 5.5-8.8×103 4.5-5.0 Unknown 
Lysozyme 3.4 14.3 10.7 75.0 
 
Ovalbumin 
  The most abundant and central protein to egg white’s functional properties in 
foods is ovalbumin.  Ovalbumin has a molecular weight of 44.5 kDa and is a monomeric 
phosphoglycoprotein with a known complete amino acid sequence of 385 residues (see 
appendix) (Doi, E. et al 1997).  It is a storage protein and major source of amino acids for 
the developing embryo (Mine, Y. et al 2008).  The N-terminus of ovalbumin is acetylated 
and contains four sulfhydryl groups and one disulfide bridge (Cys74-Cys121), which are 
inaccessible in the native state (Doi, E. et al 1997; Iametti, S. et al 1998).  Although it is a 
secretion protein, ovalbumin is lacking an N-terminal leader sequence.  Trans-membrane 
location is instead mediated by an internal sequence signal located within hydrophobic 
residues 21-47 (Huntington J. A. et al 2001; Uniprot.org, 2010).  Ovalbumin secondary 
structure has various motifs including α-helix (41%), β-sheet (34%), β-turns (12%), and 
random coils (13%) (Ngarize, S. et al 2004a).  The 3-D structure of ovalbumin is highly 
structured and has an α-helical reactive loop coming out of the main body of the protein 
on two peptide stocks and a main β-sheet A (Figure 1).  The conserved reaction center is 
located at Ala358-Ser359 (Stein, P.E. et al 1990). 
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Figure 1: The 3-D crystal structure of ovalbumin with the α-helix reaction loop in yellow 
and main β-sheet A in red (Huntington, J. A. et al 2001). 
  
Ovalbumin is a heterogeneous molecule with variation in its composition, which 
includes the degree of phosphorylation, glycosylation, and genetic variance.  Two 
possible glycosylation sites have been identified at residues Asn 293-295 (Asn-X-Thr) 
and Asn 317-319 (Asn-X-Ser).  The heterogeneous carbohydrate peptide chains contain a 
common core of mannose β (1-4) glcNAc β (1-4) glcNAc (Huntington, J. A. et al 2001).  
Purified ovalbumin contains three types, A1, A2, and A3 in a ratio of 85:12:3.  These types 
are differentiated by the degree of phosphorylation with two, one and zero 
phosphorylated sites respectively (Doi, E. et al 1997).  The phosphorylation sites are 
located at serine residues 69 and 345.  It is thought that the glutamic acids two residues 
C-terminal to the serine phosphorylation sites play a role in recognition for a protein 
kinase (Huntington, J. A. et al 2001).  The degree of phosphorylation is most likely 
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responsible for the multiple spots observed in 2-D electrophoresis analysis of ovalbumin 
(Guerin-Dubiard, C. et al 2006).  Genetic variance includes polymorphism substitutions 
at residue 290, Glu→Gln, and residue 312, Asn→Asp (Huntington, J. A. et al 2001).  
Ovalbumin also has X and Y genes with the Y-polymorphism occurring due to 
“alternative splicing processing leading to casual exon skipping events” (Guerin-Dubiard, 
C. et al 2006).  
      S-ovalbumin is found naturally in egg white and contributes to ovalbumin 
heterogeneity.  It is an alternative form of ovalbumin with greater heat stability and is 
known as “stable” ovalbumin.  The presence of S-ovalbumin is confirmed by the 
difference in denaturation temperature at 92.5°C compared to 84.5°C for ovalbumin.  
Other properties of S-ovalbumin such as molecular weight, sulfhydryl content, crystal 
formation, and electrophoretic separation are indistinguishable from ovalbumin.  
However, a slightly more compact structure has been observed by Raman difference 
spectroscopy (Doi, E. et al 1997).  The more compact structure may contribute to its heat 
stability.  S-ovalbumin has also been found to have increased surface hydrophobicity 
(Kilara, A. et al 1996).  The mechanism for conversion of ovalbumin to S-ovalbumin has 
not been confirmed but may be a result of deamidation or partial reactive loop insertion 
(Doi, E. et al 1997; Huntington, J. A. et al 2001).  S-ovalbumin content in egg white 
increases with age and can be as low as 5% in fresh egg to 81% after 6 months at 2°C 
(Kilara, A. et al 1996).  The crystal structure of S-ovalbumin has been determined 
(Yamasaki, M. et al 2003) and shows no difference in secondary structure with 
ovalbumin.  Some differences include a switch from the L to D isomers of Ser residues 
164, 236, and 320 along with a separation in a β-strand between residues 125-128.  These 
6 
 
differences decrease the solvent access to the protein core, contributing to increased 
stability. 
      The amino acid sequence and 3D structure of ovalbumin show similarities to a 
group of serine protease inhibitors known as serpins.  However, ovalbumin does not have 
inhibitory activity (Doi, E. et al 1997).  The crystal structure of ovalbumin has been used 
as a model for an un-cleaved reactive center of serpins (Stein, P. E. et al 1990).  The 
serpin family consists of over 300 different proteins, with most serving a simple function 
such as human plasma proteins that control coagulation (Huntington, J. A. et al 2001).  
Serpins share a highly ordered structure and a conserved reactive center (Stein, P. E. et al 
1990).  Like ovalbumin, the reactive center is protruded out of the main protein body on 
peptide “stalks”.  When a serpin comes in contact with a protease it activates by 
undergoing a conformational change where the reactive center loop is cleaved and 
inserted in β-sheet A.  This conversion is thermodynamically favorable and the resulting 
conformation is up to twice as stable as the native form (Huntington, J. A. et al 2001).  
The following figure illustrates a serpin protein in native and activated conformation 
(Figure 2). 
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Figure 2:  The crystal structures of native antithrombin (A) and activated antithrombin 
(B).  The reactive center loop is in yellow.  The reactive loop is inserted in β-sheet A 
shown in red Huntington, J. A. et al 2001). 
 
      Ovalbumin does not undergo this conformational change upon cleavage of its 
reactive loop which is the primary explanation why ovalbumin is not inhibitory.  The 
conformational change is dependent on the successful insertion of the reactive loop hinge 
region, labeled P15-P8 (ovalbumin sequence 338-346).  This involves alternating side 
chains of the hinge region being buried in the hydrophobic core of the protein.  Serpins 
have a highly conserved hinge region, consisting of small hydrophobic and amphipathic 
amino acids.  P14 is the first amino acid inserted followed by P12 and are conserved as 
threonine (80%) and alanine (98%) in inhibitory serpins, respectively.  These small side 
chains are one driving force for the conformational change.  In contrast, ovalbumin has a 
bulky and charged arginine at P14 and valine at P12.  This is detrimental to loop insertion 
as it is thermodynamically unfavorable due to a loss of hinge flexibility.  The cleavage of 
the reactive loop in ovalbumin actually results in a loss of 1-2°C in stability.  However 
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this is only a partial reason for lack of inhibition, as switching P14 from threonine to 
arginine in an inhibitory serpin still results in loop insertion but with reduced inhibitory 
activity (Huntington, J. A. et al 2001; Stein, P. E. et al 1990). 
Ovotransferrin 
 Ovotransferrin is the second most abundant egg white protein, accounting for 
12% of protein in egg white.  It has a molecular weight of 77.7 kDa with a pI of 6.1 and 
is a glycoprotein consisting of 686 amino acid residues (Mine, Y. et al 1995).  
Ovotransferrin is a member of an iron binding protein group known as transferrins.  Its 
iron-binding activity, KD= 10-29M (Kilara, A. et al 1996), is thought to be responsible for 
the antimicrobial properties of the protein.  Up to 2 Fe+3 and CO3-2 ions can bind per 
molecule.  The 3D structure of ovotransferrin has been determined and consists of two 
homologous lobes (N-lobe and C-lobe) in which each lobe has two domains.  The iron-
binding sites are located between these domains and include Asp63, Tyr95, Tyr188, 
His249 and Asp392, Tyr426, Tyr517, His585 in the N and C lobe respectively 
(Nakamura, R. et al 2000).  The metal binding action helps to stabilize the protein raising 
the denaturation temperature from 61°C to around 72°C when iron is bound (Kilara, A. et 
al 1996).  Ovotransferrin contains 15 disulfide bridges with 6 in the N-lobe and 9 in the 
C-lobe (Nakamura, R. et al 2000).  The lone glycan chain is composed of mannose and 
N-acetyglucosamine and is located in the C-terminal lobe (Mine, Y. et al 1995). 
Ovomucoid 
 Ovomucoid is a glycoprotein with a molecular weight of 28.0 kDa and pI of 4.1.  
About 25% of the protein is carbohydrates that are attached via Asp residues.  There are 9 
disulfide bridges and no free sulfhydryl groups.  Ovomucoid is a well known trypsin 
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inhibitor (Mine, Y. et al 1995), with a 1:1 KD of 1.5 × 10-7 M (Kilara, A. et al 1996).  The 
3D structure has 3 domains which are cross-linked via disulfide bonds.  The domains are 
homologous to pancreatic secretory trypsin inhibitor.  The trypsin inhibitor reactive site is 
located in domain 2 (Arg89-Ala90).  Domain 1 and 2 each have N-terminal carbohydrate 
chains while domain 3 can be without a carbohydrate chain.  The chains consist of 
pentaantennary and tetraantennary complexes with mannose, galactose, and N-
acetylglucosamine.  Ovomucoid’s secondary structure includes 26% α-helix, 46% β-
sheet, 10% β-turns, and 18% random coils (Nakamura, R. et al 2000).  Ovomucoid is 
very stable due to its multiple disulfide bridges and is physicochemical unchanged under 
acidic conditions at 100°C for long periods of time (Kilara, A. et al 1996).  However with 
extreme heat, trypsin inhibitory activity and immunoreactivity with some antibodies is 
lost due to the reduction and alkylation of disulfide bonds (Nakamura, R. et al 2000).           
Ovomucin 
 Ovomucin is a viscous glycoprotein that composes 1.5-3.5% of protein in egg 
white.  Its molecular weight ranges between 5.5-8.8 × 103 kDa and a pI of 4-5.5 (Mine, 
Y. et al 1995).  Ovomucin is insoluble in water unless in the presence of salt or >pH 9 
(Nakamura, R. et al 2000).  It consists of a carbohydrate poor form, α-ovomucin, and 
carbohydrate rich form, β-ovomucin.   The two forms complex to form an insoluble thick 
egg white and a combination thick and thin egg white (Mine, Y. et al 1995).  Insoluble 
egg white or thick egg white has a ratio of 84:20 α/β forms while the soluble egg white or 
thin ratio is 40:3.  The carbohydrate content of α-ovomucin and β-ovomucin are ~15% 
and ~50%, respectively.  The carbohydrate chains are 15-18.6% hexose, 7-12% 
hexosamine, and 2.5-8% sialic acid (Nakamura, R. et al 2000).  Ovomucin is an inhibitor 
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of virus hemagglutination and is an important determinant for egg quality (Kilara, A. et al 
1996) as the thinning of egg white is thought to be caused by dissociation of α-ovomucin 
from insoluble ovomucin (Nakamura, R. et al 2000).     
Lysozyme 
 Lysozyme was the first protein to be sequenced and is one of the most studied egg 
white proteins.  It is a small protein, consisting of 129 amino acids with a molecular 
weight of 14.3 kDa and a pI of 10.7.  Lysozyme contains 4 disulfide bridges with no free 
sulfhydryl groups and its 3D structure has been determined (Lesnierowski, G. et al 2007).  
With a similar 3D structure and 40% sequence homology to the milk protein α-
lactalbumin, it is possible that lysozyme and α-lactalbumin evolved from a common 
protein (Nakamura, R. et al 2000).  Lysozyme contains two domains connected by a long 
α-helix.  The N-terminal domain is mostly made up of anti-parallel β-sheet with a few α-
helices, while the other domain is mostly α-helical (Lesnierowski, G. et al 2007). 
 Lysosymes are a group of enzymes with antimicrobial function by lysis of gram 
negative bacteria.  They are found in a wide range of organisms including bacteria, 
phages, vertebrates, and invertebrates. Type C is found in chicken egg white and is the 
most common form.  Lysis of gram negative bacteria occurs with the hydrolysis of the β 
(1-4) linkage between acetylglucosamine and N-acetylmuramic acid in the cell wall 
(Nakamura, R. et al 2000).  The helix-loop-helix motif located between lysozyme’s two 
domains (Asp87-Arg114) plays an important role in this function.  The reduction of more 
than 2 of the disulfide bonds results in a loss of bioactivity (Lesnierowski, G. et al 2007).  
However, reduction of disulfide linkages significantly improves functional properties 
including gelation and foaming (Doi, E. et al 1997).  Along with its role in interaction 
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with other proteins during foaming and gelation, lysozyme may play a role in the 
thinning of egg white during storage through electrostatic interactions with ovomucin 
(Mine, Y. et al 1995).      
High Pressure Processing 
 High Pressure Processing (HPP) provides an alternative, non-thermal method for 
food preservation.  HPP was first extensively used industrially by Japan in the 1990s 
(Rovere, P. 2001) and is currently used for products such as sauces, jams, jellies, fruit 
juices, guacamole, and oysters.  Advantages of HPP include the ability to process food at 
lower temperatures, reduce microorganisms, avoid use of chemical additives for 
preservation, and produce foods with new functional properties (Rastogi, N. K. et al 
2007; San Martin, M. F. et al 2002).  This is important to consumers as there is an 
increasing demand for products that are processed naturally, retain their nutritional value, 
and are shelf-stable and safe.  Pressure is also applied uniformly throughout the food 
matrix, which eliminates the problem of uneven treatment that can occur with thermal 
methods.  In contrast to HPP, thermal processing decreases the nutritional and sensory 
properties of food due to heat induced chemical reactions such as Maillard browning and 
irreversible protein denaturation (Ngarize, S. et al 2005; San Martin, M. F. et al 2002).  
As a result of its many applications and potential to produce novel food products, HPP 
has been subject of extensive research and review (Hendrickx, M. et al 2001).   
There are also some challenges that are present with HPP.  One challenge is heat 
transfer problems that may result in non-uniformity during processing.  This is related to 
the fact that as pressure is applied or a product is compressed the temperature is 
increased.  The temperature change is dependent on a number of factors including initial 
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temperature of the product, target pressure, heat transfer to surroundings, and product 
constituents.  Water content is of particular importance as there is a 3°C temperature 
increase in water for every 100 MPa of pressure.  This is also important for the pressure 
transmitting fluid which can transmit heat to the product under pressure.  Another 
challenge is the overall lack of knowledge of HPP effects on various food systems and 
reproducibility of data due to incomplete records of processing conditions (i.e location of 
thermocouple in pressure vessel to measure temp changes) (Rastogi, N. K. et al 2007).  
Another challenge to consider is the economics of HPP as it is more expensive than 
conventional thermal processing methods.  This is associated with the need to load and 
unload due to batch systems (time), cost of automation, and initial capital of HPP unit.  
Thus, HPP has become more commonly used for niche products (Van den Berg, R. W. et 
al 2001).        
 The two major HPP units for food applications are the batch system and flow 
through system.  The flow through system is semi-continuous, requiring the product to be 
pumped (fruit juices) and is pressurized using a floating piston.  Batch systems include 
three major components: the pressure vessel, surrounding yoke, and hydraulics.  Pressure 
is applied in the vessel via a medium fluid which is pressurized with hydraulic pumps.  
The medium fluid usually consists of a water/soluble oil mixture (Van den Berg, R.W. et 
al 2001).  Batch systems also require the product to be pre-packaged in a flexible pouch 
or tube before processing (Tewari, G. 2007).  Depending on the HP unit, pressure is 
generated using either internal or external compression.  With internal compression, the 
volume of the treatment vessel is reduced by the action of hydraulic pressure from a 
piston.  The more common external compression is achieved by pumping the 
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pressurization medium into the chamber with high pressure pumps to reach the desired 
pressure (Martin San, M. F. et al 2002).   
 The structure of most food is undamaged during HPP due to isostatic pressing.  
The external pressure on the food is equal to the internal pressure when immersed in the 
pressure-transmitting medium so the product retains its original geometry.  However, 
HPP has a significant effect on functionality and the rheological properties of a product.  
HPP effects on macromolecules such as proteins, carbohydrates, and lipids are 
responsible for most of these changes as molecular interactions are affected.  Unlike 
thermal treatments, HPP does not affect covalent bonds such as cross linkages within 
macromolecules. The one exception is disulfide bonds in proteins.  In starches, pressure 
generally raises the gelatinization temperature while increasing amylase digestibility.  
HPP ultimately destroys the granular structure of starches via hydration of the amorphous 
phase and distortion of the crystalline region.  Similar to proteins, some carbohydrates 
form gels with HP treatment (Heremans, K. 2001).  HP treatment tends to increase 
peroxide values of lipids resulting from oxidation.  Para-anisidine values are also 
increased, resulting in more secondary oxidation products (Ludikhuyze, L. et al 2001).     
 HPP significantly affects secondary, tertiary, and quaternary structure of proteins.  
Changes in tertiary structure are particularly important to protein functionality (Tewari, 
G. 2007).  The structural changes are due to the breakage of non-covalent interactions 
such as hydrogen bonds, hydrophobic interactions, and ion-pair bonds.  Reformation of 
intra and inter molecular bonds results in changes in protein structure.  HPP has also been 
shown to decrease protein surface hydrophobicity while increasing solubility of casein 
proteins (Rastogi, N. K. et al 2007). The level of denaturation is dependent on a number 
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of factors including type of protein, concentration, pH, and ionic strength.  The kinetic 
relationship of protein denaturation as a function of temperature and pressure has been 
studied (Suzuki, K. 1960).  This relationship is given in the figure below (Figure 3).  The 
elliptical nature of the phase diagram indicates that at lower pressures the denaturation 
temperature of proteins increases while at higher pressures the denaturation temperature 
decreases.  Pressure denaturation is also slower at low temperatures.   
 
 
Figure 3: General schematic for the relationship of temperature and pressure to protein 
denaturation adapted from previous literature (Heremans, K. 2001). 
 
 The nature of HP-induced protein unfolding and denaturation is not fully 
understood.  It has been proposed that HP protein unfolding is a multiple step process 
involving partially unfolded states that are reversible.  As pressure is applied, 
intermediates are formed and play an important role in aggregation upon 
depressurization.  The pressure induced conformations are more susceptible to 
aggregation as hydrogen bonds can form at lower temperatures under pressure 
(Heremans, K. 2001).  Protein denaturation is generally reversible at lower pressures 
between 100-300 MPa, while at higher pressures denaturation is irreversible (Rastogi, N. 
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K. et al 2007).  Pressure denaturation is also less extensive than thermal denaturation as 
hydrogen bonds stabilize an irreversible intermolecular network of the heat unfolded 
proteins (Heremans, K. 2001).  
 HPP is also a potential tool to enhance food safety while decreasing the use of 
preservatives and limiting detrimental effects on functional and nutritional value.  There 
are many factors that contribute to variability in resistance of a microorganism to HPP.  
Some of these factors include the food system/medium, Gram +/-, and life cycle of the 
bacteria cell.  In general, Gram positive bacteria are more resistant to HPP than Gram 
negative bacteria.  Vegetative microorganisms in the growth phase are also more 
susceptible to HPP.  Application of pressure in cycles has also been found to increase 
inactivation of microorganisms (Ponce, E. et al 1998a).  HPP microbial reduction is 
normally caused by rupture of bacteria cell membranes (Ponce, E. et al 1998b).  Although 
HPP is effective in reduction of many microorganisms, spores are resistant up to 1200 
MPa (San Martin, M. F. et al 2002).  There are several studies involving the effects of 
HPP on food pathogens in whole liquid egg (Ponce, E. et al 1998a; Ponce, E. et al 1998b, 
Ponce, E. et al 1999). 
 Egg pasteurization (60°C, 3.5 min) was designed to kill the most prevalent food 
pathogen in eggs and egg products, Salmonella enteritidis.  S. enteritidis is of importance 
to food safety as it can cause severe gastroenteritis and is more heat resistant than other 
strains of Salmonella.  The potential for HPP to supplement current thermal treatments of 
whole liquid for microbial inactivation of S. enteritidis has been investigated (Ponce, E et 
al 1999).  S. enteritidis inoculated (107-108 CFU/mL) in whole liquid egg white was 
effectively destroyed via HPP.  An 8 log reduction was achieved at 20°C at 450MPa/10 
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min with 5 minute cycles.  Normally commercial eggs normally contain less than 10 S. 
enteritidis cells/egg.  Thus, HPP in conjunction with mild heat treatment, is effective in 
destruction of S. enteritidis (Ponce, E. et al 1999)     
 Ponce, E. et al (1998a) investigated the effect of HPP on Listeria innocua as a 
model for L. monocytogenes, an important food pathogen.  Liquid whole egg was 
inoculated with 106 CFU/mL and subjected to various levels of pressure and temperature.  
L. innocua was not fully inactivated by any of the treatments with the most effective 
treatment being over a 5 log reduction at 20°C at 450MPa/15 min with 5 minute cycles.  
Increasing pressure and time resulted in increased microbial inactivation.  Temperature 
also played a large role as lower temperatures were more effective in L. innocua 
inactivation at lower pressures.  In conclusion, HPP should be effective for levels (1 
CFU/ml) of L. monocytogenes found in commercial eggs (Ponce, E. et al 1998a).   
Another common food pathogen studied with HPP in whole liquid egg is 
Escherichia coli (Ponce, E. et al 1998b).  Whole liquid egg was inoculated with 106-107 
E. coli 405 and subjected to HPP at various temperatures.  Pressure was the most 
important factor in inactivation followed by temperature and time.  As pressure and time 
were increased, inactivation of E. coli was also increased.  E. coli reduction was optimal 
at 50°C with 5 min cycles at 400MPa/15min and 450 MPa/10min with a 7 log reduction.     
Raman Spectroscopy 
Raman spectroscopy is a method that can offer structural information of egg white 
proteins before and after HP or heat treatment.  The basis of Raman spectroscopy is the 
excitation of the ground electronic state of a molecule and the resulting vibrational 
transitions.  The excitation and higher energy state is achieved by directing a 
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monochromatic laser or infrared light beam at a sample.  As the molecule transitions back 
to a lower energy level a photon is scattered.  The difference in frequency between the 
photon and the light source can be detected and is known as the Raman shift.  The 
intensity of scattered light is plotted as a function of the change in wavenumber shift, 
giving the Raman spectrum.  Changes in the Raman shift of peaks (vibrational 
frequencies) and their intensities correspond to changes in protein chemical structures 
and functional groups (Herrero, A. 2008).  This provides information on the changes in 
secondary structure of food systems.  Secondary structure of proteins has various motifs 
including α-helix, β-sheet, turns, and random coils.   
Due to the fact Raman spectroscopy gives a very weak scattering signal of water, 
it is advantageous in the study of food proteins.  This is important as many common food 
matrices contain more than 75% water (Beattie, R. et al 2004).  Recently, vibrational 
spectroscopy has been used to analyze various food proteins including milk, beef, and 
fish (Li-Chan E. et al 2007; Beattie, R. et al 2004; Badii, F. et al 2006).  Studies have also 
focused on the effects of HP and heat treatment on egg white proteins like ovalbumin.  In 
HP and heat treated egg white albumen, changes in the amide III region indicate change 
in β-sheet structure with less β-sheet formation in HP samples (Ngarize, S. et al 2004b).  
There is also less of an effect on disulfide bonds using HP (400-600 MPa) when 
compared to heat (Ngarize, S. et al 2005).  Other studies show that heating pure 
ovalbumin resulted in an increase of β-sheet with a loss of α-helix secondary structure.  
HP samples doubled the amount of β-turns, leaving the β-sheet/α-helix ratio relatively the 
same.  Denaturation of ovalbumin was also shown to be less extensive at 600 MPa for 20 
minutes compared to heat at 90°C for 30 minutes (Ngarize, S. et al 2004a).  Irreversible 
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changes in the secondary structure of ovalbumin have also been reported at pressures 
over 400 MPa with a reduction in α-helix content and increase in β-sheet using circular 
dichroism and Fourier transform infrared spectroscopy (Smith, D. et al 2000).  Another 
study using CD-spectroscopy showed that additions of NaCl to ovalbumin solutions 
reduced the loss of secondary structure (Iametti, S. et al 1998).      
Protein Digestibility 
Protein digestion in-vivo involves the secretion of several digestive enzymes.  
When protein is ingested, hydrochloric acid is secreted in the stomach, followed by the 
release of the first major digestive enzyme, pepsin.  Pepsin preferentially cleaves at 
hydrophobic amino acid residues Phe, Tyr, Trp and Leu and is most active below pH 2.  
Hormones promote secretion of sodium bicarbonate into the small intestine, raising the 
pH to 8.  The proteolytic enzyme trypsin (active at pH 8) is released and cleaves on the 
carboxyl side of Lys and Arg, except when followed by Pro.  Trypsin facilitates the 
release of another major digestive enzyme, chymotrypsin, which cleaves on the carboxyl 
side of Tyr, Try, and Phe.  Both trypsin and chymotrypsin cleave proteins with much 
greater specificity than pepsin.  Other digestive enzymes include procarboxypeptidases 
and proelastase (Lehninger, A. et al 2005). 
 The in-vitro enzymatic digestion of egg white proteins has been subject to 
previous investigations.  Mine Y. et al (2004) investigated the enzymatic digestion of egg 
white lysozyme.  Egg white lysozyme hydrolysate was digested first by pepsin then 
trypsin.  This approach was taken as lysozyme is generally resistant to trypsin alone but 
not to pepsin.  It was found that pre-digestion by pepsin significantly increased hydrolysis 
by trypsin.  There was no significant difference between digests of native and heat-
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denatured lysozyme using a combination of pepsin and trypsin when analyzed with SDS-
PAGE.  Another group studied pepsin digestion of egg white ovomucoid (Kovacs-Nolan 
J. et al 2000).  Large fragments of ovomucoid were found after 6 hours of peptic 
digestion.  Unlike lysozyme, ovomucoid retained its resistance to trypsin after peptic 
digestion at enzyme to protein ratios of 1:20 and 1:200 (pH 2).   
In-vitro digestion of ovalbumin that is similar to physiological conditions has also 
been investigated (Martos, G. et al 2010).  At pH of 2 or above ovalbumin is very 
resistant to pepsin digestion at a 1:20 (enzyme: protein) ratio.  However, the presence of 
bile salts increases digestibility.  The most effective peptic digestion was achieved at pH 
1.2 with a 3:1 (enzyme: protein) ratio.  The study also indicated that pH, not enzyme 
ratio, is the more important factor in the peptic digestion of ovalbumin.  HP-treatment on 
10% egg white solutions has been shown to increase hydrolysis by trypsin (Iametti, S. et 
al 1999).  Hydrolysis by α-chymotrypsin also increases with HP-treatment (Van der 
Plancken, I. et al 2004).  Quiros and others (2007) added pepsin, trypsin, and 
chymotrypsin before HP-treatment on ovalbumin and found that this combination 
facilitated the release of peptides and increased ovalbumin susceptibility to enzymatic 
attack. 
Egg white is an important source of dietary protein.  This is primarily due to the 
high bioavailability of egg white protein and high content of essential amino acids.  Two 
major factors affect the digestibility of egg white protein; digestive health and the 
components in food.  The bioavailability of egg protein increases from 65% in raw egg to 
95% in cooked egg protein (Seuss-Baum, I. 2007).  Pressure induced egg white gels are 
more digestible than boiled egg white.  HPP treatment also does not destroy vitamins or 
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amino acids (Hayashi, et al 1989).  This indicates a greater bioavailability of protein and 
vitamins leading to increased nutritional value.   Another aspect of nutrition to consider is 
the initiation of harmful chemical reactions that can occur during processing.  Heat 
treated egg white produced lysinoalanine, an amino acid known to be a renal toxic factor 
in rats (Sternberg, M. et al 1975), while this compound was not detected in HP induced-
gels (Hayashi, et al 1989).  In addition to simple nutrition, processing can also facilitate 
the release of bioactive peptides (Kovacs-Nolan, J. et al 2005).  Bioactive peptides 
isolated from egg white protein sources and their potential health benefits are discussed 
in a later section. 
Allergenicity 
An allergy is an immune initiated response mediated by immunoglobulin (Ig) E, 
causing a state of hypersensitivity (Kovacs-Nolan, J. et al 2000).  An allergenic reaction 
is caused by specific food proteins with the ability to cross the intestinal barrier and 
causing an immune response.  This involves binding of allergenic epitopes to IgE 
antibodies, releasing histamine receptors that trigger an inflammatory immune response 
or allergic reaction.  The most common food allergies are IgE mediated (Mine, Y. et al 
2008).  The eight major food allergens include milk, eggs, fish, crustacean shellfish, tree 
nuts, peanuts, wheat, and soybean (FDA.gov, 2010).  Common characteristics of food 
allergens include water solubility, heat and acid stability, and resistance to proteolytic 
digestion (Mine, Y. et al 2002).  Food allergens must also be able to cross the intestinal 
barrier and still be large enough to bridge to IgE receptors on mast cells (Kovacs-Nolan, 
J. et al 2000; Mine, Y. et al 2008).     
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Allergenic reactions to eggs are mostly associated with egg white proteins.  
Common egg allergenic proteins include ovomucoid, ovalbumin, lysozyme, and 
ovotransferrin.  Ovomucoid is considered the most dominant egg allergen (Mine, Y. et al 
2006).  Ovalbumin has many of the properties of an allergenic protein as it is resistant to 
enzymatic digestion, is water soluble, and is stable during processing (Mine, Y. et al 
2002).  The most common allergenic reaction to ovalbumin is a type 1 reaction involving 
IgE-binding to anti-ovalbumin antibodies of a patient sera.  Most ovalbumin allergenic 
epitopes are 6-12 amino acids in length and recognition by anti-ovalbumin antibodies is 
sequential (Mine, Y. et al 2006).  Ovalbumin allergenic epitopes are mostly composed of 
hydrophobic amino acids located within β-sheet and β-turn secondary structures.  One 
major epitope is composed of a single α-helix (Mine, Y. et al 2003).   
      Processing conditions may also have an effect on the potential allergenicity of 
ovalbumin.  Lopez-Exposito, I. et al (2008) studied the effects of HP at 400MPa with 
pepsin on the proteolysis profile of ovalbumin and its effects on IgG and IgE binding.  
Their results show an increase in proteolysis and less reactivity to IgG and IgE binding, 
suggesting a possible reduction in allergenicity of ovalbumin due to HP treatment.  Other 
groups have found that heat also decreases enzymatic resistance of ovalbumin, but IgE 
binding was still present in soft and hard boiled eggs (Mine, Y. et al 2008).  Kovacs-
Nolan, J. et al (2000) also reported a reduction in IgE binding enzyme digested fragments 
of another egg white protein, ovomucoid.  Irreversible changes in the secondary structure 
of ovalbumin have also been reported at pressures over 400 MPa with a reduction in α-
helix content and increase in β-sheet using CD and FTIR spectroscopy (Smith, D. et al 
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2000).  The loss of secondary structure may have an effect on ovalbumin allergenicity 
based on the structural location of sequential epitopes. 
 Various forms of processing have the potential to alter or reduce egg white 
allergenicity as discussed earlier.  These methods include heat treatment, enzymatic 
fragmentation, and non-thermal techniques like HPP.  Since most food allergenic 
epitopes are thought to be sequential, these processes are aimed at breaking apart epitopes 
and reducing allergenicity by increasing protein digestibility (Mine, Y. et al 2008).  
Potential reduction of food allergens are mostly reported based on the reduction of IgE 
and IgG binding response to specific epitopes (Lopez-Exposito, et al 2008; Kovacs-
Nolan, J. et al 2000), which is necessary to produce an allergic reaction.  The goal of 
industry is to use these food processing techniques to produce hypoallergenic products.  
However, the most prevalent way to avoid egg allergy is by strict avoidance of egg 
containing products (Mine, Y. et al 2008).   
Bioactive Peptides 
      Bioactive peptide sequences are embedded within a protein and become active 
when released.  In foods they are usually released via enzymatic hydrolysis and may have 
an influence on health.  Bioactive peptides can also be released by proteolytic 
microorganisms and plant proteolytic enzymes (Korhonen, H. et al 2006; Minkiewicz, P. 
et al 2008).  In addition, protein denaturation by food processing like thermal or HPP can 
facilitate the release of bioactive peptides.  A large range of bioactive peptides have been 
isolated from food sources including opioid, immunodulatory, antimicrobial, mineral 
binding, growth and muscle stimulating, protease, antioxidant, and angiotensin-
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converting enzyme ACE inhibitor peptides (Korhonen, H. et al 2006; Murray, B. A. et al 
2007). 
 By far, milk is the most important and widely studied food system associated with 
bioactive peptides.  Many bioactive peptides have been discovered and identified in milk 
with a wide range of functionality (Figure 4).  The two primary methods for production 
of these include enzymatic hydrolysis and fermentation by lactic acid bacteria (LAB).  
Proteolytic enzymes have also been isolated from LAB for use in production of milk-
derived bioactive peptides.  As a result of LAB use in fermented dairy products, there is 
potential for increased concentration and possible health benefits.  In fact, bioactive 
peptides have been isolated from finished fermented dairy products such as cheese, 
yogurt, and fermented milks.   
 
 
Figure 4: Milk-derived bioactive peptide functions (adapted from: Korhonen, H. et al 
2006)  
 
24 
 
 Bioactive peptides must also be able to exert a physiological effect once 
consumed.  For example, milk-derived bioactive peptides shown to have potent ACE-
inhibitory activity in vitro failed to have any significant ACE inhibition in rats (Fuglsang, 
A. D. et al 2003).  One conclusion made was in order for a peptide to be physiologically 
active it must remain intact during digestion and be absorbed into the blood stream 
(Korhonen, H. et al 2006).  The most well-known ACE-inhibitory milk peptides include 
tripeptides, VPP and IPP with IC50 values of 9.13 ± 0.21 and 5.15 ± 0.17 µM, 
respectively (Pan, D. et al 2004).  IPP and VPP have been isolated via enzymatic 
digestion of β-casein (Shahidi, F. et al 2008).  In human studies, IPP and VPP, 
administered in sour milk (2.6 mg peptide/day) to hypertensive individuals resulted in a 
reduction of blood pressure (Hata, Y. et al 1996).  Other ACE-inhibitory milk peptides 
have shown in-vivo activity in humans and rats and have been subject to extensive review 
(Korhonen, H. et al 2006, Shahidi, F. et al 2008).  The investigations of bioactive peptide 
production from milk and the demonstrated health benefits have resulted in research in 
other food systems, including egg.             
Many bioactive peptides derived from egg white proteins via enzymatic 
hydrolysis have been identified.  These peptides mostly have ACE-inhibitory and 
antihypertensive effects.  Novel antihypertensive peptides derived from egg white 
proteins have been shown to have blood pressure lowering effects on spontaneously 
hypertensive rats (SHR) (Miguel, M. et al 2007a).  Enzymatic hydrolysis of ovalbumin 
has been shown to release ACE-inhibitory peptides (Quiros, A. et al 2007; Miguel M. et 
al 2006a; Miguel M. et al 2007b).  One study isolated ovokinin (FRADHPFL) and 
ovokinin 2-7 (RADHPF) from ovalbumin, in which both showed antihypertensive effects 
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on SHR rats (Miguel, M. et al 2006b).  A recent study isolated an ACE inhibitor peptide 
(RVPSL) from egg white protein ovotransferrin (Liu, J. et al 2010).  Antimicrobial 
peptides (IVSDGDGMNAW and HGLDNNYR) have been isolated from egg white 
lysozyme hydrolysate via hydrolysis by pepsin and trypsin.  These water soluble peptides 
exhibited bacteriostatic activity against E. Coli K-12 and S. aureus, respectively.  
Incubation with target bacteria of each peptide at a concentration of 400 µg/mL resulted 
in damage to cell membranes through direct interaction (Mine, Y. et al 2004).  Table 2 
summarizes some of the bioactive peptides isolated from egg proteins.  
Table 2:  Bioactive peptides isolated from egg proteins with antihypertensive activity 
(Miguel, M. et al 2006b) 
Sequence  Origin  Enzyme Bioactivity 
FRADHPFL Ovalbumin Pepsin Vasorelaxing/Antihypertensive 
RADHPF Ovalbumin Chymotrypsin Vasorelaxing/Antihypertensive 
RADHPFL Egg white Pepsin ACE-inhibitor/Antihypertensive 
YAEERYPIL Egg white Pepsin ACE-inhibitor/Antihypertensive 
IVF Ovalbumin Pepsin ACE-inhibitor 
FGRCVSP Ovalbumin Pepsin ACE-inhibitor 
ERKIKVYL Ovalbumin Pepsin ACE-inhibitor 
FFGRCVSP Ovalbumin Pepsin ACE-inhibitor 
LW Ovalbumin Pepsin ACE-inhibitor/Antihypertensive 
FCF Ovalbumin Pepsin ACE-inhibitor 
NIFYCP Ovalbumin Pepsin ACE-inhibitor 
RADHP Egg white Pepsin/Corolase PP ACE-inhibitor/Antihypertensive 
Oligopeptides  Egg yolk Several enzymes ACE-inhibitor/Antihypertensive 
 
      The effectiveness of a compound to inhibit a biological activity is measured by 
the half maximal inhibitory concentration (IC50).  This concentration corresponds to the 
amount of compound needed to inhibit a particular biological function by 50%.  The most 
effective ACE-inhibitor peptides corresponded to the sequences FFGRCVSP, 
ERKIKVYL, and FRADHPFL with IC50 values of 0.4, 1.2, and 3.2 µM respectively 
(Miguel, M. et al 2006a; Fujita, H. et al 2000).  The peptide with the sequence 
FRADHPFL, known as ovokinin, has been found to exert vasorelaxing effects in canine 
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mesenteric arteries and lower systolic blood pressure in SHR rats.  Hydrolysis of 
ovokinin results in the formation of peptides with the sequences of RADHPF and 
RADHP.  These peptides are much weaker ACE-inhibitors with IC50 values of 514 and 
257 µM respectively.  In addition to ACE-inhibitory properties, the sequences 
YAEERYPIL and FRADHPFL exhibit radical scavenging activity with an oxygen radical 
absorbance capacity fluorescein assay (ORAC-FL) value of 3.8 and 0.128 µmol of 
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) equivalent/µmol of 
peptide (Miguel, M. et al 2006a).  Table 3 on the next page gives each peptide and their 
ACE-inhibitory IC50 value.   
Table 3: Bioactive peptides derived from egg white with ACE-inhibitory IC50 values 
(Miguel, M. et al 2006a; Miguel, M. et al 2007a; Fujita, H. et al 2000; Liu, J. et al 2010) 
Peptide Sequence IC50 (µM) Residue Sequence in Ovalbumin 
FRADHPFL 3.2 358-365 
RADHPF 514 359-364 
RADHPFL 6.2 359-365 
YAEERYPIL 4.7 107-115 
IVF 33.1 178-180 
FGRCVSP 6.2 379-385 
ERKIKVYL 1.2 274-282 
FFGRCVSP 0.4 378-385 
LW 6.8 183, 184 
FCF 11 10-12 
NIFYCP 15 26-31 
RADHP 257 359-363      
  Residue Sequence in Ovotransferrin 
RVPSL 20 328-332 
 
      ExPASy Peptide Cutter was used to project theoretical peptides derived from 
ovalbumin using pepsin at pH 1.3.  The full ovalbumin sequence given shows the 
cleavage sites predicted by Peptide Cutter (Figure 5).  A table with a list of the sequences 
and pepsin cleavage sites is given in the appendix. 
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1   MGSIGAASME|F|C|F|DV|F|KE|LK VHHANENI|F|Y CPIAIMSA|L|A MV|Y|L|GAKDST RTQINKVVRF| 
61  DKL|PGF|GDSI EAQCGTSVNV HSSL|RDIL|NQ ITKPNDV|Y|S|F| S|L|ASRL|YAEE RY|PIL|PEY|L|Q 
121 CVKE|LY|RGGL EPIN|F|QTAAD QARE|LINS|W|V ESQTNGIIRN VLQPSSVDSQ TAMV|L|VNAIV| 
181 F|KG|LW|EKT|FK DEDTQAMP|FR VTEQESKPVQ MM|Y|QIG|L|F|RV ASMASEKMKI|LEL|P|FASGTM 
241 SM|L|V|LL|PDEV SG|L|EQ|L|ESII N|F|EK|L|TE|W|TS SNVMEERKIK V|YL|PRMKMEEK|Y|NL|TSV|L|MA 
301 MGITDV|F|SSS AN|L|SGISSAE S|L|KISQAVHA AHAEINEAGR EVVGSAEAGV DAASVSEE|F|R 
361 ADHP|FL|F|CIK HIATNAV|L|F|F| GRCVSP 
 
Figure 5: Ovalbumin sequence (NCBI Reference Sequence NP_990483.1, 2010) with 
cleavage site predicted by ExPASy Peptide Cutter with pepsin at pH 1.3.  Cleavage sites 
are represented by single vertical lines.  The highlighted sequences are those that have 
already been identified. 
 
 Other potential bioactive peptides in egg white proteins have been identified via 
sequence alignment.  Milk-derived ACE inhibitor IPP is embedded in α-ovomucin (1365-
1367) and ovotransferrin (527-529).  Milk-derived ACE inhibitor VPP is also sequenced 
in α and β subunits of ovomucin (α-1647-1649, β-765-766).  ACE inhibitory peptide YP, 
derived from whey protein, is found in the sequence of ovalbumin (112-113) and 
ovomucoid (163-164). 
Egg White Functional Properties  
Gelation 
  Gelation in egg white protein begins with the native proteins being unfolded or 
denatured.  Spherical aggregates form due to hydrophobic interactions, making the 
solution turbid.  The aggregates thicken by stabilization via sulfhydryl-disulfide reactions 
(ovalbumin). This is followed by coagulation and gelation as a result of the rapid re-
formation of hydrogen bonds (Mine, Y. et al 1995).  Ovotransferrin also plays an 
important role in gelation as it is the first egg white protein to thermally denature and 
initiate coagulation (Croguennec, T. et al 2002).  The formation of egg white gels can be 
induced by either heat, HP treatment, or under acidic conditions. 
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Egg white protein gelation is influenced by multiple factors including 
temperature, pressure, pH, and salt concentration (ionic strength).  Various forms of egg 
gels can form under thermal denaturation depending on the pH and ionic strength.  When 
the pH is near the pI of the proteins in solution (most egg white proteins are the pI ranges 
from 4-5) or the ionic strength is high denatured proteins aggregate randomly via 
hydrophobic interactions (Nakamura, R. et al 2000).  As the pH nears the pI of the 
proteins the net charge on the proteins is reduced resulting in an increase in hydrophobic 
interactions, followed by aggregation.  An increase in salt concentration, independent of 
pH, also decreases repulsive forces between proteins as negative charges are shielded by 
Na+2 ions leading to increased hydrophobic protein-protein interactions (Croguennec, T. 
et al 2002).  These conditions produce an opaque and turbid gel (Nakamura, R. et al 
2000) as the aggregates tend to be coarse and large (Croguennec, T. et al 2002).  Thus, 
the gel network is “loose” as it is composed of large aggregates bound together via 
hydrogen bonds and disulfide interactions, reducing water holding capacity (WHC) 
(Barbut, S. 1996).  One study (Croguennec, T. et al 2002) reported a >15% weight loss of 
a heat-induced egg white gel formed at pH 5 due to syneresis.  Protein gels heated above 
80°C are also more prone to syneresis and shrinkage (Nakamura, R. et al 2000). 
  In contrast, when the pH is further from the pI (above or below) or there is low 
ionic strength the denatured proteins tend to aggregate in an ordered linear manner 
forming a more transparent gel.  This is due to a decrease in electrostatic interaction at 
lower ionic strength (Nakamura, R. et al 2000).    The aggregates are also smaller, 
forming a tighter gel network with increased WHC (Barbut, S. 1996).  Croguennec, T. et 
al (2002) indicated that pH was the most important factor for the viscoelastic properties 
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of egg gels.  Their group found that the natural rise in pH of egg during storage resulted 
in gels with increased elasticity, penetration force, and viscosity index.  This increase in 
gel strength may be due to increased disulfide exchange after gel formation.  Lowering 
the pH resulted in weaker gels.  NaCl was also found to increase gel strength at pH 5, but 
had little effect at pH 7 and 9 (Croguennec, T. et al 2002).  One study involving the 
production of Chinese thousand year old eggs showed that the formation and properties 
of egg gels are also highly dependent on pH and salt concentration (Eiser, E. et al 2009).  
Another factor that influences egg white gel formation is protein concentration as this 
affects the formation of insoluble aggregates (Iametti, S. et al 1998).  At low 
concentrations a more translucent gel is formed while higher concentrations produce 
more opaque, turbid gels (Doi, E, et al 1997).  A summary of gel properties with under 
various conditions is illustrated in the Figure 6.    
   
 
Figure 6: Illustration of gel properties due to changes in pH and ionic strength 
(Doi, E, et al 1997). 
 
Another method to produce food gels is under cold acidic conditions.  This is a 2 
step process in which the proteins are first denatured thermally at neutral pH and low 
ionic strength forming soluble aggregates in solution.  Gelation is then induced by 
lowering the pH to the isoelectric point of the proteins, reducing electrostatic interactions 
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and increasing aggregation/gelation (Weijers, M. et al 2006).  Weijers, M. et al (2006) 
investigated the production of transparent egg white gels using egg white powder.  
Removal of ovotransferrin was required to induce transparent gel formation as it 
interferes with fibril/ordered formation of transparent gel networks.  This was explained 
by disulfide interactions between ovotransferrin and ovalbumin resulting in clusters of 
aggregates and hindering linear gel formation (Weijers, M. et al 2006).  This also 
explains why egg white usually forms opaque gels (Nakamura, R. et al 2000).  During 
acid-induced gel formation, fewer disulfide bonds are formed between protein molecules.  
The disulfide bonds are instead formed after the gel is cold-set (Weijers, M. et al 2006).  
This supports the conclusion found by Broersenn, K. et al (2006) that disulfide 
interactions are not the driving force of ovalbumin aggregation, but rather stabilize the 
gel network after it is formed.   
The coagulation of egg white by pressure was first observed by Bridgman (1914).  
Both heat and HP treatments on ovalbumin have been shown to expose hidden –SH 
groups via the Ellman’s reagent method (5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB)).  
These exposed groups stabilize protein aggregates, which lead to gelation (Van der 
Planken, I. et al 2005b, 2007b).  Ngarize and others (2005) reported that pressure induced 
gels were more glossy and smooth in appearance than heat treated gels.  HP-induced egg 
white gels are generally softer and more elastic than heat induced ones (Hayashi, R. et al 
1989; Ngarize, S. et al 2005).  HP gels were rubbery compared to heat treated gels, which 
were more hard and brittle.  These results were based on egg white treated between 400-
600 MPa and heat induced gels formed via 90°C for 30 min.  Gel strength values were 
comparable to heat induced gels at pressures over 650 MPa.  Egg white showed no 
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gelation at pressures of 500 MPa for 20 min (Ngarize, S. et al 2005).  Prevention of gel 
formation due to HP (800 MPa, 10 min) has been accomplished by adding NaCl or 
sucrose to 10% egg white solutions prior to HP treatment (Iametti, S. et al 1999).  The 
taste and flavor of HPP egg white gels is natural and uncooked (Hayashi, R. et al 1989).    
Foaming 
The major egg white proteins that are important to foaming are ovalbumin, 
ovomucin, ovotransferrin, lysozyme, and globulin proteins (Mine, Y. et al 1995).  
Ovalbumin plays a central role in egg white foaming abilities. When whipped, ovalbumin 
molecules are adsorbed in the air/water interface and the hydrophobic areas of the protein 
are oriented towards the gas phase of the interface.  The conformational changes in 
structure expose buried sulfhydryl groups which then become oxidized.  This results in 
the formation of disulfide bridges with adjacent ovalbumin molecules.  Aggregates are 
then formed at the air/water interface and produce a gel network that provides stability 
for the foam.  The strength of the foam network is derived from the non-covalent bonding 
and disulfide bridges formed between ovalbumin molecules as a result of its denaturation 
and conformational changes (Doi, E. et al 1997).  Orientation of the hydrophobic areas 
towards the gas phase and hydrophobic interactions also provide stability for the film 
formed around the air pocket (Nakamura, R. et al 2000).  Being the only egg white 
protein with free sulfhydryl groups, foams produced with ovalbumin tend to be more 
stable due to disulfide linkages (Lechevalier, V. et al 2003). 
One of the main factors affecting foam formation is the ability of a protein to be 
adsorbed into the air/water interface and undergo rapid conformational change (Mine, Y. 
et al 1995).  The structural modifications and conformational changes of ovalbumin, 
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ovotransferrin, and lysozyme at the air/water interface have been studied (Lechevalier, V. 
et al 2003; Lechevalier, V. et al 2005).  Both ovalbumin and ovotransferrin undergo 
changes in secondary structure via foaming with a shift from α-helix to β-sheet structures 
(sheets and turns).  This is especially evident with ovotransferrin as there is a 33% 
relative loss of α-helix and a 94% relative gain in β-sheet structure.  Ovotransferrin has 
also been shown to increase in surface hydrophobicity, which is important to foam 
stability.  In contrast, lysozyme does not undergo conformational change at the air/water 
interface, leading to poor individual foaming properties (Lechevalier, V. et al 2003).  
However, lysozyme contributes to the “synergy” of the protein mixture in egg white 
during foaming as it is unfolded and involved in electrostatic interactions with other 
proteins (Lechevalier, V. et al 2005).  The electrostatic interactions between proteins 
contribute to the foaming ability of egg white and its heat stability characteristics (Mine, 
Y. et al 1995).  Ovotransferrin contributes to this synergy via covalent aggregates at the 
air/water surface as it is the most denatured protein during foaming (Lechevalier, V. et al 
2003; Lechevalier, V. et al 2005).   
Two of the most common measures of foaming properties of egg white include 
foam overrun and foam stability.  Foam overrun (OR) is defined as the foam volume 
measured against the initial liquid volume of the solution before foaming.  Foam stability 
(FS) is a measured by the amount of liquid drainage from the foam in relation to the 
initial liquid volume before foaming.  The following equations define these 
measurements where Vf is foam volume, Vli is initial liquid volume, and DV is drained 
volume (Lomakina, K. et al 2006). 
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Foam Overrun = Vf/Vli 
 
Foam Stability = ((Vli ‒ DV) / Vl i) × 100% 
 
 There are many factors that affect egg foam properties including but not limited to 
salt concentration, sugar content, pH, and processing conditions.  These factors have been 
extensively reviewed due to egg white’s importance as a functional food ingredient 
(Lomakina, K. et al 2006).  Addition of NaCl enhances foaming ability and increases 
foam overrun.  The salt reduces protein-protein interactions (electrostatic repulsion) 
allowing them to unfold more readily and be incorporated in the air/water interface, thus 
increasing foaming capacity.  Addition of sugar to egg white often decreases foam 
expansion but increases foam stability due to an increase in viscosity (Raikos, V. et al 
2007).  The increased stability is achieved by the sugar binding excess water while the 
reduced expansion can be explained by the sugar’s stabilizing effects on protein structure 
(increase protein-protein interactions).  Ovomucin may contribute to foam stability in this 
manner due to its long carbohydrate chains that can retain water (Hammershoj, M. et al 
2008). 
With respect to pH foam overrun is highest at pH 4.8 and lowest at 10.7.  There is 
also an increase in foam overrun as pH naturally rises in egg white over time.  However, 
foam stability of aged egg white decreases due to an increased concentration of s-
ovalbumin (less hydrophilic) in old eggs and its interference with film formation around 
the air bubble.  The stability of egg white is highest at egg white natural pH of 8.6 
(Lomakina, K. et al 2006).  Lysozyme is positively charged at this pH and has the ability 
to interact with negatively charged proteins via electrostatic interactions (Mine, Y. et al 
1995).   
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Generally whipping time increases foaming ability, although excess whipping can 
reduce foam stability as smaller bubbles are formed.  Yolk contamination decreases 
foaming ability as components of yolk can complex with ovomucin hindering foam 
formation.  Pasteurization decreases foaming abilities of egg white due to the formation 
of an ovomucin-lysozyme complex when ovotransferrin is denatured at 53°C.  Removal 
of this complex is necessary to regain normal foaming properties (Lomakina, K. et al 
2006).  Additions of metallic ions like Cu+2 that can bind and stabilize ovotransferrin are 
used to retain foaming properties of pasteurized egg white products (Nakamura, N. et al 
2000).  Heat is used to “set” egg white foams via coagulation that produces a stable 
structure (meringues) (Mine, Y. et al 1995).      
HP treatment has been shown to have positive effects on the functional properties 
of egg white.  First, HP treated egg albumen retains its foaming and heat induced gelation 
properties (Iametti, S. et al 1999).  While both HP and heat affect the foaming properties 
of egg white, HPP has been shown to increase its foaming abilities.  Van der Plancken 
and others (2007a) studied the foaming properties of 10% egg white solutions at pH 
levels corresponding to fresh (7.6) and aged egg white (8.8).  The best foam with respect 
to most volume and average density has been reported with HP treated egg white at pH 
8.8.  However, the highest density foam was reported with non-treated egg white at pH 
7.6.  Both HP and heat treatments were shown to reduce collapse in foamed egg white.     
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Purpose of Work 
Egg white proteins are an important and desirable ingredient to the food industry 
due to their functional properties which include gelling, foaming, emulsification, and 
binding adhesion.  These properties are incorporated in many products like meringues, 
processed meat products, and baked goods (Mine, Y. et al 1995).  As a result of egg 
white being a valuable ingredient to the food industry, it is important to determine the 
effects of processing on egg white proteins.  HPP is an alternative non-thermal food 
processing method that has shown promise in the development of new food products with 
added functional and health benefits.  Thus, the purpose of this research was to evaluate 
the effects of HPP on egg white protein and the impact it has on egg white protein 
digestibility and egg white as a functional food ingredient.  Egg white is well recognized 
as an excellent nutrition source and this work is aimed at increasing the understanding of 
its potential health benefits in terms of bioactivity and allergen reduction.   
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Materials and Methods 
High Pressure Treatment 
      Eggs were obtained from a local supermarket and the egg white was separated 
from the yolk.  Eggs were grade A large and had a pH of 9.1.    Samples of egg white 
were placed in sausage casing and vacuum sealed in polyethylene bags for HP treatment.  
Pressure treatments were applied at 400, 600, and 800 MPa for 5 min at 4°C using a 
Stansted ISO-Lab High Pressure Food Processor.  The temperature of the pressurization 
vessel was monitored and ranged between 4 and 10°C during processing.  The processing 
fluid consisted of a propylene glycol/water mixture.  Treated samples were stored at 4°C 
until analysis.  HPP was repeated for all analyses to ensure consistent treatment 
conditions and results.  
 Raman Spectroscopy 
      Egg white was heated at 65, 85, and 95°C for 5 minutes and refrigerated 
overnight then placed in VWR glass vials (#66011-020).  HP treated samples of egg 
white were prepared as described before (400, 600, and 800 MPa) and prepared for 
Raman analysis the same as the heat treated samples.  Egg white without heat or HP 
treatment was analyzed as the control.  Raman spectra were recorded at room temperature 
(~20°C) using an Enwave Optronics spectrometer.  The laser excitation wavelength was 
785 nm.  Spectra were collected using an integration time of 120 s, with the averaging of 
3 spectra, and boxcar smoothing set to 2.  The spectra was analyzed for changes in 
protein secondary structure based on shifts and magnitude of peaks corresponding to the 
amide I and III regions. 
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In-vitro pepsin digestion 
      The in-vitro pepsin digestion protocol used was similar to the one described by 
Zeece et al. (2008).  A stock pepsin (Sigma P6887)  solution was prepared by dissolving 
18 mg in 10 ml cold simulated gastric fluid (SGF) containing 0.1 N HCl, 0.03 M NaCl, 
pH 1.2 (Sigma G3285).  The enzyme was completely dissolved by vortexing and placed 
on ice.  The pepsin solution was used for a maximum of 2 hours for digestions, and then a 
fresh solution was prepared for subsequent digestions. 
      The HP and heat treated samples (85 and 95°C for 5 min) were diluted 1:10 in 
nanopure H2O and homogenized with a brief 10 second pulse to uniformly distribute the 
sample in solution.  Incubations were set up by adding 1.2 mL SGF-pepsin solution to a 
1.5 mL microfuge tube.  The incubation tubes were equilibrated in a 37°C water bath for 
5 minutes.  The digestion was initiated by adding 70 µL (~70µg egg protein) egg white 
sample.  This gave an approximate enzyme to protein ratio of 3:1, assuming the whole 
egg white had a protein concentration of 10% (determined via BCA method using BSA 
as the standard).  The digestion was stopped by withdrawing 200 µL from the incubation 
tube and placing it in a 1.5 mL microfuge tube containing solution A(80 µL Na2CO3 with 
10 µL 10% SDS) at 30s, 2, 4, 8, 15, and 30 minutes.  The samples were immediately 
vortexed and placed on ice.  A control 0 time tube was prepared by adding 50 µg test 
protein to a tube containing 200 µL SGF-pepsin and solution A, which was vortexed and 
placed on ice.  Control tubes were also prepared without SGF-pepsin by adding 50 µg 
test protein to 200 µL SGF with solution A.  Additionally, a tube containing SGF-pepsin 
was incubated at 37°C for 30 minutes to monitor any pepsin self-digestion products.  
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Digestions with the control and 800 MPa sample were also completed with pepsin to 
protein ratio of 1:20. 
SDS-PAGE  
      Each time point sample and controls were prepared by adding 35 µL tracking dye 
solution (Bio-Rad tricine sample buffer with β-mercaptoethanol) and heating at 50°C for 
2 minutes.  The samples were then centrifuged for 2 min at 10,000 g and stored at -20°C 
until SDS-PAGE analysis.  SDS-PAGE was performed by loading 35 µL of sample (~13 
µg protein) on 10-20% gradient tricine pre-cast Bio-Rad Criterion gels.  Gels were 
stained overnight in 0.1% Coomassie Brilliant Blue R-250 with 50% methanol, 10% 
acetic acid and de-stained in 10% methanol, 7% acetic acid.  Digital images of gels were 
taken and protein bands of interest were sent for MS analysis.  
RP-HPLC 
Samples were prepared for RP-HPLC analysis by performing the in-vitro pepsin 
digestion as before but using 90 µL 0.4 M NH4HCO3 as the stop solution.  The digested 
samples were centrifuged for 10 min at 17,000 rcf and the supernatant was removed and 
filtered with a YM3 3000 molecular weight cut off filter (MWCO) spin filter at 14,000 
rcf until 10% of original volume remained.  The filtered samples were dried using a 
Centra-Vap and stored at -20°C until analysis.  Dried samples were re-suspended in 50 
µL 0.1% TFA in nanopure water and diluted for RP-HPLC analysis.   
      RP-HPLC of the digestion products was performed using a Waters 510 HPLC 
system equipped with a tunable absorbance detector set to 214 nm and a HP 3395 
Integrator.  The column was a 2.1×150 mm Waters XBridge BEH130 C18; 3.5µm particle 
size.  An automated gradient controller controlled the elution of solvent and the sample 
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was manually injected.  The injection volume was 5 µL.  Solvent A was 0.1% TFA in 
nanopure water and solvent B was 0.1% TFA in acetonitrile.  The column was 
equilibrated with 100% A.  The flow rate was 0.25 ml/min.  Peptides were eluted with a 
linear gradient from 0 to 70% B in A over 15 min, then isocratic elution of 70% B, 
followed by 5 minute linear gradient to 100 % B. Chromatograms were compared to 
determine the profile of components and treatment induced changes.   
Liquid Chromatography/Mass Spec/Mass Spce (LC/MS/MS) analysis 
Samples were prepared for LC/MS/MS analysis by performing the in-vitro pepsin 
digestion as before but using 90 µL 0.4 M NH4HCO3 as the stop solution.  The digested 
samples were centrifuged for 10 min at 17,000 rcf and the supernatant was removed and 
filtered with a YM3 3000 molecular weight cut off (MWCO) spin filter at 14,000 rcf until 
10% of original volume remained.  The filtered samples were dried using a Centra-Vap 
and stored at -20°C until purification.  Samples were purified prior to MS analysis using 
Pierce PepCleanTM C-18 spin columns (#89873).  Protocols for purification and clean-up 
were followed as described by the instruction manual.  Eluted digests were dried using a 
Centra-Vap and stored at -20°C until being sent for LC/MS/MS analysis.     
2-Dimensional (2D) Electrophoresis 
 Digestion samples of the control and 800 MPa at time 0 and 15m (1:20 pepsin to 
protein ratio) were subject to 2D analysis.  The digestions were performed as described in 
RP-HPLC.  An aliquot of digested sample containing approximately 200 ug protein was 
dried using a Centra-Vap and stored at -20°C until analysis.  Each sample was rehydrated 
using 200 uL Bio-Rad Ready Prep 2D Rehydration/Sample Buffer (#1632106).  First 
dimension separation of the proteins was performed using isoelectric focusing (IEF) with 
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Bio-Rad Ready Strips IPG with a pH range of 3-10 (#163-2000) following instructions 
from kit.  After IEF was complete the strips were equilibrated for SDS-PAGE separation 
on a rocker tray for 5 minutes at room temperature in 5 mL buffer I (0.05 M Tris-Cl pH 
6.8, 6M Urea, 1% SDS, 50 mM DTT), followed by buffer II (0.05 M Tris-Cl pH 6.8, pH 
6.8, 6M Urea, 1% SDS, 50 mM iodoacetamide), and buffer III (0.05 Tris-Cl pH 6.8, 1% 
SDS).   
SDS-PAGE was performed using 10-20% gradient Tris-HCl pre-cast Bio-Rad 
Criterion gels.  Gels were stained overnight in 0.1% Coomassie Brilliant Blue R-250 with 
50% methanol, 10% acetic acid and de-stained in 10% methanol, 7% acetic acid.  Digital 
images of gels were taken and protein spots of interest were sent for MS analysis.  
Texture and Color Analysis 
      The gel texture of HP treated egg white samples (600 and 800 MPa, 5 min) and 
the heat treated sample at 95°C for 10 min were analyzed.  These were the only 
conditions analyzed that produced a gel suitable (non-runny, stable) for texture analysis.  
The pH of the egg white used for texture analysis was 9.1.  The pH was also adjusted to 
6.0 using tartaric acid to study the effects of lowered pH.  Unlike previous HP treatments, 
samples for texture and color analysis were treated with a pressure vessel temperature set 
at 10°C with processing temperatures ranging between 30-40°C.  Treatment for 
functional properties was completed on a 900 plunger press system (Standsted Fluid 
Power Ltd, Essex, UK) and accounts for the changes in treatment conditions.  All other 
HPP conditions remained the same. 
      Textural properties were evaluated with a TA.XT2 Texture Analyzer with a 5 kg 
load cell.  Egg samples were cut to a height of 20 mm with a diameter of 23 mm.  The 
41 
 
sample was then compressed twice (2 bite cycle) with a 50% penetration value using a 
cylindrical probe (TA-4, 37 mm diameter).  The compression speed was set to 1.2 mm/s.  
Texture Technologies texture profile analysis was used to determine the properties of 
each gel according to Bourne (1982). The properties analyzed were hardness, 
cohesiveness, springiness, gumminess, and resilience.  Each sample was measured 5 
times. 
      The color of the gels were analyzed using a Minolta colorimeter with the Hunter 
L, a, b color scale.  Egg samples were cut to a height of 10 mm with a diameter of 23 
mm.  L, a, and b measurements were taken 5 times per sample using 10°/D65 as the light 
source. 
 Syneresis occurred in all gels analyzed.  The discharged liquid was collected and 
subject to SDS-PAGE analysis.  Conditions for electrophoresis were the same as 
previously described.      
Foaming Ability 
      The foaming procedure used in this experiment followed a protocol similar to the 
one described by Van der Plancken et al (2007a).  Egg white was diluted 1:10 in 
nanopure H2O and stirred until homogenous (pH 9.1).  Adjustment in pH of 10% 
solutions was achieved by using varying amounts of 0.02% potassium bitartrate (KT) in 
place of water to lower the pH to 6.0 and 4.5 prior to HP-treatment.  The HP-treatment 
conditions were the same as those used in the texture and color analysis.  Control samples 
at each pH were also analyzed.   
      A volume of 30 ml 10% egg white was placed in a 400 mL beaker and whipped 
using a motorized whisk for 2 minutes.  The resulting foam and liquid was transferred 
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into a 250 mL graduated cylinder and air pockets removed with two quick downward 
shakes.  The volume of the foam and liquid was recorded every 5 min for 15 min and at 
30 min post-foam.  Each sample was measured 5 times.  Foam overrun and stability were 
calculated for each sample (Lomakina, K. et al 2006). 
Statistical Analysis 
  Texture, color, and foaming properties were subject to analysis of variance to 
determine statistical significance (p<0.05) using SAS (Version 9.2, SAS Institute Inc., 
Cary, NC).  Reproducibility of the results were analyzed using an F-test (p<0.05).  
Difference least squares means and Duncan’s multiple range test were also used to 
determine statistical significance.  
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Results and Discussion 
 
 High pressure treatment has been used with a number of food systems (milk, 
muscle, soy, etc) to alter properties of constituent proteins and has been subject to review 
(Rastogi, N. K. et al 2007).  Investigations of egg systems in particular, have shown that 
HP treatment denatures ovalbumin and alters foaming properties of diluted egg white 
(Smith, D. et al 2000, Van der Plancken, I. et al 2007a).  Work presented here extends 
those investigations to gain more complete understanding of the effects of HP treatment 
on the complement of proteins found in egg white.  To achieve this goal, Raman 
spectroscopy and in-vitro pepsin digestion were used to assess the effect of HP treatment 
on egg white proteins.  Raman spectroscopy was used to determine protein 
conformational changes resulting from HP treatment.  Similarly, in-vitro pepsin 
digestibility was used to determine the effects of HP treatment on the denaturation of egg 
white proteins and gain greater understanding of proteins affected by identifying the 
peptide products of digestion.  The effect of HP treatment on egg white functionality 
(gelation, texture, foaming, and color) was also investigated. 
Raman Spectroscopy 
 
Raman spectroscopy is a method that offers structural information of egg white 
proteins before and after HP or heat treatment.  This method has also been used to 
investigate structural changes in other food systems like milk, beef, and fish (Li-Chan E. 
et al 2007; Beattie, R. et al 2004; Badii, F. et al 2006).  The regions of Raman spectra 
most useful in determining protein secondary structure are the amide I (1600-1700 cm-1), 
amide II (1510-1560 cm-1), and amide III (1200-1300 cm-1) bands.  Another important 
region for secondary structure is the C-C stretching region between 890-1060 cm-1 
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(Herrero, A. 2008).  The Raman spectrum of untreated control egg white is shown in 
Figure 7. 
 
Figure 7:  Raman spectra (900-1800 cm-1) for untreated control whole egg white.  
Spectral regions important to protein secondary structure are labeled.  The spectra were 
auto-baselined with Enwave Optronics software. 
 
 The control egg white spectra were used as a base for comparison to determine 
changes in secondary structure of HP and heated egg white (Figure 8)  HP or heat 
treatment resulted in more pronounced and larger bands in the CH-stretching (1510-1560 
cm-1 ) and amide III (1200-1300 cm-1) regions.  This indicates an increase in 
hydrophobicity, most likely due to hydrophobic interactions involved in gelation and the 
formation of aggregates.  Although not indicated in the amide III regions of the spectra, 
other studies examining the effects of HP and heat on ovalbumin found changes that 
indicated a decrease in β-sheet structure (Ngarize, S. et al 2004b).  
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Figure 8:  Raman spectra (900-1800 cm-1) HP and heat treated whole egg white.  The 
spectra were auto-baselined with Enwave Optronics software.  See methods for 
measurement and treatment conditions. 
 
There were several major changes observed in spectra between the control and 
treated samples with respect to protein secondary structure.  A decrease in the band at 
980-990 cm-1 was observed in HP-treated egg white and at temperatures 85°C and 95°C 
(Figure 9).  This region of Raman spectra represents C-C stretching and corresponds to 
alpha helical content.  Thus, HP and heat both contribute to a decrease in α-helical 
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structure upon treatment.  Heat treatment at 65°C showed no apparent affect on 
secondary structure in this region of spectra.  Previous comparisons between heat and 
HP-treated ovalbumin indicated protein denaturation was less extensive with pressure 
than heat.  However, both altered secondary structure by increasing the β-sheet/α-helix 
ratio (Ngarize, S. et al 2004a). 
 
Figure 9:  Raman spectra detailing C-C stretching region (950-1000 cm-1) of HP and heat 
treated egg white.  The spectra were auto-baselined with Enwave Optronics software.  
See methods for measurement and treatment conditions. 
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The amide I region also revealed changes in secondary structure with a shift to β-
sheet (Figure 10).  An increase of the broad band at 1632-1640 cm-1 indicates an increase 
in intramolecular β-sheet.  Both HP and heat treatments also resulted in a shift downfield 
of the band at 1632-1640 cm-1 and shoulder at 1640 cm-1.  This shift to higher frequencies 
is evidence of a loss of α-helix.  In addition, the increase of the Raman band at 1624 cm-1 
corresponds to an increase in exposed β-sheet.  The broad α-helical band at 1650-1670 
cm-1 was not observed in heat or HP-treated egg white.  The absence of this band 
indicates a loss of α-helix.  The Raman band at 1670 cm-1 arising also indicates an 
increase in β-sheet. 
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Figure 10:  Raman spectra detailing amide I region (1620-1685 cm-1) of HP and heat 
treated egg white.  The spectra were auto-baselined with Enwave Optronics software.  
See methods for measurement and treatment conditions. 
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Protein Digestibility 
 
 Pepsin digestibility of HP-treated egg white was examined using an in-vitro 
digestion in simulated gastric fluid.  Whole egg white was treated with pressures up to 
800 MPa.  The control egg white was held at 4°C at ambient pressure.  Specific egg white 
proteins were identified based on migration patterns in the gel gradient.  Control egg 
white was resistant to pepsin digestion, particularly the ovalbumin band (Figure 11).  
Intensity of the ovalbumin band in the control showed little decrease up to 15 min 
incubation time at a 3:1 pepsin ratio (enzyme: protein).  Other investigations (Martos, G. 
et al 2010) showed resistance of ovalbumin to pepsin digestion at a more physiological 
enzyme to protein ratio of 1:20.  HP- treatment resulted in an increase in pepsin 
hydrolysis of ovalbumin.  Hydrolysis of ovalbumin with digestive enzymes trypsin and 
chymotrypsin has also been shown to increase with HP-treatment (Iametti, S. et al 1999, 
Van der Plancken, I. et al 2004).  When compared to the control ovalbumin band, 
pressure treatment of 400 MPa decreased band intensity significantly after 8 min (Lane 
8).  At 600 MPa, the ovalbumin band is lighter at all time points, with a disappearance of 
the band observed after 8 min (Lane 8).  Increased ovalbumin susceptibility to pepsin 
digestion was especially evident at 800 MPa with no band observed after 30s (Lane 5).  
In previous studies, Quiros, A. and others (2007) added pepsin, trypsin, and 
chymotrypsin before HP-treatment on ovalbumin.  This increased the enzymatic 
hydrolysis of ovalbumin.  One key distinction between the approaches of Quiros, A. et al 
and the work presented in this paper is pepsin digestion of samples was completed post-
HP-treatment compared to pre-HP-treatment (Quiros, A. et al 2007).   
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The ovotransferrin band disappeared after 30s (Lane 5) digestion in all egg white 
samples indicating ovotransferrin is readily digested by pepsin.  The lysozyme band 
faded in intensity after 2 min (Lane 6) of digestion in the control sample.  Mine Y. et al 
(2004) investigated the enzymatic digestion of egg white lysozyme and also found little 
resistance to pepsin hydrolysis.  Pressures of 600 MPa and greater decreased lysozyme 
band intensity when compared to the control.  The lysozyme band was absent after 30s 
(Lane 5) at 800 MPa.   
 
Figure 11: Effects of HP treatment on in-vitro digestion of whole egg white. Samples 
were pressurized at 400, 600 and 800 MPa for 5 minutes and subsequently digested with 
pepsin (3:1 enzyme: substrate ratio) in simulated gastric fluid (pH 1.2).  SDS-PAGE was 
performed by loading ~13µg protein for each lane on 10-20% gradient tricine gels.  
Lanes 1-3 correspond to molecular weight standards, egg white, and pepsin respectively.  
Lanes 4-10 correspond to digestion incubation times of 0, 30s, 2, 4, 8, 15, and 30 min 
respectively.    
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Egg white was also heat treated at temperatures up to 95°C (5 min).  Like HP-
treatment, thermal treatments increased pepsin digestibility of egg white ovalbumin 
(Figure 12).  Degradation of the ovalbumin band was observed after 2-4 min (Lanes 6-7) 
of digestion at 95°C.  However, a faint ovalbumin band remained throughout all 
incubation times.  The ovotransferrin band intensity was decreased after heat treatment 
before pepsin digestion (Lane 2 and 4).  An explanation for the loss in intensity before 
digestion was attributed to the low denaturation temperature of ovotransferrin (61°C) and 
subsequent protein degradation.  Effects on the lysozyme band were similar to 800 MPa 
treatments.  The lysozyme band on the 85°C gel was also similar to 800 MPa treatments.  
Treatment at 65°C and 85°C show little difference from control in respect to ovalbumin 
and ovotransferrin.  HP-treatment at 800 MPa resulted in greater digestibility of egg 
white proteins over thermal treatments (Figure 12). 
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Figure 12: Comparison of HP and heat treated egg white digestion with pepsin and 
separated by SDS-PAGE as described in Fig 11.  Samples were pressurized at 400, 600 
and 800 MPa for 5 minutes or heated for 5 min at 65, 85, or 95°C.  Lanes 1-3 correspond 
to molecular weight standards, egg white, and pepsin respectively.  Lanes 4-10 
correspond to digestion incubation times of 0, 30s, 2, 4, 8, 15, and 30 min respectively.   
 
 HP-treated egg white pepsin digestibility was also examined at a more 
physiological enzyme: protein ratio of 1:20.  Only control and 800 MPa samples were 
chosen for this analysis to exhibit the greatest contrast between samples.  Two-
dimensional electrophoresis was applied for analysis of digestions with an IEF pH range 
of 3-10 (Figure 13, 14).  This pH range was chosen as most pI values of major egg white 
proteins are covered (exception of lysozyme, pI of 10.2).  The control and 800 MPa 
pepsin digestions at time 0 were essentially the same.  As incubation time was increased 
to 15 m, the 800 MPa gel showed increased protein digestion as multiple spots were 
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evident around pH 4 and 6.  These spots mostly corresponded to fragments of ovalbumin 
(pH 4-5) and ovotransferrin (pH 6) as identified by mass spectrometry analysis (Table 4).  
Specifically, spot 20 (Fig 13) was identified as ovotransferrin and its various isoforms.  
The polymorphisms of ovotransferrin may be attributed to varying degrees of 
glycosylation or level of bound iron.  For instance, the “halo” form of ovotransferrin 
contains bound iron (Superti, F. et al 2007).  The string of spots in line with spot 20 at a 
lower pH was identified as fragments of ovotransferrin in previous studies (Guerin-
Dubiard, C. et al 2006). 
 Ovalbumin was another protein in which more than one form was identified with 
mass spectrometry.  In many instances (spots 1-3, 5-7, 9, 10), the crystal structure of S-
ovalbumin was identified.  However, S-ovalbumin properties such as electrophoretic 
separation are indistinguishable from ovalbumin (Doi, E. et al 1997).  A blast comparison 
between ovalbumin and S-ovalbumin also shows no sequence difference.  Its 
identification cannot be confirmed with electrophoretic analysis but its contribution to 
spot intensity is possible.  S-ovalbumin increases in concentration as egg white ages 
(Kilara, A. et al 1996) and its presence in the samples is logical as the pH of the egg 
white used for all experiments (9.1) was above fresh pH (7.6).  Other variations of 
ovalbumin revealed by 2D analysis were ovalbumin related X (spots 3 and 6) and Y 
proteins (spots 1, 3, 4, 6, 8, 9, 11, 14, 15).  The nature of the X and Y related 
polymorphisms are unexplained other than ovalbumin containing both X and Y genes.  
However, the sequence homology is identical between X and Y related proteins with X 
being a fragment of Y (Guerin-Dubiard, C. et al 2006).   
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Other protein fragments identified were from egg white lysozyme, ovomucoid, 
protein TENP, Hep21 protein, ovoinhibitors.  TENP was first identified in unfertilized 
egg white by Guerin-Dubiard, C. et al, 2006.  TENP is a member of the bactericidal 
permeability-increasing protein family and is expressed in developing neural tissues 
(Guerin-Dubiard, C. et al 2006).  Like TENP, Hep21 was also recently discovered in hen 
egg white and has unknown biological activity (Nau, F. et al 2003).  Other spots labeled 
A and B in Control 0 of Figure 13 correspond to proteins identified in previous 
proteomic studies of egg white proteins.  Spot A can be attributed (assumed to be) to 
ovalbumin (pI 4.6) and its 3 phosphorylated isoforms, as identified in previous proteomic 
studies.  Spot B can be identified based on previous studies as possible fragments of 
ovoglycoprotiens and ovomucoid (pI 4.1) (Guerin-Dubiard, C. et al 2006).  The control 
showed increased protein degradation after 30 min of digestion with several spots 
observed at pH 4-5.  At 30 min and 800 MPa intensity of spots present at 15 m was 
decreased indicating further degradation of protein fragments. 
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Figure 13: 2-D separation of pepsin digested (1:20 enzyme to protein ratio) control (0.1 
MPa) whole egg white in simulated gastric fluid (pH 1.2).  Digestions were carried out at 
37°C for 0, 15, and 30 min.  Protein load was 200 µg and IEF separation was performed 
on a 3-10 pH gradient for 35k volt hours.  Second dimension separation was performed 
on10-20% gradient Tris-HCl SDS-PAGE gels.  Identities of labeled spots were 
determined by MS sequencing of excised plugs and listed in Table 4. 
56 
 
 
Figure 14: 2-D separation of pepsin digested (1:20 enzyme to protein ratio) 800 MPa 
treated whole egg white in simulated gastric fluid (pH 1.2).  Digestions were carried out 
at 37°C for 0, 15, and 30 min.  Separations were performed on 200 µg aliquots as 
described in Fig 13.  Identities of labeled spots were determined by MS sequencing of 
excised plugs and listed in Table 4. 
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Table 4: Proteins identified via mass spectrometry after 2-D electrophoresis 
Spot # Protein Identification Gi Peptides Matches 
1 Chain A, Crystal Structure Of S-Ovalbumin gi|34811330    34 
Ovomucoid gi|124757     5 
ovalbumin-related protein Y gi|71897377     1 
 
2 Chain A, Crystal Structure Of S-Ovalbumin gi|34811330      10 
 Ovomucoid gi|124757     12 
 Ovotransferrin gi|1351295    1 
    
3 Chain A, Crystal Structure Of S-Ovalbumin  gi|34811330     43 
ovalbumin  gi|28566340 39 
Ovalbumin-related protein X gi|129295  2 
ovalbumin-related protein Y gi|71897377     1 
   
4 ovalbumin-related protein Y gi|71897377  3 
   
5 Chain A, Crystal Structure Of S-Ovalbumin  gi|34811330     44 
ovalbumin  gi|28566340     41 
unnamed protein product [Gallus gallus] gi|63052      12 
   
6 Chain A, Crystal Structure Of S-Ovalbumin gi|34811330     21 
protein TENP [Gallus gallus] gi|46048814 4 
Ovotransferrin gi|1351295   3 
Chain A, Chicken Egg-White Lysozyme Core Mutants gi|157831883   1 
ovalbumin-related protein Y  gi|71897377  2 
Ovalbumin-related protein X gi|129295    1 
   
7 Chain A, Crystal Structure Of S-Ovalbumin gi|34811330  7 
Ovalbumin gi|129293    7 
   
8 Ovalbumin gi|129293  7 
ovalbumin N term fragment gi|223059  5 
ovalbumin-related protein Y gi|71897377     1 
   
9 Chain A, Crystal Structure Of S-Ovalbumin  gi|34811330    16 
Ovalbumin gi|129295     1 
ovalbumin-related protein Y gi|71897377     1 
   
10 Ovalbumin gi|129293     31 
Chain A, Crystal Structure Of S-Ovalbumin gi|34811330    31 
Ovotransferrin gi|1351295     6 
ovotransferrin BB type gi|71274075 6 
Ovalbumin gi|129294      10 
protein TENP [Gallus gallus] gi|46048814     4 
ovoinhibitor precursor  gi|71895337     2 
Chain A, Chicken Egg-White Lysozyme Core Mutants gi|157831883     1 
   
11 Ovalbumin gi|129293     29 
Ovotransferrin gi|1351295    10 
unnamed protein product [Gallus gallus] gi|63052     17 
protein TENP [Gallus gallus] gi|46048814   3 
Ovalbumin gi|129294     2 
ovalbumin N term fragment gi|223059     3 
ovalbumin-related protein Y  gi|71897377     2 
   
12 Ovotransferrin gi|1351295     17 
ovotransferrin BB type gi|71274075     17 
Ovalbumin gi|129293      12 
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12 Ovotransferrin gi|3024757     8 
Lysozyme gi|126608     2 
Chain A, Chicken Egg-White Lysozyme Core Mutants gi|157831883    2 
Ovomucoid  gi|124757      4 
protein TENP [Gallus gallus] gi|46048814    1 
   
13 
 
Ovalbumin gi|129293      12 
Ovotransferrin gi|1351295  10 
Ovotransferrin gi|3024757  6 
Chain A, Chicken Egg-White Lysozyme Core Mutants gi|157831883     1 
ovoinhibitor precursor gi|71895337     2 
protein TENP [Gallus gallus] gi|46048814  1 
   
14 ovotransferrin precursor gi|45385813     10 
ovotransferrin CC type gi|71274077    10 
Ovalbumin gi|129293    7 
protein TENP [Gallus gallus] gi|46048814    3 
Ovomucoid gi|124757     2 
Chain A, Chicken Egg-White Lysozyme Core Mutants gi|157831883     1 
ovalbumin-related protein Y gi|71897377     1 
   
15 Ovotransferrin gi|1351295   11 
ovotransferrin BB type  gi|71274075   11 
Ovalbumin gi|129293     6 
protein TENP [Gallus gallus] gi|46048814     1 
ovalbumin-related protein Y  gi|71897377    1 
   
16 Ovotransferrin gi|1351295 7 
Lysozyme  gi|126608     4 
Lysozyme gi|742827    4 
Chain A, Im Mutant Of Lysozyme gi|15988033     4 
Chain A, Chicken Egg-White Lysozyme Core Mutants gi|157831883     2 
unnamed protein product [Gallus gallus] gi|63052    6 
   
17 Chain A, Aluminum-Bound Ovotransferrin  gi|83754919 24 
ovotransferrin CC type  gi|71274077  22 
Lysozyme gi|126608     5 
Chain A, Im Mutant Of Lysozyme gi|15988033     5 
Chain A, Chicken Egg-White Lysozyme Core Mutants gi|157831883     4 
Lysozyme gi|742827     3 
unnamed protein product [Gallus gallus] gi|63052   3 
protein TENP [Gallus gallus] gi|46048814   1 
   
18 Hep21 protein [Gallus gallus] gi|45383131    2 
Ovalbumin gi|129293   4 
Ovotransferrin gi|1351295    3 
Chain A, Chicken Egg-White Lysozyme Core Mutants gi|157831883  1 
   
19 Chain A, Aluminum-Bound Ovotransferrin gi|83754919       79 
Ovotransferrin gi|1351295     77 
Chain A, Ovotransferrin, N-Terminal Lobe, Holo Form gi|14719680 36 
Ovalbumin gi|129293 9 
   
20 Chain A, Aluminum-Bound Ovotransferrin gi|83754919     99 
ovotransferrin CC type gi|71274077     94 
Ovotransferrin gi|1351295    96 
Chain A, Ovotransferrin, N-Terminal Lobe, Holo Form gi|14719680     46 
Ovotransferrin gi|3024757     16 
Ovalbumin gi|129293     2 
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Bioactive Peptides 
 
In-vitro pepsin digestions (30 min incubation) of control and 800 MPa samples 
(3:1 ratio) were subject to LC/MS/MS analysis.  The analysis was focused on small 
peptides with a molecular weight <3000 Da.  This was accomplished with centrifugation 
through 3000 Da membrane filters.  Samples underwent a clean-up step using Pierce 
PepCleanTM C-18 spin columns and were then dried for LC/MS/MS analysis.  The mass 
spectrometry data was subjected to a Mascot search for possible sequence matches in egg 
white proteins. 
 The mass spectrometry analysis of the control and 800 MPa samples had great 
contrast.  No peptide fragment sequences corresponding to egg white proteins were found 
using standard Mascot search parameters (NCBInr 20100701 metazoa database, 
significance threshold p < 0.05).  Identified sequences via Mascot in the control sample 
were all pepsin derived.  The number of proteins matched and unmatched sequences was 
also substantially less in the control sample.  This is another indication of increased 
pepsin digestibility as a result of pressure treatment.  Pepsin digests of 800 MPa treated 
egg white resulted in peptides from several egg white proteins.  The egg white proteins 
included ovalbumin (gi 28566340), ovotransferrin (gi 83754919), lysozyme mutant (gi 
10120553), and protein TENP (gi 46048814).  However, none of the Mascot scores were 
significant to confirm a specific hit based on protein scores.  The fragment sequences 
were still present regardless of the inability to significantly confirm the parent protein.   
 The egg derived peptide products resulting from 800 MPa pepsin digestion 
ranged from 9 to 28 amino acids in length.  One peptide with possible antihypertensive 
activity, YAEERYPIL, was identified in the 800 MPa pepsin digested sample.  The 
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origin of YAEERYPIL is ovalbumin (107-115) and has been identified in previous 
literature with an ACE inhibitor IC50 value of 4.7 µM (Miguel, M. et al 2006a; Miguel, 
M. et al 2007a).  YAEERYPIL also exhibits radical scavenging activity of 3.8 µmol of 
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) equivalent/µmol of 
peptide and delays LDL lipid oxidation.  Studies by Miguel et al (2006a) of 
YAEERYPIL show the peptide is further hydrolyzed by pepsin in pancreatic extract to 
YAEER and YPI.  The resulting products do not show as high of activity as 
YAEERYPIL before peptic digestion with an IC50 value of >1000 µg/mL (Miguel, M. et 
al 2006a).  The digestion products of YAEERYPIL were not observed in this analysis.  
However, this does not mean YAEER or YPI were not present, as these peptides may be 
beyond the detection limit of the MS analysis performed.  This is also true for other 
potential bioactive peptides as many are < 9 amino acids in length (the smallest length 
peptide related to egg protein found/identified). 
 Another sequence with potential ACE-inhibitor bioactivity was found within a 
fragment identified in the 800 MPa sample (LKRVPSLM).  The origin of LKRVPSLM 
is ovotransferrin and the sequence, RVPSL (328-332), has been identified in previous 
literature with an ACE inhibitor IC50 value of 20 µM (Liu, J. et al 2010).  Further 
digestion with pepsin using ExPASy Peptide Cutter of LKRVPSLM results in the 
fragment KRVPSL.  Under physiological digestion, trypsin and chymotrypsin would also 
be present.  Theoretically, the bioactive sequence RVPSL could be released with trypsin 
hydrolysis as it cleaves on the carboxyl side of Lys.  However, trypsin would potentially 
cleave Arg, resulting in the peptide fragment VPSL.  A summary of identified digestion 
products from egg white protein sources are given in Tables 5-8. 
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 Ovalbumin contains peptides exhibiting immunomodulating properties which 
show activity against foreign materials in the body and help in immune function (Wu, J. 
et al 2010).  Two peptides derived from ovalbumin have been reported to show this 
activity, SVNVHSSL (77-84 residues) and YRGGLEPIN (126-134).  Both peptides are 
currently under investigation for cancer immunotherapy applications and have been 
shown to increase immune response (Goldberg, et al 2003).  One of these peptides, 
YRGGLEPIN, was embedded in one of the peptide fragments identified in the 800 MPa 
pepsin digestion sample, LYRGGLEPINF.  Again, further hydrolysis by pepsin would 
theoretically release the bioactive sequence YRGGLEPIN as predicted by ExPASy 
Peptide Cutter.  The results presented suggest HPP has the potential to increase release of 
bioactive peptides in egg white proteins and be beneficial to egg white nutritional value. 
Table 5: Pepsin digestion products identified from 800 MPa treated egg white 
corresponding to ovalbumin.  Amino acids before and after identified sequence are given. 
Mass Exp Mass Theo Sequence Ovalbumin 
residue 
894.53 894.43  A.MPFRVTE.Q + Oxidation (M) 197-203 
1035.49 1035.52  Q.ITKPNDVYS.F 91-99 
1076.51 1076.5  E.QESKPVQMM.Y 204-212 
1099.53 1099.45  A.FKDEDTQAM.P + Oxidation (M) 189-197 
1152.63 1152.58  L.YAEERYPIL.P 107-115 
1160.58 1160.65  M.ASEKMKILEL.P 224-233 
1176.61 1176.57  F.DKLPGFGDSIE.A 61-71 
1182.46 1182.59  Q.ITKPNDVYSF.S 91-100 
1193.57 1193.56  F.EKLTEWTSSN.V 263-272 
1209.69 1209.64  M.VYLGAKDSTRT.Q 42-52 
1229.68 1229.64  W.VESQTNGIIRN.V 150-160 
1277.6 1277.68  E.LYRGGLEPINF.Q 125-135 
1277.65 1277.63  L.NQITKPNDVYS.F 89-99 
1277.74 1277.68  E.LYRGGLEPINF.Q 125-135 
1282.7 1282.59  I.LELPFASGTMSM.L 231-242 
1305.68 1305.68  L.SGISSAESLKISQ.A 314-326 
1305.78 1305.7  M.KILELPFASGTM.S 229-240 
1339.81 1339.75  G.IIRNVLQPSSVD.S 157-168 
1415.74 1415.72  S.WVESQTNGIIRN.V 149-160 
1424.7 1424.69  L.NQITKPNDVYSF.S 89-100 
1430.82 1430.76  F.KELKVHHANENI.F 19-28 
1450.86 1450.78  M.VYLGAKDSTRTQI.N 42-54 
1523.89 1523.77  M.KILELPFASGTMSM.L 229-242 
1554.81 1554.84  G.IIRNVLQPSSVDSQ.T 157-170 
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1564.83 1564.82  M.VYLGAKDSTRTQIN.K 42-55 
1616.89 1616.83  L.KISQAVHAAHAEINE.A 323-337 
1692.98 1692.92  M.VYLGAKDSTRTQINK.V 42-56 
1726.92 1726.92  G.IIRNVLQPSSVDSQTA.X 157-172 
1812.93 1812.84  A.FKDEDTQAMPFRVTE.Q 189-203 
1852.09 1851.95  M.ASEKMKILELPFASGTM.S 224-240 
1857.95 1857.96  G.IIRNVLQPSSVDSQTAM.V 157-173 
1874.06 1873.96  G.IIRNVLQPSSVDSQTAM.V + Oxidation (M) 157-173 
1941 1940.89  A.FKDEDTQAMPFRVTEQ.E 189-204 
2332.21 2332.17  W.VESQYNGIIRNVLQPSSVDSQ.T 150-170 
2679.62 2679.5  G.IIRNVLQPSSVDSQTAPVLVNAIVF.K 157-181 
 
Table 6: Pepsin digestion products identified from 800 MPa treated egg white 
corresponding to ovotransferrin.  Amino acids before and after identified sequence are 
given. 
Mass Exp Mass Theo Sequence Ovotransferrin 
residue 
894.45 894.44  F.LSKAQSDF.G 267-274 
942.6 942.57  M.LKRVPSLM.D 307-314 
1145.67 1145.58  T.YKEFLGDKF.Y 653-661 
1165.62 1165.56  F.LSKAQSDFGVD.T 267-277 
1207.61 1207.5  E.NAPDQKDEYE.L 216-225 
1340.83 1340.72  L.GRSAGWNIPIGTL.I 120-132 
1403.82 1403.79  F.HLFGPPGKKDPVL.K 283-295 
1440.88 1440.83  F.EAGLAPYKLKPIAA.E 66-79 
1456.82 1456.75  S.MRKDQLTPSPRE.N 331-342 
1501.71 1501.62  A.EVYEHTEGSTTSY.Y 80-92 
1522.79 1522.89  A.VVVRPEKANKIRD.L 594-606 
1569.97 1569.88  F.EAGLAPYKLKPIAAE.V 66-80 
1816.14 1816.01  Q.VFEAGLAPYKLKPIAAE.V 64-80 
1823.97 1823.86  F.VKHTTVNENAPDQKDE.Y 208-223 
1987.06 1986.93  F.VKHTTVNENAPDQKDEY.E 208-224 
2116.11 2115.97  F.VKHTTVNENAPDQKDEYE.L 208-225 
2229.18 2229.05  F.VKHTTVNENAPDQKDEYEL.L 208-226 
 
Table 7: Pepsin digestion products identified from 800 MPa treated egg white 
corresponding to lysozyme mutant. Amino acids before and after identified sequence are 
given. 
Mass Exp Mass Theo Sequence Lysozyme mutant 
residue 
1656.83 1656.7  F.NTQATNRNTDGSTDY.G 39-53 
1939.97 1939.89  F.NTQATNRNTDGSTDYGIL.Q 39-56 
3313.66 3313.48 F.NTQATNRNTDGSTDYGILQINSRWWCNDA.R 39-67 
 
Table 8: Pepsin digestion products identified from 800 MPa treated egg white 
corresponding to protein TENP. Amino acids before and after identified sequence are 
given. 
Mass Exp Mass Theo Sequence protein TENP 
1099.63 1099.55  L.YHEDLPITL.S 288-296 
1353.84 1353.74  A.VVPVPVSPVPFSM.P 219-231 
1780.09 1779.96  F.QVAGAVVPVPVSPVPFSM.P 214-231 
2501.47 2501.35  L.DKVVDVDKLCLDVSKLLLFPNE.Q 152-173 
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The fragments isolated in this work were overlaid on the sequences of common 
egg white allergens ovalbumin, ovotransferrin, and lysozyme (Figure 15).  Select 
ovalbumin allergenic epitope sequences are highlighted in yellow.  The highlighted 
ovalbumin sequences correspond to epitope regions with distinct IgE recognition in 
human patients with secondary structure that has been determined (Mine, Y. et al 2003).  
The change in secondary structure due to HP-treatment as determined by Raman analysis 
may have an effect on the allergenicity (IgE binding) of these epitopes.  Other reported 
allergenic epitopes in human patients correspond to ovalbumin sequence 2-11, 12-20, 34-
78, 42-172, 302-286, and 348-386 (Mine, Y. et al 2008).  Many of these epitopes are 
overlapping and when combined, have extensive sequence coverage.  Figure 15 
illustrates the fragmentation of epitope sequences as a result of pressure treatment and 
subsequent pepsin digestion.  As reported previously, HP-treatment has the potential to 
reduce allergenicity (IgE binding) by increasing proteolysis (Lopez-Exposito, I. et al 
2008).  The rationale behind this conclusion is the fact that most food egg white protein 
epitopes are sequential and thus by increasing proteolysis it may reduce allergenic 
response (IgE binding) (Mine, Y. et al 2008).  No specific epitopes have been 
characterized in human studies relating to egg allergy for ovotransferrin or lysozyme.      
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Ovalbumin 
     1 MGSIGAASME FCFDVFKELK VHHANENIFY CPIAIMSALA MVYLGAKDST  
    51 RTQINKVVRF DKLPGFGDSI EAQCGTSVNV HSSLRDILNQ ITKPNDVYSF  
   101 SLASRLYAEE RYPILPEYLQ CVKELYRGGL EPINFQTAAD QARELINSWV  
   151 ESQXNGIIRN VLQPSSVDSQ TAXVLVNAIV FKGLWEKAFK DEDTQAMPFR  
   201 VTEQESKPVQ MMYQIGLFRV ASMASEKMKI LELPFASGTM SMLVLLPDEV  
   251 SGLEQLESII NFEKLTEWTS SNVMEERKIK VYFPRMKMEE KYNLTSVLMA  
   301 MGITDVFSSS ANLSGISSAE SLKISQAVHA AHAEINEAGR EVVGSAEAGV  
   351 DAASVSEEFR ADHPFLFCIK HIATNAVLFF GRCVSP 
Ovotransferrin 
     1 APPKSVIRWC TISSPEEKKC NNLRDLTQQE RISLTCVQKA TYLDCIKAIA  
    51 NNEADAISLD GGQVFEAGLA PYKLKPIAAE VYEHTEGSTT SYYAVAVVKK  
   101 GTEFTVNDLQ GKTSCHTGLG RSAGWNIPIG TLIHRGAIEW EGIESGSVEQ  
   151 AVAKFFSASC VPGATIEQKL CRQCKGDPKT KCARNAPYSG YSGAFHCLKD  
   201 GKGDVAFVKH TTVNENAPDQ KDEYELLCLD GSRQPVDNYK TCNWARVAAH  
   251 AVVARDDNKV EDIWSFLSKA QSDFGVDTKS DFHLFGPPGK KDPVLKDLLF  
   301 KDSAIMLKRV PSLMDSQLYL GFEYYSAIQS MRKDQLTPSP RENRIQWCAV  
   351 GKDEKSKCDR WSVVSNGDVE CTVVDETKDC IIKIMKGEAD AVALDGGLVY  
   401 TAGVCGLVPV MAERYDDESQ CSKTDERPAS YFAVAVARKD SNVNWNNLKG  
   451 KKSCHTAVGR TAGWVIPMGL IHNRTGTCNF DEYFSEGCAP GSPPNSRLCQ  
   501 LCQGSGGIPP EKCVASSHEK YFGYTGALRC LVEKGDVAFI QHSTVEENTG  
   551 GKNKADWAKN LQMDDFELLC TDGRRANVMD YRECNLAEVP THAVVVRPEK  
   601 ANKIRDLLER QEKRFGVNGS EKSKFMMFES QNKDLLFKDL TKCLFKVREG  
   651 TTYKEFLGDK FYTVISSLKT CNPSDILQMC SFLEGK 
Lysozyme 
     1 KVFGRCELAA AMKRHGLDNY RGYSLGNWVC AAKFESNFNT QATNRNTDGS  
    51 TDYGILQINS RWWCNDARTP GSRNLCNIPC SALLSSDITA SVNCAKKIVS  
   101 DGNGMNAWVA WRNRCKGTDV QAWIRGCRL 
Protein TENP 
     1 MGALLALLDP VQPTRAPDCG GILTPLGLSY LAEVSKPHAE VVLRQDLMPK  
    51 EPQTCSLAPW SPAGTELPAV KVADLWLSVI PEAGLRLGIE VELRIAPLHT  
   101 VPMPVRISIR ADLHVDMGPD GNLQLLTSAC RPTVQAQSTR EAESKSSRSI  
   151 LDKVVDVDKL CLDVSKLLLF PNEQLMSLTA LFPVTPNCQL QYLALAAPVF  
   201 SKQGIALSLQ TTFQVAGAVV PVPVSPVPFS MPELASTSTS HLILALSEHF  
   251 YTSLYFTLER AGAFNMTIPS MLTTATLAQK ITQVGSLYHE DLPITLSAAL  
   301 RSSPRVVLEE GRAALKLFLT VHIGAGSPDF QSFLSVSADV TRAGLQLSVS  
   351 DTRMMISTAV IEDAELSLAA SNVGLVRAAL LEELFLAPVC QQVPAWMDDV  
   401 LREGVHLPHM SHFTYTDVNV VVHKDYVLVP CKLKLRSTMA  
 
Figure 15:  Sequence coverage of identified peptides in 800 MPa pepsin digested 
sample.  Matched sequences are shown in red.  Highlighted yellow areas indicate 
identified ovalbumin allergenic (IgE) epitopes with distinct IgE recognition reported in 
human egg-allergenic persons (Mine, Y. et al 2003). 
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Egg White Functionality  
 
Gel Texture and Color 
 Texture properties of HP-treated (600 and 800 MPa) and heat-treated (95°C) egg 
white gels were investigated as described in the methods.  Samples adjusted to pH 6 with 
tartaric acid prior to HP or thermal treatments were also analyzed.  Textural profile 
analysis was applied as described by Bourne (1982) to determine gel hardness, 
gumminess, cohesiveness, and resilience.  The texture profile consists of a two bite cycle 
which produces an output of two peaks (Figure 16). 
 
Figure 16: Texture profile of representative runs for samples treated at 95°C, 600 MPa 
and 800 MPa at natural pH (9.11).  Also included are profiles for whole egg white 
adjusted to pH 6 with tartaric acid and treated at 600 and 800 MPa. 
  
Gels formed with heat at 95°C had an average hardness value of 2329 g, over 
twice the value (1114.89 g) of HP-induce gels at 800 MPa (Figure 17).  The softest gel 
was observed at 600 MPa.  Reduction of pH decreased the hardness of heat induced gels 
while it increased the hardness of HP gels.  Gel gumminess followed a similar pattern to 
gel hardness with heat induced gels being gummier (Figure 18). 
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Figure 17: Effect of heat and HP-treatment on egg white gel hardness at natural pH 
(9.11) and pH adjusted with tartaric acid (pH 6.0).  Same letters above each bar for each 
sample denote means are not significantly different (α=0.05) using Duncan’s test and 
Dunnet least square means.  Error bars are ± 1 standard deviation 
 
 
Figure 18: Effect of heat and HP-treatment on egg white gel gumminess at natural pH 
(9.11) and pH adjusted with tartaric acid (pH 6.0).  Same letters above each bar for each 
sample denote means are not significantly different (α=0.05) using Duncan’s test and 
Dunnet least square means.  Error bars are ± 1 standard deviation. 
 
Gels formed with HP at 800MPa were more resilient (instant springiness) than 
heat induced gels (Figure 19).   Resilience decreased as pH was decreased at 800 MPa.  
However, lowered pH increased resilience at 600 MPa.  This may be explained by the 
softness and almost jelly like state (semi-solid) of the 600 MPa gel which could prevent 
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instant springiness/bounce back.  Extended error bars for 600 MPa may also be explained 
by its semi-solid state.  Resilience of heat induced gels was decreased at pH 6.0.  Gel 
cohesiveness showed little difference between treatments with HP-induced gels having 
slightly higher values (Figure 20). 
 
Figure 19: Effect of heat and HP-treatment on egg white gel resilience at natural pH 
(9.11) and pH adjusted with tartaric acid (pH 6.0).  Same letters above each bar for each 
sample denote means are not significantly different (α=0.05) using Duncan’s test and 
Dunnet least square means.  Error bars are ± 1 standard deviation. 
 
 
Figure 20: Effect of heat and HP-treatment on egg white gel cohesiveness at natural pH 
(9.11) and pH adjusted with tartaric acid (pH 6.0).  Same letters above each bar for each 
sample denote means are not significantly different (α=0.05) using Duncan’s test and 
Dunnet least square means.  Error bars are ± 1 standard deviation. 
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 As in previous studies (Hayashi, R. et al 1989; Ngarize, S. et al 2005), HP-
induced gels were softer and more elastic than thermally induced gels.  The textural 
properties of heat-induced gels tended to have greater measurement variation, particularly 
the hardness and gumminess properties.  These variations may be explained by uneven 
heat transfer during treatment or insufficient cooking time (softer near the middle of 
sample).  In this respect, HP-induced gels were more uniform.  Lowering the pH changed 
the appearance of egg white gels as they were more granular (Figure 21) 
 
Figure 21: Cross section of pH 9.11 and 6.0 800 MPa treated gels.   
 
 Gel syneresis was observed in all samples.  Heat-induced gels noticeably 
decreased in diameter/size once cooled after treatment.  This was expected as others have 
reported shrinkage of heat-induced gels due to lowered water holding capacity 
(Croguennec, T. et al 2002, Nakamura, R. et al 2000).  Liquid discharged from the gel 
was subject to SDS-PAGE analysis (Figure 22).  Lysozyme bands were absent from the 
discharge liquid.  This indicates it was incorporated in the gel matrix.  The ovotransferrin 
band was present, indicating it may be less important to gel structure.  The ovalbumin 
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band decreased in intensity as pressure was increased.  Thus, as pressure was increased 
ovalbumin was further incorporated in the gel matrix.   
 
Figure 22: SDS-PAGE analysis of gel syneresis liquid using 10-20% gradient Tricine 
gels.  Lanes 1-6 (10 µg load) correspond to molecular weight standards, control, 600 
MPa, 600 MPa pH 6, 800 MPa, 800 MPa pH 6 respectively. Lanes 7-12 have a protein 
load of 20 ug. 
 
 The color of egg gels was analyzed and compared using the Hunter color scale 
(Figure 23).  Heat treated gels (95°C, 10 min) had a significantly higher L-value than HP 
gels (α=0.05).  Increasing levels of pressure did not significantly affect L-values.  
Lowering the pH to 6.0 with tartaric acid improved overall gel appearance, resulting in 
brighter/more white gels with both heat and HP gels (Figure 24). 
 
Figure 23: Hunter L, a, b color scale 
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Figure 24: Effect of heat and HP-treatment on egg white color L values at natural pH 
(9.11) and pH adjusted with tartaric acid (pH 6.0).  Same letters above each bar for each 
sample denote means are not significantly different (α=0.05) using Duncan’s test and 
Dunnet least square means.  Error bars are ± 1 standard deviation. 
 
 All egg white gels produced negative a-values which indicate a greener color 
according to the Hunter scale.  Heat-induced gels had the lowest a-value at -4.55.  This 
was closely followed by the 800 MPa gel (-4.10).  Lowering the pH resulted in 
significantly increased a-values (Figure 25).  With respect to b-values (Figure 26), 
lowering the pH significantly increased the value indicating a more yellow color.  Heat-
induced gels also had a higher b-value than HP-gels.  Although ‘a’ and b-values indicate 
the presence of other colors, all gels were visually white. 
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Figure 25: Effect of heat and HP-treatment on egg white color a values at natural pH 
(9.11) and pH adjusted with tartaric acid (pH 6.0).  Same letters above each bar for each 
sample denote means are not significantly different (α=0.05) using Duncan’s test and 
Dunnet least square means.  Error bars are ± 1 standard deviation. 
 
 
Figure 26: Effect of heat and HP-treatment on egg white color a values at natural pH 
(9.11) and pH adjusted with tartaric acid (pH 6.0).  Same letters above each bar for each 
sample denote means are not significantly different (α=0.05) using Duncan’s test and 
Dunnet least square means.  Error bars are ± 1 standard deviation. 
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Foaming Properties 
 
 Foaming properties of egg white solutions (10% v/v) were analyzed with varying 
levels of pressure and pH as described in the methods.  Whole egg white was not used for 
foaming analysis due to pressure induced gelation at 600 and 800 MPa.  Thus, all egg 
white was diluted to 10% with RO water.  Only the natural pH (9.11) of the egg white 
was used in pressure treatments as egg white solutions of pH 6.0 and pH 4.5 resulted in 
protein precipitation after HPP.    
Pressure treatment of 10% egg white solutions at pH 9.11 resulted in a 
homogenous solution with improved foaming capacity over the control (see Figure 27).  
Increasing pressure resulted in an increase in foam volume.  Foam overrun was 
significantly (α = 0.05) increased at 800 MPa at all time points.  At 5 min and 30 min 
there was no significant difference in foam overrun between 600 and 800 MPa.  Foam 
overrun was slightly increased at 600 MPa, but this increase was not statistically 
significant.  Van der Plancken et al (2007a) also found HP treatment resulting in 
increased foam capacity.  Increased foam overrun with HPP can be attributed to partial 
unfolding of egg white protein associated with pressure which contributes to absorption 
into air-water interface. 
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Figure 27: Effect of HPP (5 min) on 10% egg white solution foam overrun at pH 9.11 
and at 0.1 MPa (control), 600 MPa, and 800 MPa.  Time intervals represent measurement 
of foam overrun post-foaming.  Same letters above each bar for each time point denote 
means are not significantly different (α=0.05) using Duncan’s test and Dunnet least 
square means.  Error bars are ± 1 standard deviation. 
 
 The foaming properties of egg white solutions were also highly dependent on pH.  
The greatest foam overrun was achieved at pH 4.5 while foaming ability was 
significantly decreased at pH 6 (Figure 28).  The increased foam overrun at pH 4.5 could 
be attributed to major egg white proteins important to foaming properties, ovalbumin and 
ovomucin, which have respective pI of 4.5 and 4.1.  At pH 4.5, the two proteins are 
uncharged resulting in a reduction of electrostatic repulsion between protein molecules.  
This allows for easier absorption into the air-water interface when foamed due to easier 
protein unfolding.  The decrease in foam overrun at pH 6 may be due to increased 
electrostatic protein-protein interactions, which would decrease absorption into the air-
water interface.  
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Figure 28: Effect of pH on 10% egg white solution foam overrun at pH 9.11 (control), 
pH 6.0, and pH 4.5 at room temperature (20°C).  Time intervals represent measurement 
of foam overrun post-foaming.  Same letters above each bar for each time denote means 
are not significantly different (α=0.05) using Duncan’s test and Dunnet least square 
means.  Error bars are ± 1 standard deviation. 
  
 Foam stability was also used to access the effect of HPP or pH on egg white 
foaming properties.  HPP significantly reduced foam stability with the exception of the 
800 MPa 0 time point.  This result was in contrast to another study (Van der Plancken et 
al 2007a), which found HP treatment increased overall foam stability.  As foam stability 
is a function of liquid drainage from the foam, the increased stability of 800 MPa at the 0 
time point was attributed to the increased foam volume and incorporation of liquid in the 
foam.  However, liquid drainage was the greatest over the first 5 minutes post-foam (800 
MPa) as indicated by the slope and drop in stability as seen in Figure 29. 
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Figure 29: Effect of HPP (5 min) on 10% egg white solution foam stability at pH 9.11 
and at 0.1 MPa (control), 600 MPa, and 800 MPa.  Time intervals represent measurement 
of foam stability post-foaming.  Same letters above each point for each time denote 
means are not significantly different (α=0.05) using Duncan’s test and Dunnet least 
square means. 
 
With respect to pH, egg white solutions at pH 4.5 were the most stable followed 
by the control sample at pH 9.11.  The foam produced at pH 4.5 was also thicker and had 
a creamy texture.  Foam stability was significantly decreased at pH 6.  This was 
attributed to the volume of liquid not incorporated into the foam.  The rate of foam 
collapse/liquid drainage at pH 6 was similar to control as seen in Figure 30. 
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Figure 30: Effect of pH on 10% egg white solution foam stability at pH 9.11 (control), 
pH 6, and pH 4.5 at room temperature (20°C).  Time intervals represent measurement of 
foam stability post-foaming.  Same letters above each bar for each time denote means are 
not significantly different (α=0.05) using Duncan’s test and Dunnet least square means. 
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Conclusions 
 
The effects of HPP on egg white protein and its impact on egg white protein 
pepsin digestibility and egg white functional properties were evaluated.  HPP increased 
digestibility of egg white proteins, specifically ovalbumin, lysozyme, and ovotransferrin 
as evidenced by SDS-PAGE.  Two-dimensional electrophoretic analysis also indicated an 
increase in digestibility due to HPP.  HPP resulted in a shift in secondary structure with 
an increase in β-sheet/α-helix ratio as determined via Raman analysis.  The 
conformational changes in secondary structure indicate HPP promotes protein unfolding 
which may increase susceptibility to enzymatic hydrolysis.   Another consequence of a 
shift in secondary structure may be a change in allergenicity of egg white proteins as 
some epitopes (ovalbumin) may be structurally dependant (Mine, Y. et al 2003).  
Sequential epitopes may also be fragmented leading to a reduction in IgE binding 
(Lopez-Exposito, I. et al 2008, Kovacs-Nolan, J. et al 2000).  Similar effects on 
digestibility and secondary structure were also apparent with thermal treatments.  Mass 
spectrometry analysis showed a relative abundance of peptide fragments isolated from 
800 MPa egg white pepsin digestions compared to the control.  ACE-inhibitory peptide 
YAEERYPIL was identified as a pepsin digestion product of HP-treated egg white.  The 
evidence of greater protein fragmentation indicates HPP facilitates digestion of egg white 
proteins and possibly release of sequence embedded bioactive peptides.  This work has 
shown the potential of HPP in increasing the overall nutrition of egg white (digestibility).  
HPP may also affect allergenicity by fragmentation of allergenic epitopes with changes in 
secondary structure. 
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Overall the effects of HPP on egg white functionality were favorable.  HPP 
improved foaming properties of egg white at pressures up to 800 MPa.  Due to 
precipitation of whole egg white proteins at pressures used in this study (400, 600, and 
800 MPa), a combination of lower pressure and thermal treatment possibly could be 
applied to improve foaming properties of liquid egg products.  Lowering the pH to 4.5 
with potassium bitartrate resulted in the best foaming properties. HPP at pressures of 800 
MPa resulted in firm egg white gels comparable to thermally-induced gels (95°).  In 
general, HPP gels were less hard but more elastic than heat-treated gels.  HPP gel texture 
properties were also more consistent.  This was primarily due to uniform pressure 
application.  Lowering the pH (pH 6) of egg white prior to HP or heat treatment 
improved overall gel appearance. 
This work has presented some of the effects of HPP on egg white protein 
digestibility and functional properties.  Egg white is one of the best sources of nutritional 
protein.  Thus, more research is needed to evaluate the potential health benefits of HPP 
on egg white protein and the release of bioactive sequences.  HPP is an emerging 
technology with the potential to increase nutritional benefits and add new functional 
properties to food products.  As an alternative to thermal processes and HPP’s inherent 
advantages discussed in this work, it is important to continue HPP research on food 
products.                    
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Appendix 
 
Experimental Protocols 
 
Raman Spectroscopy Protocol 
 
Materials 
Egg white 
 
Sample Preparation 
1. Measure pH of whole egg white. 
2. Adjust to desired pH by adding granular tartaric acid to egg white 
3. Place in flexible plastic sausage casing to from uniform cylinder upon treatment 
4. Treat via thermal (95°C) or pressure treatment (400-800 MPa) 
5. Place in VWR glass vials (#66011-020) 
 
Raman Analysis: Enwave Optronics Spectrometer (785 nm laser) 
1. Set integration time for 120s, average to 3, and boxcar smoothing to 2. 
2. Measure spectrum at room temperature using untreated egg white as a control 
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In vitro digestibility (3:1 pepsin : protein ratio) Protocol 
 
Solutions 
Simulated Gastric Fluid (SGF): 0.1 N HCl, 0.03 M NaCl, pH 1.2 (Sigma G3285) 
Pepsin: Crystallized Porcine 3000 units/mg (Sigma P6887) 
0.2 M Na2CO3 
10% SDS 
0.4 M NH4HCO3 
 
Pepsin Preparation 
Dissolve 18 mg pepsin 10 mL of cold SGF.  Vortex until completely dissolved.  Keep on 
ice for 2 hours then discard 
 
Sample Preparation 
1. Determine protein concentration 
2. Dilute egg white sample to a concentration of approximately 10 µg/µL (normally 
1:10 dilution) 
 
Digestion Procedure 
1. Add 1.2 mL pepsin-SGF solution into a 1.5 mL microfuge tube and equilibrate at 
37°C for 5 min.  Pepsin solution should be freshly made and kept on ice.  Discard 
after 2 hours. 
2. Control: 0 time tube :  To this tube add 80 µL 0.2 M Na2CO3 and 10 µL 10% SDS 
followed by 50 µg test protein.  Then add 200 µL of SGF-Pepsin and mix 
immediately  
3. Digestion Reaction: Add an aliquot (max 70µL) of protein equivalent to 70 µg to 
the tube containing 1.2 mL pepsin-SGF.  Timing of reaction starts from pipetting 
of protein. 
4. Stop the reaction at 30 s, 2, 4, 8, 15, and 30 min by withdrawing 200 µL from the 
incubation tube and adding to a labeled tube containing 80 µL 0.2 M Na2CO3 and 
10 µL 10 % SDS. 
5. NOTE: Replace 80 µL 0.2 M Na2CO3 and 10 µL 10 % SDS solution with ~90 µL 
0.4 M NH4HCO3 or enough to bring pH 7-8 for HPLC or LC/MS/MS samples. 
 
For SDS-analysis: 
1. Add 35 µL SDS sample prep solution and heat at 50°C for 2 min 
2. Centrifuge for 2 min at 10,000 g and load 35 µL (~13µg protein) on 10-20% 
gradient gels or place in freezer at -20°C until SDS analysis. 
 
For HPLC or LC/MS/MS: 
1. Dry sample via centrivap and store at -20°C for analysis. 
 
 
 
 
 
87 
 
HPLC or LC/MS/MS sample preparation 
 
1.  Use only digestions stopped with 0.4 M NH4HCO3 stop solution 
2. Centrifuge 10 min at 17,000 RCF and collect supernatant 
3. Filter supernatant with YM3 3000 molecular cut off spin filters at 14,000 RCF 
until 10% of original volume remains (~30-45 minutes to filter 500 µL) 
4. Dry using Centra-Vap and store at -20°C till analysis 
5. For HPLC samples suspend in buffer and dilute accordingly for analysis 
6. Purify samples for MS analysis with Pierce PepCleanTM C-18 spin columns 
(#89873) and follow protocols as described in instruction manual.   
 
Gelation Properties Protocol 
 
Materials 
Tartaric Acid (Acros Organics #137855000) 
Egg white 
 
Sample Preparation 
6. Measure pH of whole egg white. 
7. Adjust to desired pH by adding granular tartaric acid to egg white 
8. Place in flexible plastic sausage casing to from uniform cylinder upon treatment 
9. Induce gelation via thermal (95°C) or pressure treatment (600-800 MPa) 
10. Carefully remove packaging making sure not to disturb gel structure 
 
Textural Analysis: TA.XT2 Texture Analyzer 
1. Calibrate texture analyzer with a 5 kg load cell 
2. Cut egg gels to a height of 20 mm (diameter 23 mm) 
3. Program texture analyzer to compress sample twice (2 bite cycle) with a 50 % 
penetration value and set compression speed to 1.2 mm/s 
4. Fit the analyzer with cylindrical test probe TA-4, 37mm diameter and run cycle 
5. Use Texture Technologies texture profile analysis to determine gel properties as 
described by Bourne (1982). 
 
Color Analysis: Minolta colorimeter equipped with Hunter color difference meter 
1. Cut egg samples to a height of 10 mm (diameter 23 mm) 
2. Take color measurements using colorimeter (10°/D65 light source) 
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Foaming Abilities Protocol 
 
Materials 
0.2 % Potassium Bitartrate (KT) (Fisher Scientific S76971) 
Egg white 
 
Sample Preparation 
11. Measure pH of whole egg white. 
12. Control: 90 mL DI water, 10 mL egg white, measure and record pH 
13. KT:  Dilute egg white with 10-30 mL DI water before adjusting pH with KT 
solution.  Adjust pH to 4.5 and pH 6 and bring final volume to 100 mL with DI 
water.  
  
Approximate amounts of 0.2% KT solution for each pH with starting egg white pH of 
9.1: 
 
pH Approximate mL0.2% KT 
4 80-90 mL 
5 60-70 mL 
6 30-40 mL 
 
Foaming 
1. Separate 100 mL solutions of 10% egg white solutions into 30 mL aliquots in 400 
mL beakers, making sure the solution is homogenous as possible before 
separation 
2. Foam each 30 mL solution for 2 minutes 
3. Transfer contents to graduated cylinder within 1:30 min  
4. Give 2 quick shakes downward to settle foam in cylinder 
5. Start timer and record total volume and volume of liquid 
6. Record at 0, 5, 10, 15, and 30 minutes 
7. Use these values to calculate volume of foam, foam overrun, and foam stability at 
each time point 
 
𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂 =  𝑓𝑓𝐹𝐹𝐹𝐹𝐹𝐹 𝑂𝑂𝐹𝐹𝑣𝑣𝑂𝑂𝐹𝐹𝑂𝑂30 𝐹𝐹𝑚𝑚  
 
𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 𝑆𝑆𝑆𝑆𝐹𝐹𝑆𝑆𝑣𝑣𝑆𝑆𝑆𝑆𝑆𝑆 =  30 𝐹𝐹𝑚𝑚 − 𝑚𝑚𝑆𝑆𝐿𝐿𝑂𝑂𝑆𝑆𝐿𝐿 𝑂𝑂𝐹𝐹𝑣𝑣𝑂𝑂𝐹𝐹𝑂𝑂30 𝐹𝐹𝑚𝑚  × 100 
 
𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 𝑂𝑂𝐹𝐹𝑣𝑣𝑂𝑂𝐹𝐹𝑂𝑂 = 𝑇𝑇𝐹𝐹𝑆𝑆𝐹𝐹𝑣𝑣 𝑉𝑉𝐹𝐹𝑣𝑣𝑂𝑂𝐹𝐹𝑂𝑂 − 𝑚𝑚𝑆𝑆𝐿𝐿𝑂𝑂𝑆𝑆𝐿𝐿 𝑉𝑉𝐹𝐹𝑣𝑣𝑂𝑂𝐹𝐹𝑂𝑂 
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A1: Peptide sequences of ovalbumin predicted by ExPASy Peptide Cutter with pepsin at 
pH 1.3. 
Cleavage 
Site 
Cleaving 
Enzyme 
Resulting peptide sequence  Peptide length 
[aa] 
Peptide 
mass [Da] 
10 Pepsin(pH1.3) MGSIGAASME 10 953.093  
11 Pepsin (pH1.3) F 1 165.192  
12 Pepsin (pH1.3) C 1 121.154  
13 Pepsin (pH1.3) F 1 165.192  
15 Pepsin (pH1.3) DV 2 232.236  
16 Pepsin (pH1.3) F 1 165.192  
18 Pepsin (pH1.3) KE 2 275.305  
28 Pepsin (pH1.3) LKVHHANENI 10 1174.325  
29 Pepsin (pH1.3) F 1 165.192  
38 Pepsin (pH1.3) YCPIAIMSA 9 968.194  
39 Pepsin (pH1.3) L 1 131.175  
42 Pepsin (pH1.3) AMV 3 319.419  
43 Pepsin (pH1.3) Y 1 181.191  
44 Pepsin (pH1.3) L 1 131.175  
60 Pepsin (pH1.3) GAKDSTRTQINKVVRF 16 1820.082  
63 Pepsin (pH1.3) DKL 3 374.437  
66 Pepsin (pH1.3) PGF 3 319.360  
84 Pepsin (pH1.3) GDSIEAQCGTSVNVHSSL 18 1803.918  
88 Pepsin (pH1.3) RDIL 4 515.610  
97 Pepsin (pH1.3) NQITKPNDV 9 1028.130  
98 Pepsin (pH1.3) Y 1 181.191  
99 Pepsin (pH1.3) S 1 105.093  
100 Pepsin (pH1.3) F 1 165.192  
101 Pepsin (pH1.3) S 1 105.093  
102 Pepsin (pH1.3) L 1 131.175  
106 Pepsin (pH1.3) ASRL 4 445.519  
112 Pepsin (pH1.3) YAEERY 6 829.865  
115 Pepsin (pH1.3) PIL 3 341.451  
118 Pepsin (pH1.3) PEY 3 407.423  
119 Pepsin (pH1.3) L 1 131.175  
124 Pepsin (pH1.3) QCVKE 5 605.707  
126 Pepsin (pH1.3) LY 2 294.351  
134 Pepsin (pH1.3) RGGLEPIN 8 854.961  
135 Pepsin (pH1.3) F 1 165.192  
144 Pepsin (pH1.3) QTAADQARE 9 989.010  
148 Pepsin (pH1.3) LINS 4 445.516  
149 Pepsin (pH1.3) W 1 204.228  
174 Pepsin (pH1.3) VESQTNGIIRNVLQPSSVDS
QTAMV 
25 2673.978  
175 Pepsin (pH1.3) L 1 131.175  
180 Pepsin (pH1.3) VNAIV 5 514.622  
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181 Pepsin (pH1.3) F 1 165.192  
183 Pepsin (pH1.3) KG 2 203.241  
185 Pepsin (pH1.3) LW 2 317.388  
188 Pepsin (pH1.3) EKT 3 376.410  
198 Pepsin (pH1.3) FKDEDTQAMP 10 1181.283  
212 Pepsin (pH1.3) FRVTEQESKPVQMM 14 1709.996  
213 Pepsin (pH1.3) Y 1 181.191  
216 Pepsin (pH1.3) QIG 3 316.357  
217 Pepsin (pH1.3) L 1 131.175  
218 Pepsin (pH1.3) F 1 165.192  
230 Pepsin (pH1.3) RVASMASEKMKI 12 1350.658  
233 Pepsin (pH1.3) LEL 3 373.450  
234 Pepsin (pH1.3) P 1 115.132  
242 Pepsin (pH1.3) FASGTMSM 8 830.969  
243 Pepsin (pH1.3) L 1 131.175  
244 Pepsin (pH1.3) V 1 117.148  
246 Pepsin (pH1.3) LL 2 244.334  
252 Pepsin (pH1.3) PDEVSG 6 602.599  
253 Pepsin (pH1.3) L 1 131.175  
255 Pepsin (pH1.3) EQ 2 275.261  
256 Pepsin (pH1.3) L 1 131.175  
261 Pepsin (pH1.3) ESIIN 5 574.632  
262 Pepsin (pH1.3) F 1 165.192  
264 Pepsin (pH1.3) EK 2 275.305  
265 Pepsin (pH1.3) L 1 131.175  
267 Pepsin (pH1.3) TE 2 248.236  
268 Pepsin (pH1.3) W 1 204.228  
281 Pepsin (pH1.3) TSSNVMEERKIKV 13 1520.764  
283 Pepsin (pH1.3) YL 2 294.351  
291 Pepsin (pH1.3) PRMKMEEK 8 1048.284  
292 Pepsin (pH1.3) Y 1 181.191  
294 Pepsin (pH1.3) NL 2 245.278  
297 Pepsin (pH1.3) TSV 3 305.331  
298 Pepsin (pH1.3) L 1 131.175  
306 Pepsin (pH1.3) MAMGITDV 8 837.017  
307 Pepsin (pH1.3) F 1 165.192  
312 Pepsin (pH1.3) SSSAN 5 464.432  
313 Pepsin (pH1.3) L 1 131.175  
321 Pepsin (pH1.3) SGISSAES 8 736.734  
322 Pepsin (pH1.3) L 1 131.175  
358 Pepsin (pH1.3) KISQAVHAAHAEINEAGRE
VVGSAEAGVDAASVSEE 
36 3589.835  
359 Pepsin (pH1.3) F 1 165.192  
364 Pepsin (pH1.3) RADHP 5 594.628  
366 Pepsin (pH1.3) FL 2 278.351  
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367 Pepsin (pH1.3) F 1 165.192  
377 Pepsin (pH1.3) CIKHIATNAV 10 1069.287  
378 Pepsin (pH1.3) L 1 131.175  
379 Pepsin (pH1.3) F 1 165.192  
380 Pepsin (pH1.3) F 1 165.192  
386 end of sequence GRCVSP  6 617.721  
 
A2: Proteins identified via mass spectrometry after 2-D electrophoresis. Included in the 
table are peptide fragments identified and corresponding mouse scores. 
Spot # Protein Indentification Gi Peptides 
Matches 
 
1 Chain A, Crystal Structure 
Of S-Ovalbumin 
gi|34811330    34 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       390.72 779.42 779.38 40  R.LYAEER.Y 
605.28 1208.54 1208.51 61  K.DEDTQAMPFR.V 
624.34 1246.67 1246.62 31  R.ADHPFLFCIK.H 
673.39 1344.77 1344.73 83  K.HIATNAVLFFGR.C 
778.38 1554.74 1554.71 90  K.AFKDEDTQAMPFR.V 
791.38 1580.74 1580.71 112  K.LTEWTSSNVMEER.K 
844.4 1686.78 1686.83 93  R.GGLEPINFQTAADQAR.E 
592 1772.97 1772.89 99  K.ISQAVHAAHAEINEAGR.E 
761.02 2280.05 2280.17 95  R.DILNQITKPNDVYSFSLASR.L 
767.4 2299.19 2299.13 70  R.VTEQESKPVQMMYQIGLFR.V + Oxidation (M) 
1246.69 2491.36 2491.3 115  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Dioxidation 
(M) 
1022.54 3064.58 3064.5 42  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
1030.57 3088.7 3088.63 41  R.NVLQPSSVDSQTAMVLVNAIVFKGLWEK.A + 
Oxidation (M) 
1299.04 3894.09 3893.99 114  
K.ILELPFAAGTMSMLVLLPDEVSGLEQLESIINFEK.L 
+ Dioxidation (M); Oxidation (M) 
     
1 Ovomucoid gi|124757     5 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 446.27 890.53 890.45 39  K.VMVLCNR.A 
544.8 1087.59 1087.56 76  K.VEQGASVDKR.H 
881.04 2640.1 2640.14 86  R.AFNPVCGTDGVTYDNECLLCAHK.V 
     
1 ovalbumin-related protein Y gi|71897377     1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 533.78 1065.54 1065.51 58  K.IAFNTEDTR.E 
     
2 Chain A, Crystal Structure 
Of S-Ovalbumin 
gi|34811330      10 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 799.39 1596.76 1596.71 75  K.LTEWTSSNVMEER.K + Oxidation (M) 
844.43 1686.85 1686.83 96  R.GGLEPINFQTAADQAR.E 
772.74 2315.2 2315.13 31  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
826.14 2475.38 2475.3 87  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Oxidation 
(M) 
761.41 3041.62 3041.55 1  R.DILNQITKPNDVYSFSLASRLYAEER.Y 
1022.53 3064.58 3064.5 27  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
     
2 Ovomucoid gi|124757     12 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 446.27 890.53 890.45 38  K.VMVLCNR.A 
881.09 2640.26 2640.14 68  R.AFNPVCGTDGVTYDNECLLCAHK.V 
2 Ovotransferrin gi|1351295    1      
 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
534.27 1066.52 1066.49 53  K.AQSDFGVDTK.S 
     
3 Chain A, Crystal Structure 
Of S-Ovalbumin  
gi|34811330     43 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       390.72 779.42 779.38 48  R.LYAEER.Y 
613.27 1224.53 1224.51 38  K.DEDTQAMPFR.V + Oxidation (M) 
624.34 1246.67 1246.62 37  R.ADHPFLFCIK.H 
749.41 1496.81 1496.76 2  R.YPILPEYLQCVK.E + Dioxidation (C) 
778.39 1554.77 1554.71 82  K.AFKDEDTQAMPFR.V 
791.36 1580.7 1580.71 112  K.LTEWTSSNVMEER.K 
794.4 1586.78 1586.7 -7  K.AFKDEDTQAMPFR.V + Dioxidation (M) 
807.38 1612.75 1612.7 -28  K.LTEWTSSNVMEER.K + Dioxidation (M) 
844.38 1686.74 1686.83 96  R.GGLEPINFQTAADQAR.E 
591.99 1772.95 1772.89 92  K.ISQAVHAAHAEINEAGR.E 
761.1 2280.28 2280.17 74  R.DILNQITKPNDVYSFSLASR.L 
772.71 2315.12 2315.13 61  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
1230.71 2459.4 2459.31 91  R.NVLQPSSVDSQTAMVLVNAIVFK.G 
1049.59 3145.74 3145.65 1  R.NVLQPQSVDSQTAMVLVNAIVFKGLWEK.A + 
Dioxidation (M) 
1299.05 3894.12 3893.99 99  
K.ILELPFAAGTMSMLVLLPDEVSGLEQLESIINFEK.L 
+ Dioxidation (M); Oxidation (M) 
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3 ovalbumin  gi|28566340 39 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       390.72 779.42 779.38 48  R.LYAEER.Y 
613.27 1224.53 1224.51 38  K.DEDTQAMPFR.V + Oxidation (M) 
624.34 1246.67 1246.62 37  R.ADHPFLFCIK.H 
749.41 1496.81 1496.76 2  R.YPILPEYLQCVK.E + Dioxidation (C) 
778.39 1554.77 1554.71 82  K.AFKDEDTQAMPFR.V 
791.36 1580.7 1580.71 112  K.LTEWTSSNVMEER.K 
844.38 1686.74 1686.83 96  R.GGLEPINFQTAADQAR.E 
591.99 1772.95 1772.89 92  K.ISQAVHAAHAEINEAGR.E 
761.1 2280.28 2280.17 74  R.DILNQITKPNDVYSFSLASR.L 
772.71 2315.12 2315.13 61  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
1230.71 2459.4 2459.31 91  R.NVLQPSSVDSQTAMVLVNAIVFK.G 
1299.05 3894.12 3893.99 99  
K.ILELPFASGTMSMLVLLPDEVSGLEQLESIINFEK.L 
+ Dioxidation (M) 
     
3 Ovalbumin-related protein X gi|129295  2 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 512.76 1023.5 1023.46 63  K.TAFNAEDTR.E 
963.16 2886.45 2886.49 49  K.ILELPFASGDLSMLVLLPDEVSDLER.I + Oxidation 
(M) 
     
3 ovalbumin-related protein Y gi|71897377     1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 533.78 1065.54 1065.51 58  K.IAFNTEDTR.E 
     
4 ovalbumin-related protein Y gi|71897377  3 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       676.82 1351.62 1351.56 54  K.FCFDVFNEMK.V 
695.38 1388.74 1388.66 30  K.FYTGGVEEVNFK.T 
771.91 1541.81 1541.75 47  K.TFSVLPEYLSCAR.K 
     
5 Chain A, Crystal Structure 
Of S-Ovalbumin  
gi|34811330     44 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 605.29 1208.57 1208.51 66  K.DEDTQAMPFR.V 
778.4 1554.78 1554.71 75  K.AFKDEDTQAMPFR.V 
791.38 1580.74 1580.71 98  K.LTEWTSSNVMEER.K 
844.47 1686.92 1686.83 99  R.GGLEPINFQTAADQAR.E 
592.01 1773.01 1772.89 76  K.ISQAVHAAHAEINEAGR.E 
620.35 1858.03 1857.96 50  R.ELINSWVESQTNGIIR.N 
750.42 2248.23 2248.12 52  K.ELYRGGLEPINFQTAADQAR.E 
772.74 2315.2 2315.13 63  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
831.47 2491.4 2491.3 97  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Dioxidation 
(M) 
1030.6 3088.77 3088.63 66  R.NVLQPSSVDSQTAMVLVNAIVFKGLWEK.A + 
Oxidation (M) 
     
5 ovalbumin  gi|28566340     41 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 605.29 1208.57 1208.51 66  K.DEDTQAMPFR.V 
778.4 1554.78 1554.71 75  K.AFKDEDTQAMPFR.V 
791.38 1580.74 1580.71 98  K.LTEWTSSNVMEER.K 
844.47 1686.92 1686.83 99  R.GGLEPINFQTAADQAR.E 
592.01 1773.01 1772.89 76  K.ISQAVHAAHAEINEAGR.E 
620.35 1858.03 1857.96 50  R.ELINSWVESQTNGIIR.N 
750.42 2248.23 2248.12 52  K.ELYRGGLEPINFQTAADQAR.E 
772.74 2315.2 2315.13 63  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
831.47 2491.4 2491.3 97  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Dioxidation 
(M) 
1030.6 3088.77 3088.63 66  R.NVLQPSSVDSQTAMVLVNAIVFKGLWEK.A + 
Oxidation (M) 
     
5 unnamed protein product 
[Gallus gallus] 
gi|63052      12 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 710.38 1418.75 1418.67 25  R.ELINSWVESQTN.- 
844.47 1686.92 1686.83 99  R.GGLEPINFQTAADQAR.E 
750.42 2248.23 2248.12 52  K.ELYRGGLEPINFQTAADQAR.E 
     
6 Chain A, Crystal Structure 
Of S-Ovalbumin 
gi|34811330     21 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       613.28 1224.55 1224.51 57  K.DEDTQAMPFR.V + Oxidation (M) 
673.4 1344.78 1344.73 69  K.HIATNAVLFFGR.C 
786.39 1570.77 1570.71 47  K.AFKDEDTQAMPFR.V + Oxidation (M) 
791.39 1580.76 1580.71 112  K.LTEWTSSNVMEER.K 
844.45 1686.89 1686.83 44  R.GGLEPINFQTAADQAR.E 
887.49 1772.96 1772.89 76  K.ISQAVHAAHAEINEAGR.E 
620.35 1858.03 1857.96 72  R.ELINSWVESQTNGIIR.N 
772.73 2315.17 2315.13 69  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
826.14 2475.4 2475.3 76  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Oxidation 
(M) 
1019.5 3055.48 3055.46 60  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 
Dioxidation (M); Oxidation (M); Dioxidation (C) 
1299.05 3894.12 3893.99 102  
K.ILELPFASGTMSMLVLLPDEVSGLEQLESIINFEK.L 
+ 2 Oxidation (M) 
     
6 protein TENP [Gallus gallus] gi|46048814 4 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 820 1637.98 1637.91 70  K.VADLWLSVIPEAGLR.L 
766.42 2296.23 2296.24 73  K.ITQVGSLYHEDLPITLSAALR.S 
967.53 2899.55 2899.46 49  R.AALLEELFLAPVCQQVPAWMDDVLR.E + 
Oxidation (M) 
817.67 3266.66 3266.58 46  R.ADLHVDMGPDGNLQLLTSACRPTVQAQSTR.E + 
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Oxidation (M) 
     
6 Ovotransferrin gi|1351295   3 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 481.26 960.51 960.49 38  R.IQWCAVGK.D 
521.31 1040.61 1040.56 60  R.KDQLTPSPR.E 
885.12 2652.34 2652.24 88  R.WSVVSNGDVECTVVDETKDCIIK.I 
     
6 Chain A,Chicken Egg-White 
Lysozyme Core Mutants 
gi|157831883   1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 877.45 1752.89 1752.83 106  R.NTDGSTDYGLLQINSR.W 
     
6 ovalbumin-related protein Y  gi|71897377  2 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 501.74 1001.47 1001.42 23  R.EMPFSMTK.E + 2 Oxidation (M) 
706.89 1411.76 1411.72 47  R.YNPTNAILFFGR.Y 
     
6 Ovalbumin-related protein X gi|129295    1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 512.76 1023.51 1023.46 67  K.TAFNAEDTR.E 
     
7 Chain A, Crystal Structure 
Of S-Ovalbumin 
gi|34811330  7 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       799.39 1596.78 1596.71 70  K.LTEWTSSNVMEER.K + Oxidation (M) 
844.46 1686.9 1686.83 90  R.GGLEPINFQTAADQAR.E 
772.74 2315.2 2315.13 22  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
826.13 2475.37 2475.3 92  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Oxidation 
(M) 
1299.03 3894.08 3893.99 88  
K.ILELPFAAGTMSMLVLLPDEVSGLEQLESIINFEK.L 
+ Dioxidation (M); Oxidation (M) 
     
7 Ovalbumin gi|129293    7 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       799.39 1596.78 1596.71 70  K.LTEWTSSNVMEER.K + Oxidation (M) 
844.46 1686.9 1686.83 90  R.GGLEPINFQTAADQAR.E 
772.74 2315.2 2315.13 22  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
826.13 2475.37 2475.3 92  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Oxidation 
(M) 
1299.03 3894.08 3893.99 86  
K.ILELPFASGTMSMLVLLPDEVSGLEQLESIINFEK.L 
+ Dioxidation (M) 
     
8 Ovalbumin gi|129293  7 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       791.38 1580.75 1580.71 108  K.LTEWTSSNVMEER.K 
844.44 1686.86 1686.83 90  R.GGLEPINFQTAADQAR.E 
891.42 1780.82 1780.78 30  M.GSIGAASMEFCFDVFK.E + Oxidation (M) 
826.13 2475.36 2475.3 94  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Oxidation 
(M) 
1298.99 3893.93 3893.99 69  
K.ILELPFASGTMSMLVLLPDEVSGLEQLESIINFEK.L 
+ Dioxidation (M) 
     
8 ovalbumin N term fragment gi|223059  5 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       891.42 1780.82 1780.78 30  -.GSIGAASMEFCFDVFK.E + Oxidation (M) 
734.05 2199.12 2199.06 41  K.VHHANENIFYCPIAIMSAL.- 
     
8 ovalbumin-related protein Y gi|71897377     1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 676.79 1351.56 1351.56 62  K.FCFDVFNEMK.V + Oxidation (M) 
     
9 Chain A, Crystal Structure 
Of S-Ovalbumin  
gi|34811330    16 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 605.28 1208.54 1208.51 66  K.DEDTQAMPFR.V 
778.36 1554.7 1554.71 96  K.AFKDEDTQAMPFR.V 
791.38 1580.75 1580.71 85  K.LTEWTSSNVMEER.K 
772.72 2315.14 2315.13 74  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
826.12 2475.33 2475.3 95  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Oxidation 
(M) 
     
9 Ovalbumin gi|129295     1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 512.75 1023.48 1023.46 63  K.TAFNAEDTR.E 
     
9 ovalbumin-related protein Y gi|71897377     1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 676.79 1351.57 1351.56 49  K.FCFDVFNEMK.V + Oxidation (M) 
     
10 Ovalbumin gi|129293     31 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 624.31 1246.6 1246.62 49  R.ADHPFLFCIK.H 
673.38 1344.74 1344.73 79  K.HIATNAVLFFGR.C 
524.59 1570.74 1570.71 72  K.AFKDEDTQAMPFR.V + Oxidation (M) 
791.38 1580.74 1580.71 108  K.LTEWTSSNVMEER.K 
844.43 1686.84 1686.83 58  R.GGLEPINFQTAADQAR.E 
887.42 1772.83 1772.89 129  K.ISQAVHAAHAEINEAGR.E 
891.42 1780.83 1780.78 37  M.GSIGAASMEFCFDVFK.E + Oxidation (M) 
1005 2007.98 2007.94 147  R.EVVGSAEAGVDAASVSEEFR.A 
772.72 2315.14 2315.13 62  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
826.1 2475.29 2475.3 93  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Oxidation 
(M) 
1022.52 3064.54 3064.5 80  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
1299.03 3894.06 3893.99 40  
K.ILELPFASGTMSMLVLLPDEVSGLEQLESIINFEK.L 
+ Dioxidation (M) 
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10 Chain A, Crystal Structure 
Of S-Ovalbumin 
gi|34811330    31 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 624.31 1246.6 1246.62 49  R.ADHPFLFCIK.H 
673.38 1344.74 1344.73 79  K.HIATNAVLFFGR.C 
524.59 1570.74 1570.71 72  K.AFKDEDTQAMPFR.V + Oxidation (M) 
791.38 1580.74 1580.71 108  K.LTEWTSSNVMEER.K 
844.43 1686.84 1686.83 58  R.GGLEPINFQTAADQAR.E 
887.42 1772.83 1772.89 129  K.ISQAVHAAHAEINEAGR.E 
891.42 1780.83 1780.78 37  -.GSIGAASMEFCFDVFK.E + Oxidation (M) 
1005 2007.98 2007.94 147  R.EVVGSAEAGVDAASVSEEFR.A 
772.72 2315.14 2315.13 62  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
826.1 2475.29 2475.3 93  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Oxidation 
(M) 
1022.52 3064.54 3064.5 80  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
1299.03 3894.06 3893.99 40  
K.ILELPFAAGTMSMLVLLPDEVSGLEQLESIINFEK.L 
+ Dioxidation (M); Oxidation (M) 
     
10 Ovotransferrin gi|1351295     6 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 521.29 1040.57 1040.56 60  R.KDQLTPSPR.E 
524.27 1046.52 1046.52 42  K.YFGYTGALR.C 
534.26 1066.51 1066.49 50  K.AQSDFGVDTK.S 
445.24 1332.7 1332.65 21  R.IQWCAVGKDEK.S 
512.32 1533.94 1533.84 73  R.SAGWNIPIGTLLHR.G 
848.42 1694.84 1694.82 38  R.DDNKVEDIWSFLSK.A 
     
10 ovotransferrin BB type gi|71274075 6 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 521.29 1040.57 1040.56 60  R.KDQLTPSPR.E 
524.27 1046.52 1046.52 42  K.YFGYTGALR.C 
534.26 1066.51 1066.49 50  K.AQSDFGVDTK.S 
445.24 1332.7 1332.65 21  R.IQWCAVGKDEK.S 
512.32 1533.94 1533.84 73  R.SAGWNIPIGTLIHR.G 
848.42 1694.84 1694.82 38  R.DDNKVEDIWSFLSK.A 
     
10 Ovalbumin gi|129294      10 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 887.42 1772.83 1772.89 129  K.ISQAVHAAHAEINEAGR.D 
891.42 1780.83 1780.78 37  M.GSIGAASMEFCFDVFK.E + Oxidation (M) 
558.28 2229.11 2229.08 14  R.VTEQESKPVQMMYQIGSFK.V 
     
10 protein TENP [Gallus gallus] gi|46048814     4 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 819.98 1637.94 1637.91 49  K.VADLWLSVIPEAGLR.L 
967.51 2899.5 2899.46 64  R.AALLEELFLAPVCQQVPAWMDDVLR.E + 
Oxidation (M) 
817.65 3266.56 3266.58 54  R.ADLHVDMGPDGNLQLLTSACRPTVQAQSTR.E + 
Oxidation (M) 
     
10 ovoinhibitor precursor  gi|71895337     2 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 574.78 1147.54 1147.51 54  K.DGTSWVACPR.N 
926.76 2777.26 2777.22 86  R.NLKPVCGTDGSTYSNECGICLYNR.E 
     
10 Chain A, Chicken Egg-White 
Lysozyme Core Mutants 
gi|157831883     1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 877.44 1752.87 1752.83 110  R.NTDGSTDYGLLQINSR.W 
     
11 Ovalbumin gi|129293     29 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 382.28 762.54 762.44 21  K.VVRFDK.L 
605.28 1208.54 1208.51 62  K.DEDTQAMPFR.V 
624.33 1246.65 1246.62 37  R.ADHPFLFCIK.H 
673.38 1344.75 1344.73 65  K.HIATNAVLFFGR.C 
778.38 1554.75 1554.71 91  K.AFKDEDTQAMPFR.V 
791.38 1580.75 1580.71 118  K.LTEWTSSNVMEER.K 
844.42 1686.83 1686.83 93  R.GGLEPINFQTAADQAR.E 
591.99 1772.95 1772.89 73  K.ISQAVHAAHAEINEAGR.E 
761.04 2280.1 2280.17 95  R.DILNQITKPNDVYSFSLASR.L 
772.7 2315.09 2315.13 71  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
826.1 2475.28 2475.3 102  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Oxidation 
(M) 
1022.52 3064.53 3064.5 123  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
     
11 Ovotransferrin gi|1351295    10 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 481.26 960.51 960.49 42  R.IQWCAVGK.D 
521.29 1040.56 1040.56 52  R.KDQLTPSPR.E 
524.27 1046.52 1046.52 39  K.YFGYTGALR.C 
534.26 1066.51 1066.49 50  K.AQSDFGVDTK.S 
601.23 1200.45 1200.59 26  K.SDFHLFGPPGK.K 
667.35 1332.68 1332.65 56  R.IQWCAVGKDEK.S 
718.88 1435.74 1435.73 35  K.KGTEFTVNDLQGK.T 
735.36 1468.71 1468.65 49  K.DEYELLCLDGSR.Q 
885.1 2652.29 2652.24 96  R.WSVVSNGDVECTVVDETKDCIIK.I 
     
11 unnamed protein product 
[Gallus gallus] 
gi|63052     17 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 382.28 762.54 762.44 21  K.VVRFDK.L 
844.42 1686.83 1686.83 93  R.GGLEPINFQTAADQAR.E 
877.9 1753.78 1753.77 12  M.GSIAAASMEFCFDVFK.E + Oxidation (M); 
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Oxidation (C) 
761.04 2280.1 2280.17 95  R.DILNQITKPNDVYSFSLASR.L 
1022.52 3064.53 3064.5 123  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
     
11 protein TENP [Gallus gallus] gi|46048814   3 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 819.97 1637.92 1637.91 84  K.VADLWLSVIPEAGLR.L 
967.51 2899.5 2899.46 54  R.AALLEELFLAPVCQQVPAWMDDVLR.E + 
Oxidation (M) 
817.68 3266.68 3266.58 74  R.ADLHVDMGPDGNLQLLTSACRPTVQAQSTR.E + 
Oxidation (M) 
     
11 Ovalbumin gi|129294     2 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 472.77 943.53 943.53 17  R.DILNQITK.Q 
591.99 1772.95 1772.89 73  K.ISQAVHAAHAEINEAGR.D 
     
11 ovalbumin N term fragment gi|223059     3 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 739.37 2215.09 2215.06 55  K.VHHANENIFYCPIAIMAAL.- + Dioxidation (M) 
     
11 ovalbumin-related protein Y  gi|71897377     2 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 533.77 1065.52 1065.51 55  K.IAFNTEDTR.E 
676.8 1351.59 1351.56 17  K.FCFDVFNEMK.V + Oxidation (M) 
     
12 Ovotransferrin gi|1351295     17 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       404.19 806.37 806.35 27  K.TCNWAR.V 
444.22 886.43 886.41 19  K.SCHTAVGR.T 
474.77 947.52 947.51 38  R.ISLTCVQK.A 
481.25 960.48 960.49 34  R.IQWCAVGK.D 
494.76 987.5 987.46 55  K.TSCHTGLGR.S 
521.29 1040.56 1040.56 60  R.KDQLTPSPR.E 
524.27 1046.53 1046.52 44  K.YFGYTGALR.C 
534.26 1066.51 1066.49 53  K.AQSDFGVDTK.S 
612.32 1222.62 1222.62 54  K.VEDIWSFLSK.A 
667.34 1332.66 1332.65 65  R.IQWCAVGKDEK.S 
718.87 1435.73 1435.73 135  K.KGTEFTVNDLQGK.T 
512.27 1533.77 1533.84 72  R.SAGWNIPIGTLLHR.G 
822.42 1642.83 1642.78 84  R.LCQLCQGSGGIPPEK.C 
848.42 1694.83 1694.82 79  R.DDNKVEDIWSFLSK.A 
980.5 1958.99 1958.96 74  R.GAIEWEGIESGSVEQAVAK.F 
1012.48 2022.94 2022.92 94  R.WSVVSNGDVECTVVDETK.D 
     
12 ovotransferrin BB type gi|71274075     17 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       404.19 806.37 806.35 27  K.TCNWAR.V 
444.22 886.43 886.41 19  K.SCHTAVGR.T 
474.77 947.52 947.51 38  R.ISLTCVQK.A 
481.25 960.48 960.49 34  R.IQWCAVGK.D 
494.76 987.5 987.46 55  K.TSCHTGLGR.S 
521.29 1040.56 1040.56 60  R.KDQLTPSPR.E 
524.27 1046.53 1046.52 44  K.YFGYTGALR.C 
534.26 1066.51 1066.49 53  K.AQSDFGVDTK.S 
612.32 1222.62 1222.62 54  K.VEDIWSFLSK.A 
667.34 1332.66 1332.65 65  R.IQWCAVGKDEK.S 
718.87 1435.73 1435.73 135  K.KGTEFTVNDLQGK.T 
512.27 1533.77 1533.84 72  R.SAGWNIPIGTLIHR.G 
822.42 1642.83 1642.78 84  R.LCQLCQGSGGIPPEK.C 
848.42 1694.83 1694.82 79  R.DDNKVEDIWSFLSK.A 
980.5 1958.99 1958.96 74  R.GAIEWEGIESGSVEQAVAK.F 
1012.48 2022.94 2022.92 94  R.WSVVSNGDVECTVVDETK.D 
     
12 Ovalbumin gi|129293      12 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 524.59 1570.74 1570.71 77  K.AFKDEDTQAMPFR.V + Oxidation (M) 
891.43 1780.85 1780.78 11  M.GSIGAASMEFCFDVFK.E + Oxidation (M) 
772.73 2315.16 2315.13 46  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
826.13 2475.35 2475.3 82  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Oxidation 
(M) 
1022.52 3064.53 3064.5 103  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
     
12 Ovotransferrin gi|3024757     8 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 404.19 806.37 806.35 27  K.TCNWAR.V 
444.22 886.43 886.41 19  K.SCHTAVGR.T 
481.25 960.48 960.49 34  K.IQWCAVGK.D 
494.76 987.5 987.46 55  K.TSCHTGLGR.S 
667.34 1332.66 1332.65 65  K.IQWCAVGKDEK.S 
512.27 1533.77 1533.84 72  R.SAGWNIPIGTLIHR.E 
1012.48 2022.94 2022.92 10  R.WSVVSNGEVECTILDDNK.D + Oxidation (C) 
     
12 Lysozyme gi|126608     2 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       714.85 1427.68 1427.64 92  K.FESNFNTQATNR.N 
877.43 1752.85 1752.83 126  R.NTDGSTDYGILQINSR.W 
     
12 Chain A, Chicken Egg-White 
Lysozyme Core Mutants 
gi|157831883    2 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 714.85 1427.68 1427.64 92  K.FESNFNTQATNR.N 
877.43 1752.85 1752.83 126  R.NTDGSTDYGLLQINSR.W 
     
12 Ovomucoid  gi|124757      4 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
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 544.8 1087.59 1087.56 75  K.VEQGASVDKR.H 
881.02 2640.05 2640.14 87  R.AFNPVCGTDGVTYDNECLLCAHK.V 
     
12 protein TENP [Gallus gallus] gi|46048814    1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 819.97 1637.93 1637.91 100  K.VADLWLSVIPEAGLR.L 
     
13 Ovalbumin gi|129293      12 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       613.27 1224.52 1224.51 54  K.DEDTQAMPFR.V + Oxidation (M) 
524.59 1570.74 1570.71 75  K.AFKDEDTQAMPFR.V + Oxidation (M) 
791.37 1580.73 1580.71 101  K.LTEWTSSNVMEER.K 
772.73 2315.16 2315.13 55  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
826.11 2475.31 2475.3 93  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Oxidation 
(M) 
1022.51 3064.52 3064.5 108  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
     
13 Ovotransferrin gi|1351295  10 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 474.76 947.52 947.51 60  R.ISLTCVQK.A 
481.25 960.49 960.49 39  R.IQWCAVGK.D 
492.25 982.49 982.48 35  K.ATYLDCIK.A 
524.27 1046.52 1046.52 28  K.YFGYTGALR.C 
618.78 1235.55 1235.55 48  R.WCTISSPEEK.K 
667.35 1332.68 1332.65 56  R.IQWCAVGKDEK.S 
821.42 1640.82 1640.79 20  K.FFSASCVPGATIEQK.L 
1012.48 2022.95 2022.92 97  R.WSVVSNGDVECTVVDETK.D 
885.1 2652.28 2652.24 95  R.WSVVSNGDVECTVVDETKDCIIK.I 
     
13 Ovotransferrin gi|3024757  6 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 481.25 960.49 960.49 39  K.IQWCAVGK.D 
492.25 982.49 982.48 35  K.ATYLDCIK.A 
667.35 1332.68 1332.65 56  K.IQWCAVGKDEK.S 
821.42 1640.82 1640.79 20  K.FFSASCVPGATIEQK.L 
1012.48 2022.95 2022.92 12  R.WSVVSNGEVECTILDDNK.D + Oxidation (C) 
     
13 Chain A, Chicken Egg-White 
Lysozyme Core Mutants 
gi|157831883     1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 877.44 1752.87 1752.83 131  R.NTDGSTDYGLLQINSR.W 
     
13 ovoinhibitor precursor gi|71895337     2 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 882.41 1762.8 1762.78 85  R.QEIPEIDCDQYPTR.K 
1028.81 3083.42 3083.32 36  R.ILSPVCGTDGFTYDNECGICAHNAEQR.T 
     
13 protein TENP [Gallus gallus] gi|46048814  1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 819.97 1637.93 1637.91 87  K.VADLWLSVIPEAGLR.L 
     
14 ovotransferrin precursor gi|45385813     10 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       445.23 888.45 888.43 48  R.DLTQQER.I 
474.7 947.39 947.51 54  R.ISLTCVQK.A 
492.25 982.49 982.48 35  K.ATYLDCIK.A 
524.27 1046.52 1046.52 46  K.YFGYTGALR.C 
618.77 1235.53 1235.55 52  R.WCTISSPEEK.K 
822.4 1642.79 1642.78 101  R.LCQLCQGSGGIPPEK.C 
878.77 2633.3 2633.3 93  K.AIANNEADAISLDGGQVFEAGLAPYK.L 
885.1 2652.27 2652.24 111  R.WSVVSNGDVECTVVDETKDCIIK.I 
     
14 ovotransferrin CC type gi|71274077    10 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 445.23 888.45 888.43 48  R.DLTQQER.I 
466.76 931.51 931.52 44  R.IALTCVQK.A 
492.25 982.49 982.48 35  K.ATYLDCIK.A 
524.27 1046.52 1046.52 46  K.YFGYTGALR.C 
618.77 1235.53 1235.55 52  R.WCTISSPEEK.K 
822.4 1642.79 1642.78 101  R.LCQLCQGSGGIPPEK.C 
878.77 2633.3 2633.3 93  K.AIANNEADAISLDGGQVFEAGLAPYK.L 
885.1 2652.27 2652.24 111  R.WSVVSNGDVECTVVDETKDCIIK.I 
     
14 Ovalbumin gi|129293    7 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 524.58 1570.73 1570.71 63  K.AFKDEDTQAMPFR.V + Oxidation (M) 
772.72 2315.15 2315.13 33  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
1238.66 2475.32 2475.3 82  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Oxidation 
(M) 
767.17 3064.65 3064.5 84  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
     
14 protein TENP [Gallus gallus] gi|46048814    3 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 819.97 1637.92 1637.91 90  K.VADLWLSVIPEAGLR.L 
967.5 2899.49 2899.46 61  R.AALLEELFLAPVCQQVPAWMDDVLR.E + 
Oxidation (M) 
     
14 Ovomucoid gi|124757     2 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 544.8 1087.59 1087.56 71  K.VEQGASVDKR.H 
881.04 2640.09 2640.14 25  R.AFNPVCGTDGVTYDNECLLCAHK.V 
     
14 Chain A, Chicken Egg-White 
Lysozyme Core Mutants 
gi|157831883     1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 877.43 1752.84 1752.83 95  R.NTDGSTDYGLLQINSR.W 
     
14 ovalbumin-related protein Y gi|71897377     1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
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 676.79 1351.57 1351.56 52  K.FCFDVFNEMK.V + Oxidation (M) 
     
15 Ovotransferrin gi|1351295   11 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 520.76 1039.5 1039.49 30  R.RANVMDYR.E + Oxidation (M) 
524.27 1046.53 1046.52 43  K.YFGYTGALR.C 
534.26 1066.5 1066.49 67  K.AQSDFGVDTK.S 
601.31 1200.61 1200.59 69  K.SDFHLFGPPGK.K 
665.36 1328.71 1328.69 37  K.SDFHLFGPPGKK.D 
718.88 1435.75 1435.73 121  K.KGTEFTVNDLQGK.T 
512.29 1533.85 1533.84 77  R.SAGWNIPIGTLLHR.G 
980.49 1958.96 1958.96 84  R.GAIEWEGIESGSVEQAVAK.F 
683.37 2047.09 2047.05 56  R.ECNLAEVPTHAVVVRPEK.A 
     
15 ovotransferrin BB type  gi|71274075   11 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       520.76 1039.5 1039.49 30  R.RANVMDYR.E + Oxidation (M) 
524.27 1046.53 1046.52 43  K.YFGYTGALR.C 
534.26 1066.5 1066.49 -50  K.AQSDFGVDTK.S 
534.26 1066.5 1066.49 67  K.AQSDFGVDTK.S 
601.31 1200.61 1200.59 69  K.SDFHLFGPPGK.K 
665.36 1328.71 1328.69 37  K.SDFHLFGPPGKK.D 
718.88 1435.75 1435.73 121  K.KGTEFTVNDLQGK.T 
512.29 1533.85 1533.84 77  R.SAGWNIPIGTLIHR.G 
980.49 1958.96 1958.96 84  R.GAIEWEGIESGSVEQAVAK.F 
683.37 2047.09 2047.05 56  R.ECNLAEVPTHAVVVRPEK.A 
     
15 Ovalbumin gi|129293     6 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 624.33 1246.64 1246.62 39  R.ADHPFLFCIK.H 
673.38 1344.75 1344.73 73  K.HIATNAVLFFGR.C 
1238.67 2475.32 2475.3 86  R.NVLQPSSVDSQTAMVLVNAIVFK.G + Oxidation 
(M) 
767.14 3064.53 3064.5 82  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
     
15 protein TENP [Gallus gallus] gi|46048814     1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 819.98 1637.94 1637.91 57  K.VADLWLSVIPEAGLR.L 
     
15 ovalbumin-related protein Y  gi|71897377    1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 706.87 1411.73 1411.72 49  R.YNPTNAILFFGR.Y 
     
16 Ovotransferrin gi|1351295 7 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       474.77 947.52 947.51 41  R.ISLTCVQK.A 
524.28 1046.54 1046.52 39  K.YFGYTGALR.C 
529.3 1056.58 1056.59 49  K.FYTVISSLK.T 
618.78 1235.55 1235.55 50  R.WCTISSPEEK.K 
873.97 1745.93 1745.92 70  K.EFLGDKFYTVISSLK.T 
1008.45 2014.88 2014.88 84  K.TCNPSDILQMCSFLEGK.- + Oxidation (M) 
     
16 Lysozyme  gi|126608     4 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 497.2 992.38 992.39 27  R.WWCNDGR.T 
877.43 1752.84 1752.83 130  R.NTDGSTDYGILQINSR.W 
836.74 2507.2 2507.18 71  R.NLCNIPCSALLSSDITASVNCAK.K 
879.44 2635.29 2635.28 14  R.NLCNIPCSALLSSDITASVNCAKK.I 
     
16 Lysozyme gi|742827    4 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 497.2 992.38 992.39 27  R.WWCNDGR.T 
877.43 1752.84 1752.83 130  R.NTDGSTDYGILQINSR.W 
836.74 2507.2 2507.18 58  R.NLCNIPCSALLSSDTIASVNCAK.K 
879.44 2635.29 2635.28 14  R.NLCNIPCSALLSSDTIASVNCAKK.I 
     
16 Chain A, Im Mutant Of 
Lysozyme 
gi|15988033     4 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       497.2 992.38 992.39 27  R.WWCNDGR.T 
877.43 1752.84 1752.83 130  R.NTDGSTDYGILQINSR.W 
836.74 2507.2 2507.06 62  R.NLCNMPCSALLSSDITASVNCAK.K + Dioxidation 
(M); 2 Dioxidation (C) 
     
16 Chain A, Chicken Egg-White 
Lysozyme Core Mutants 
gi|157831883     2 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 497.2 992.38 992.39 27  R.WWCNDGR.T 
877.43 1752.84 1752.83 130  R.NTDGSTDYGLLQINSR.W 
     
16 unnamed protein product 
[Gallus gallus] 
gi|63052    6 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 1022.5 3064.49 3064.5 104  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
     
17 Chain A, Aluminum-Bound 
Ovotransferrin  
gi|83754919 24 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 402.72 803.43 803.41 36  K.KCNNLR.D 
434.72 867.43 867.39 46  R.ANVMDYR.E 
445.23 888.45 888.43 45  R.DLTQQER.I 
457.77 913.52 913.53 36  K.IRDLLER.Q 
492.25 982.48 982.48 39  K.ATYLDCIK.A 
512.76 1023.5 1023.49 38  R.RANVMDYR.E 
529.29 1056.57 1056.59 49  K.FYTVISSLK.T 
618.78 1235.55 1235.55 53  R.WCTISSPEEK.K 
455.56 1363.67 1363.64 52  R.WCTISSPEEKK.C 
821.4 1640.78 1640.79 84  K.FFSASCVPGATIEQK.L 
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873.93 1745.84 1745.92 114  K.EFLGDKFYTVISSLK.T 
980.49 1958.96 1958.96 28  R.GAIEWEGIESGSVEQAVAK.F 
1008.44 2014.87 2014.88 128  K.TCNPSDILQMCSFLEGK.- + Oxidation (M) 
683.35 2047.02 2047.05 71  R.ECNLAEVPTHAVVVRPEK.A 
878.78 2633.31 2633.3 49  K.AIANNEADAISLDGGQVFEAGLAPYK.L 
     
17 ovotransferrin CC type  gi|71274077  22 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       402.72 803.43 803.41 36  K.KCNNLR.D 
434.72 867.43 867.39 46  R.ANVMDYR.E 
445.23 888.45 888.43 45  R.DLTQQER.I 
457.77 913.52 913.53 36  K.IRDLLER.Q 
466.76 931.51 931.52 59  R.IALTCVQK.A 
492.25 982.48 982.48 39  K.ATYLDCIK.A 
512.76 1023.5 1023.49 38  R.RANVMDYR.E 
618.78 1235.55 1235.55 53  R.WCTISSPEEK.K 
455.56 1363.67 1363.64 52  R.WCTISSPEEKK.C 
821.4 1640.78 1640.79 84  K.FFSASCVPGATIEQK.L 
980.49 1958.96 1958.96 28  R.GAIEWEGIESGSVEQAVAK.F 
1008.44 2014.87 2014.88 128  K.TCNPSDILQMCSFLEGK.- + Oxidation (M) 
683.35 2047.02 2047.05 71  R.ECNLAEVPTHAVVVRPEK.A 
878.78 2633.31 2633.3 49  K.AIANNEADAISLDGGQVFEAGLAPYK.L 
     
17 Lysozyme gi|126608     5 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 437.78 873.54 873.41 46  R.HGLDNYR.G 
663.32 1324.63 1324.62 66  R.GYSLGNWVCAAK.F 
714.83 1427.65 1427.64 101  K.FESNFNTQATNR.N 
877.43 1752.84 1752.83 129  R.NTDGSTDYGILQINSR.W 
836.74 2507.19 2507.18 25  R.NLCNIPCSALLSSDITASVNCAK.K 
     
17 Chain A, Im Mutant Of 
Lysozyme 
gi|15988033     5 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       437.78 873.54 873.41 46  R.HGLDNYR.G 
663.32 1324.63 1324.62 66  R.GYSLGNWVCAAK.F 
714.83 1427.65 1427.64 101  K.FESNFNTQATNR.N 
877.43 1752.84 1752.83 129  R.NTDGSTDYGILQINSR.W 
836.74 2507.19 2507.05 16  R.NLCNMPCSALLSSDITASVNCAK.K + Oxidation 
(C); Sulfo (C) 
     
17 Chain A,Chicken Egg-White 
Lysozyme Core Mutants 
gi|157831883     4 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       437.78 873.54 873.41 46  R.HGLDNYR.G 
663.32 1324.63 1324.62 66  R.GYSLGNWVCAAK.F 
714.83 1427.65 1427.64 101  K.FESNFNTQATNR.N 
877.43 1752.84 1752.83 129  R.NTDGSTDYGLLQINSR.W 
     
17 Lysozyme gi|742827     3 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 663.32 1324.63 1324.62 66  R.GYSLGNWVCAAK.F 
877.43 1752.84 1752.83 129  R.NTDGSTDYGILQINSR.W 
836.74 2507.19 2507.18 17  R.NLCNIPCSALLSSDTIASVNCAK.K 
     
17 unnamed protein product 
[Gallus gallus] 
gi|63052   3 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 1022.55 3064.61 3064.5 69  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
     
17 protein TENP [Gallus gallus] gi|46048814   1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 819.97 1637.92 1637.91 51  K.VADLWLSVIPEAGLR.L 
     
18 Hep21 protein [Gallus gallus] gi|45383131    2 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       789.8 1577.58 1577.58 73  R.YSCCETDLCNEK.W 
995.95 1989.88 1989.9 116  K.VTLYYQQGCTSALNCGR.E 
     
18 Ovalbumin gi|129293   4 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 844.43 1686.85 1686.83 64  R.GGLEPINFQTAADQAR.E 
1230.66 2459.31 2459.31 31  R.NVLQPSSVDSQTAMVLVNAIVFK.G 
767.17 3064.65 3064.5 78  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
     
18 Ovotransferrin gi|1351295    3 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 524.27 1046.52 1046.52 39  K.YFGYTGALR.C 
821.41 1640.8 1640.79 49  K.FFSASCVPGATIEQK.L 
873.97 1745.94 1745.92 54  K.EFLGDKFYTVISSLK.T 
     
18 Chain A, Chicken Egg-White 
Lysozyme Core Mutants 
gi|157831883  1 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 877.42 1752.83 1752.83 126  R.NTDGSTDYGLLQINSR.W 
     
19 Chain A, Aluminum-Bound 
Ovotransferrin 
gi|83754919       79 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 404.18 806.35 806.35 35  K.TCNWAR.V 
416.74 831.46 831.42 33  K.NKADWAK.N 
434.72 867.42 867.39 44  R.ANVMDYR.E 
445.23 888.44 888.43 46  R.DLTQQER.I 
447.27 892.52 892.52 52  R.VAAHAVVAR.D 
457.75 913.49 913.53 39  K.IRDLLER.Q 
474.77 947.53 947.51 59  R.ISLTCVQK.A 
475.26 948.51 948.51 58  K.DSAIMLKR.V + Oxidation (M) 
481.24 960.47 960.49 40  R.IQWCAVGK.D 
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492.27 982.54 982.48 35  K.ATYLDCIK.A 
497.26 992.51 992.5 48  K.RFGVNGSEK.S 
512.76 1023.5 1023.49 40  R.RANVMDYR.E 
518.24 1034.47 1034.54 81  K.DGKGDVAFVK.H 
524.29 1046.56 1046.52 44  K.YFGYTGALR.C 
529.28 1056.55 1056.59 49  K.FYTVISSLK.T 
534.26 1066.5 1066.49 42  K.AQSDFGVDTK.S 
546.82 1091.63 1091.62 53  K.DLLFKDLTK.C 
594.35 1186.68 1186.7 82  K.DPVLKDLLFK.D 
597.24 1192.47 1192.49 47  K.FMMFESQNK.D + 2 Oxidation (M) 
601.29 1200.56 1200.59 58  K.SDFHLFGPPGK.K 
602.29 1202.56 1202.57 49  K.DSNVNWNNLK.G 
612.29 1222.57 1222.62 59  K.VEDIWSFLSK.A 
618.74 1235.47 1235.55 53  R.WCTISSPEEK.K 
654.83 1307.64 1307.64 60  K.GTEFTVNDLQGK.T 
443.9 1328.69 1328.69 45  K.SDFHLFGPPGKK.D 
667.34 1332.66 1332.65 59  R.IQWCAVGKDEK.S 
677.34 1352.66 1352.63 73  K.HTTVNENAPDQK.D 
455.6 1363.76 1363.64 55  R.WCTISSPEEKK.C 
704.82 1407.63 1407.62 53  K.SKFMMFESQNK.D + 2 Oxidation (M) 
705.39 1408.76 1408.76 72  K.DLLFKDSAIMLK.R + Oxidation (M) 
718.86 1435.71 1435.73 134  K.KGTEFTVNDLQGK.T 
735.32 1468.63 1468.65 79  K.DEYELLCLDGSR.Q 
512.28 1533.82 1533.84 72  R.SAGWNIPIGTLIHR.G 
821.4 1640.78 1640.79 93  K.FFSASCVPGATIEQK.L 
826.92 1651.82 1651.83 45  K.TDERPASYFAVAVAR.K 
836.37 1670.72 1670.75 88  R.NAPYSGYSGAFHCLK.D 
873.92 1745.82 1745.92 112  K.EFLGDKFYTVISSLK.T 
603.95 1808.84 1808.85 69  K.FMMFESQNKDLLFK.D + 2 Oxidation (M) 
913.89 1825.76 1825.8 109  K.NLQMDDFELLCTDGR.R 
980.47 1958.93 1958.96 117  R.GAIEWEGIESGSVEQAVAK.F 
666.94 1997.81 1997.89 44  K.NLQMDDFELLCTDGRR.A + Oxidation (M) 
1008.39 2014.77 2014.88 118  K.TCNPSDILQMCSFLEGK.- + Oxidation (M) 
683.34 2047 2047.05 69  R.ECNLAEVPTHAVVVRPEK.A 
850.67 2549 2549.02 46  R.TGTCNFDEYFSEGCAPGSPPNSR.L 
878.77 2633.3 2633.3 104  K.AIANNEADAISLDGGQVFEAGLAPYK.L 
885.08 2652.22 2652.24 95  R.WSVVSNGDVECTVVDETKDCIIK.I 
935.42 2803.24 2803.27 112  K.HTTVNENAPDQKDEYELLCLDGSR.Q 
936.14 2805.39 2805.37 92  K.GEADAVALDGGLVYTAGVCGLVPVMAER.Y + 
Oxidation (M) 
1065.54 3193.59 3193.58 102  K.IMKGEADAVALDGGLVYTAGVCGLVPVMAER.Y 
+ 2 Oxidation (M) 
     
19 Ovotransferrin gi|1351295     77 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       404.18 806.35 806.35 35  K.TCNWAR.V 
416.74 831.46 831.42 33  K.NKADWAK.N 
419.22 836.42 836.4 45  R.FGVNGSEK.S 
434.72 867.42 867.39 44  R.ANVMDYR.E 
445.23 888.44 888.43 46  R.DLTQQER.I 
447.27 892.52 892.52 52  R.VAAHAVVAR.D 
457.75 913.49 913.53 39  K.IRDLLER.Q 
474.77 947.53 947.51 59  R.ISLTCVQK.A 
475.26 948.51 948.51 58  K.DSAIMLKR.V + Oxidation (M) 
481.24 960.47 960.49 40  R.IQWCAVGK.D 
492.27 982.54 982.48 35  K.ATYLDCIK.A 
497.26 992.51 992.5 48  K.RFGVNGSEK.S 
512.76 1023.5 1023.49 40  R.RANVMDYR.E 
518.24 1034.47 1034.54 81  K.DGKGDVAFVK.H 
524.29 1046.56 1046.52 44  K.YFGYTGALR.C 
529.28 1056.55 1056.59 49  K.FYTVISSLK.T 
534.26 1066.5 1066.49 42  K.AQSDFGVDTK.S 
546.82 1091.63 1091.62 53  K.DLLFKDLTK.C 
594.35 1186.68 1186.7 82  K.DPVLKDLLFK.D 
597.24 1192.47 1192.49 47  K.FMMFESQNK.D + 2 Oxidation (M) 
601.29 1200.56 1200.59 58  K.SDFHLFGPPGK.K 
602.29 1202.56 1202.57 49  K.DSNVNWNNLK.G 
612.29 1222.57 1222.62 59  K.VEDIWSFLSK.A 
618.74 1235.47 1235.55 53  R.WCTISSPEEK.K 
654.83 1307.64 1307.64 60  K.GTEFTVNDLQGK.T 
443.9 1328.69 1328.69 45  K.SDFHLFGPPGKK.D 
667.34 1332.66 1332.65 59  R.IQWCAVGKDEK.S 
677.34 1352.66 1352.63 73  K.HTTVNENAPDQK.D 
455.6 1363.76 1363.64 55  R.WCTISSPEEKK.C 
704.82 1407.63 1407.62 53  K.SKFMMFESQNK.D + 2 Oxidation (M) 
705.39 1408.76 1408.76 72  K.DLLFKDSAIMLK.R + Oxidation (M) 
718.86 1435.71 1435.73 134  K.KGTEFTVNDLQGK.T 
735.32 1468.63 1468.65 79  K.DEYELLCLDGSR.Q 
512.28 1533.82 1533.84 72  R.SAGWNIPIGTLLHR.G 
821.4 1640.78 1640.79 93  K.FFSASCVPGATIEQK.L 
826.92 1651.82 1651.83 45  K.TDERPASYFAVAVAR.K 
836.37 1670.72 1670.75 88  R.NAPYSGYSGAFHCLK.D 
873.92 1745.82 1745.92 112  K.EFLGDKFYTVISSLK.T 
603.95 1808.84 1808.85 69  K.FMMFESQNKDLLFK.D + 2 Oxidation (M) 
913.89 1825.76 1825.8 109  K.NLQMDDFELLCTDGR.R 
980.47 1958.93 1958.96 117  R.GAIEWEGIESGSVEQAVAK.F 
666.94 1997.81 1997.89 44  K.NLQMDDFELLCTDGRR.A + Oxidation (M) 
1008.39 2014.77 2014.88 118  K.TCNPSDILQMCSFLEGK.- + Oxidation (M) 
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683.34 2047 2047.05 69  R.ECNLAEVPTHAVVVRPEK.A 
850.67 2549 2549.02 46  R.TGTCNFDEYFSEGCAPGSPPNSR.L 
885.08 2652.22 2652.24 95  R.WSVVSNGDVECTVVDETKDCIIK.I 
935.42 2803.24 2803.27 112  K.HTTVNENAPDQKDEYELLCLDGSR.Q 
936.14 2805.39 2805.37 92  K.GEADAVALDGGLVYTAGVCGLVPVMAER.Y + 
Oxidation (M) 
1065.54 3193.59 3193.58 102  K.IMKGEADAVALDGGLVYTAGVCGLVPVMAER.Y 
+ 2 Oxidation (M) 
     
19 Chain A, Ovotransferrin, N-
Terminal Lobe, Holo Form 
gi|14719680 36 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       404.18 806.35 806.35 35  K.TCNWAR.V 
445.23 888.44 888.43 46  R.DLTQQER.I 
447.27 892.52 892.52 52  R.VAAHAVVAR.D 
474.77 947.53 947.51 59  R.ISLTCVQK.A 
475.26 948.51 948.51 58  K.DSAIMLKR.V + Oxidation (M) 
492.27 982.54 982.48 35  K.ATYLDCIK.A 
518.24 1034.47 1034.54 81  K.DGKGDVAFVK.H 
534.26 1066.5 1066.49 42  K.AQSDFGVDTK.S 
594.35 1186.68 1186.7 82  K.DPVLKDLLFK.D 
601.29 1200.56 1200.59 58  K.SDFHLFGPPGK.K 
612.29 1222.57 1222.62 59  K.VEDIWSFLSK.A 
618.74 1235.47 1235.55 53  R.WCTISSPEEK.K 
654.83 1307.64 1307.64 60  K.GTEFTVNDLQGK.T 
443.9 1328.69 1328.69 45  K.SDFHLFGPPGKK.D 
677.34 1352.66 1352.63 73  K.HTTVNENAPDQK.D 
455.6 1363.76 1363.64 55  R.WCTISSPEEKK.C 
705.39 1408.76 1408.76 72  K.DLLFKDSAIMLK.R + Oxidation (M) 
718.86 1435.71 1435.73 134  K.KGTEFTVNDLQGK.T 
735.32 1468.63 1468.65 79  K.DEYELLCLDGSR.Q 
512.28 1533.82 1533.84 72  R.SAGWNIPIGTLLHR.G 
821.4 1640.78 1640.79 93  K.FFSASCVPGATIEQK.L 
836.37 1670.72 1670.75 88  R.NAPYSGYSGAFHCLK.D 
980.47 1958.93 1958.96 117  R.GAIEWEGIESGSVEQAVAK.F 
883.47 2647.37 2647.31 50  K.AIANNEADAITLDGGQVFEAGLAPYK.L 
935.42 2803.24 2803.27 112  K.HTTVNENAPDQKDEYELLCLDGSR.Q 
     
19 Ovalbumin gi|129293 9 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 624.32 1246.63 1246.62 19  R.ADHPFLFCIK.H 
761.92 1521.82 1521.79 38  R.YPILPEYLQCVK.E 
786.37 1570.72 1570.71 57  K.AFKDEDTQAMPFR.V + Oxidation (M) 
799.36 1596.71 1596.71 104  K.LTEWTSSNVMEER.K + Oxidation (M) 
844.4 1686.79 1686.83 96  R.GGLEPINFQTAADQAR.E 
772.71 2315.11 2315.13 55  R.VTEQESKPVQMMYQIGLFR.V + 2 Oxidation (M) 
820.79 2459.34 2459.31 57  R.NVLQPSSVDSQTAMVLVNAIVFK.G 
1022.55 3064.64 3064.5 36  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
     
20 Chain A, Aluminum-Bound 
Ovotransferrin 
gi|83754919     99 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 397.28 792.55 792.41 43  K.DSAIMLK.R + Oxidation (M) 
404.18 806.34 806.35 35  K.TCNWAR.V 
419.27 836.53 836.4 45  R.FGVNGSEK.S 
434.7 867.39 867.39 44  R.ANVMDYR.E 
445.23 888.44 888.43 41  R.DLTQQER.I 
447.25 892.49 892.52 51  R.VAAHAVVAR.D 
457.27 912.53 912.47 34  K.DQLTPSPR.E 
457.74 913.46 913.53 36  K.IRDLLER.Q 
474.69 947.36 947.51 32  R.ISLTCVQK.A 
492.28 982.54 982.48 34  K.ATYLDCIK.A 
494.75 987.48 987.46 56  K.TSCHTGLGR.S 
497.26 992.5 992.5 56  K.RFGVNGSEK.S 
512.75 1023.49 1023.49 32  R.RANVMDYR.E 
518.27 1034.53 1034.54 78  K.DGKGDVAFVK.H 
524.27 1046.53 1046.52 46  K.YFGYTGALR.C 
529.24 1056.48 1056.59 49  K.FYTVISSLK.T 
534.24 1066.47 1066.49 32  K.AQSDFGVDTK.S 
566.23 1130.45 1130.42 54  R.YDDESQCSK.T 
594.35 1186.69 1186.7 89  K.DPVLKDLLFK.D 
597.26 1192.5 1192.49 44  K.FMMFESQNK.D + 2 Oxidation (M) 
601.26 1200.51 1200.59 61  K.SDFHLFGPPGK.K 
612.31 1222.6 1222.62 59  K.VEDIWSFLSK.A 
618.77 1235.52 1235.55 53  R.WCTISSPEEK.K 
654.79 1307.56 1307.64 69  K.GTEFTVNDLQGK.T 
443.89 1328.64 1328.69 38  K.SDFHLFGPPGKK.D 
667.33 1332.65 1332.65 55  R.IQWCAVGKDEK.S 
455.55 1363.62 1363.64 51  R.WCTISSPEEKK.C 
696.82 1391.62 1391.62 71  K.SKFMMFESQNK.D + Oxidation (M) 
735.3 1468.59 1468.65 74  K.DEYELLCLDGSR.Q 
512.25 1533.72 1533.84 59  R.SAGWNIPIGTLIHR.G 
790.91 1579.81 1579.83 53  R.TAGWVIPMGLIHNR.T + Oxidation (M) 
821.4 1640.78 1640.79 77  K.FFSASCVPGATIEQK.L 
551.61 1651.82 1651.83 43  K.TDERPASYFAVAVAR.K 
836.33 1670.64 1670.75 87  R.NAPYSGYSGAFHCLK.D 
873.91 1745.8 1745.92 111  K.EFLGDKFYTVISSLK.T 
603.98 1808.92 1808.85 69  K.FMMFESQNKDLLFK.D + 2 Oxidation (M) 
913.85 1825.68 1825.8 104  K.NLQMDDFELLCTDGR.R 
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980.48 1958.95 1958.96 124  R.GAIEWEGIESGSVEQAVAK.F 
666.97 1997.9 1997.89 53  K.NLQMDDFELLCTDGRR.A + Oxidation (M) 
1012.45 2022.9 2022.92 92  R.WSVVSNGDVECTVVDETK.D 
1016.42 2030.83 2030.87 20  K.TCNPSDILQMCSFLEGK.- + Dioxidation (M) 
512.8 2047.17 2047.05 42  R.ECNLAEVPTHAVVVRPEK.A 
878.77 2633.28 2633.3 120  K.AIANNEADAISLDGGQVFEAGLAPYK.L 
910.76 2729.27 2729.27 16  R.VPSLMDSQLYLGFEYYSAIQSMR.K + 2 Oxidation 
(M) 
936.12 2805.35 2805.37 119  K.GEADAVALDGGLVYTAGVCGLVPVMAER.Y + 
Oxidation (M) 
1065.52 3193.53 3193.58 91  K.IMKGEADAVALDGGLVYTAGVCGLVPVMAER.Y 
+ 2 Oxidation (M) 
     
20 ovotransferrin CC type gi|71274077     94 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 397.28 792.55 792.41 43  K.DSAIMLK.R + Oxidation (M) 
404.18 806.34 806.35 35  K.TCNWAR.V 
419.27 836.53 836.4 45  R.FGVNGSEK.S 
434.7 867.39 867.39 44  R.ANVMDYR.E 
445.23 888.44 888.43 41  R.DLTQQER.I 
447.25 892.49 892.52 51  R.VAAHAVVAR.D 
457.27 912.53 912.47 34  K.DQLTPSPR.E 
457.74 913.46 913.53 36  K.IRDLLER.Q 
492.28 982.54 982.48 34  K.ATYLDCIK.A 
494.75 987.48 987.46 56  K.TSCHTGLGR.S 
497.26 992.5 992.5 56  K.RFGVNGSEK.S 
512.75 1023.49 1023.49 32  R.RANVMDYR.E 
518.27 1034.53 1034.54 78  K.DGKGDVAFVK.H 
524.27 1046.53 1046.52 46  K.YFGYTGALR.C 
534.24 1066.47 1066.49 32  K.AQSDFGVDTK.S 
566.23 1130.45 1130.42 54  R.YDDESQCSK.T 
594.35 1186.69 1186.7 89  K.DPVLKDLLFK.D 
597.26 1192.5 1192.49 44  K.FMMFESQNK.D + 2 Oxidation (M) 
601.26 1200.51 1200.59 61  K.SDFHLFGPPGK.K 
612.31 1222.6 1222.62 59  K.VEDIWSFLSK.A 
618.77 1235.52 1235.55 53  R.WCTISSPEEK.K 
654.79 1307.56 1307.64 69  K.GTEFTVNDLQGK.T 
443.89 1328.64 1328.69 38  K.SDFHLFGPPGKK.D 
667.33 1332.65 1332.65 55  R.IQWCAVGKDEK.S 
455.55 1363.62 1363.64 51  R.WCTISSPEEKK.C 
696.82 1391.62 1391.62 71  K.SKFMMFESQNK.D + Oxidation (M) 
735.3 1468.59 1468.65 74  K.DEYELLCLDGSR.Q 
512.25 1533.72 1533.84 59  R.SAGWNIPIGTLIHR.G 
790.91 1579.81 1579.83 53  R.TAGWVIPMGLIHNR.T + Oxidation (M) 
821.4 1640.78 1640.79 77  K.FFSASCVPGATIEQK.L 
551.61 1651.82 1651.83 43  K.TDERPASYFAVAVAR.K 
836.33 1670.64 1670.75 87  R.NAPYSGYSGAFHCLK.D 
603.98 1808.92 1808.85 69  K.FMMFESQNKDLLFK.D + 2 Oxidation (M) 
913.85 1825.68 1825.8 104  K.NLQMDDFELLCTDGR.R 
980.48 1958.95 1958.96 124  R.GAIEWEGIESGSVEQAVAK.F 
666.97 1997.9 1997.89 53  K.NLQMDDFELLCTDGRR.A + Oxidation (M) 
1012.45 2022.9 2022.92 92  R.WSVVSNGDVECTVVDETK.D 
1016.42 2030.83 2030.87 20  K.TCNPSDILQMCSFLEGK.- + Dioxidation (M) 
512.8 2047.17 2047.05 42  R.ECNLAEVPTHAVVVRPEK.A 
858 2570.99 2570.97 88  R.TGTCNFNEYFSEGCAPGSPPNSR.L + Sulfo (C) 
878.77 2633.28 2633.3 120  K.AIANNEADAISLDGGQVFEAGLAPYK.L 
910.76 2729.27 2729.27 16  R.VPSLMDSQLYLGFEYYSAIQSMR.K + 2 Oxidation 
(M) 
936.12 2805.35 2805.37 119  K.GEADAVALDGGLVYTAGVCGLVPVMAER.Y + 
Oxidation (M) 
     
20 Ovotransferrin gi|1351295    96 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 397.28 792.55 792.41 43  K.DSAIMLK.R + Oxidation (M) 
404.18 806.34 806.35 35  K.TCNWAR.V 
419.27 836.53 836.4 45  R.FGVNGSEK.S 
434.7 867.39 867.39 44  R.ANVMDYR.E 
445.23 888.44 888.43 41  R.DLTQQER.I 
447.25 892.49 892.52 51  R.VAAHAVVAR.D 
457.27 912.53 912.47 34  K.DQLTPSPR.E 
457.74 913.46 913.53 36  K.IRDLLER.Q 
474.69 947.36 947.51 32  R.ISLTCVQK.A 
492.28 982.54 982.48 34  K.ATYLDCIK.A 
494.75 987.48 987.46 56  K.TSCHTGLGR.S 
497.26 992.5 992.5 56  K.RFGVNGSEK.S 
512.75 1023.49 1023.49 32  R.RANVMDYR.E 
518.27 1034.53 1034.54 78  K.DGKGDVAFVK.H 
524.27 1046.53 1046.52 46  K.YFGYTGALR.C 
529.24 1056.48 1056.59 49  K.FYTVISSLK.T 
534.24 1066.47 1066.49 32  K.AQSDFGVDTK.S 
566.23 1130.45 1130.42 54  R.YDDESQCSK.T 
594.35 1186.69 1186.7 89  K.DPVLKDLLFK.D 
597.26 1192.5 1192.49 44  K.FMMFESQNK.D + 2 Oxidation (M) 
601.26 1200.51 1200.59 61  K.SDFHLFGPPGK.K 
612.31 1222.6 1222.62 59  K.VEDIWSFLSK.A 
618.77 1235.52 1235.55 53  R.WCTISSPEEK.K 
654.79 1307.56 1307.64 69  K.GTEFTVNDLQGK.T 
443.89 1328.64 1328.69 38  K.SDFHLFGPPGKK.D 
667.33 1332.65 1332.65 55  R.IQWCAVGKDEK.S 
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455.55 1363.62 1363.64 51  R.WCTISSPEEKK.C 
696.82 1391.62 1391.62 71  K.SKFMMFESQNK.D + Oxidation (M) 
735.3 1468.59 1468.65 74  K.DEYELLCLDGSR.Q 
512.25 1533.72 1533.84 59  R.SAGWNIPIGTLLHR.G 
790.91 1579.81 1579.83 53  R.TAGWVIPMGLIHNR.T + Oxidation (M) 
821.4 1640.78 1640.79 77  K.FFSASCVPGATIEQK.L 
551.61 1651.82 1651.83 43  K.TDERPASYFAVAVAR.K 
836.33 1670.64 1670.75 87  R.NAPYSGYSGAFHCLK.D 
873.91 1745.8 1745.92 111  K.EFLGDKFYTVISSLK.T 
603.98 1808.92 1808.85 69  K.FMMFESQNKDLLFK.D + 2 Oxidation (M) 
913.85 1825.68 1825.8 104  K.NLQMDDFELLCTDGR.R 
980.48 1958.95 1958.96 124  R.GAIEWEGIESGSVEQAVAK.F 
666.97 1997.9 1997.89 53  K.NLQMDDFELLCTDGRR.A + Oxidation (M) 
1012.45 2022.9 2022.92 92  R.WSVVSNGDVECTVVDETK.D 
1016.42 2030.83 2030.87 20  K.TCNPSDILQMCSFLEGK.- + Dioxidation (M) 
512.8 2047.17 2047.05 42  R.ECNLAEVPTHAVVVRPEK.A 
910.76 2729.27 2729.27 16  R.VPSLMDSQLYLGFEYYSAIQSMR.K + 2 Oxidation 
(M) 
936.12 2805.35 2805.37 119  K.GEADAVALDGGLVYTAGVCGLVPVMAER.Y + 
Oxidation (M) 
1065.52 3193.53 3193.58 91  K.IMKGEADAVALDGGLVYTAGVCGLVPVMAER.Y 
+ 2 Oxidation (M) 
     
20 Chain A, Ovotransferrin, N-
Terminal Lobe, Holo Form 
gi|14719680     46 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
       397.28 792.55 792.41 43  K.DSAIMLK.R + Oxidation (M) 
404.18 806.34 806.35 35  K.TCNWAR.V 
445.23 888.44 888.43 41  R.DLTQQER.I 
447.25 892.49 892.52 51  R.VAAHAVVAR.D 
474.69 947.36 947.51 32  R.ISLTCVQK.A 
492.28 982.54 982.48 34  K.ATYLDCIK.A 
494.75 987.48 987.46 56  K.TSCHTGLGR.S 
518.27 1034.53 1034.54 78  K.DGKGDVAFVK.H 
534.24 1066.47 1066.49 32  K.AQSDFGVDTK.S 
594.35 1186.69 1186.7 89  K.DPVLKDLLFK.D 
601.26 1200.51 1200.59 61  K.SDFHLFGPPGK.K 
612.31 1222.6 1222.62 59  K.VEDIWSFLSK.A 
618.77 1235.52 1235.55 53  R.WCTISSPEEK.K 
654.79 1307.56 1307.64 69  K.GTEFTVNDLQGK.T 
443.89 1328.64 1328.69 38  K.SDFHLFGPPGKK.D 
455.55 1363.62 1363.64 51  R.WCTISSPEEKK.C 
735.3 1468.59 1468.65 74  K.DEYELLCLDGSR.Q 
512.25 1533.72 1533.84 59  R.SAGWNIPIGTLLHR.G 
821.4 1640.78 1640.79 77  K.FFSASCVPGATIEQK.L 
836.33 1670.64 1670.75 87  R.NAPYSGYSGAFHCLK.D 
980.48 1958.95 1958.96 124  R.GAIEWEGIESGSVEQAVAK.F 
883.44 2647.3 2647.31 56  K.AIANNEADAITLDGGQVFEAGLAPYK.L 
910.76 2729.27 2729.27 16  R.VPSLMDSQLYLGFEYYSAIQSMR.- + 2 Oxidation 
(M) 
     
20 Ovotransferrin gi|3024757     16 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 397.28 792.55 792.41 43  K.DSAIMLK.R + Oxidation (M) 
404.18 806.34 806.35 35  K.TCNWAR.V 
447.25 892.49 892.52 51  R.VAAHAVVAR.D 
492.28 982.54 982.48 34  K.ATYLDCIK.A 
494.75 987.48 987.46 56  K.TSCHTGLGR.S 
518.27 1034.53 1034.54 78  K.DGKGDVAFVK.H 
594.35 1186.69 1186.7 89  K.DPVLKDLLFK.D 
667.33 1332.65 1332.65 55  K.IQWCAVGKDEK.S 
735.3 1468.59 1468.65 74  K.DEYELLCLDGSR.Q 
512.25 1533.72 1533.84 59  R.SAGWNIPIGTLIHR.E 
821.4 1640.78 1640.79 77  K.FFSASCVPGATIEQK.L 
1012.45 2022.9 2022.92 8  R.WSVVSNGEVECTILDDNK.D + Oxidation (C) 
     
20 Ovalbumin gi|129293     2 Observed   Mr(expt)   Mr(calc)   Score   Peptide 
 820.79 2459.35 2459.31 9  R.NVLQPSSVDSQTAMVLVNAIVFK.G 
767.13 3064.49 3064.5 46  K.VHHANENIFYCPIAIMSALAMVYLGAK.D + 2 
Oxidation (M) 
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A3: Gel hardness, gumminess, cohesiveness, and resilience values with one standard 
deviation error 
Sample Hardness Gumminess  Cohesiveness  Resilience 
95°C 2329.73 ± 209.16 1565.76 ± 184.43 0.67 ± 0.04 0.43 ± 0.03 
95°C pH 6 1105.30 ± 282.41 580.99 ± 108.85 0.53 ± 0.05 0.19 ± 0.03 
600 MPa 403.54 ± 93.40 276.82 ± 93.75 0.69 ± 0.17 0.18 ± 0.08 
600 MPa pH 6 723.99 ± 124.11 503.41 ± 78.90 0.70 ± 0.01 0.32 ± 0.02 
800 MPa 1114.89 ± 118.16 912.79 ± 114.63 0.82 ± 0.03 0.52 ± 0.01 
800 MPa pH 6 1498.45 ± 119.13 1003.12 ± 69.07 0.67 ± 0.01 0.31 ± 0.01 
 
A4: Gel color values with one standard deviation error 
Sample L-value a-value b-value 
95C 85.75 ± 0.48 -4.55 ± 0.33 6.50 ±  0.92 
95C pH6 87.75 ± 1.24 -2.99 ± 0.32 9.24 ±0.70 
600MPa 81.87 ± 0.56 -3.63 ± 0.33 4.99 ± 1.09 
600MPa pH6 88.97 ± 0.51 -1.92 ± 0.35 7.19 ± 0.75 
800MPa 82.46 ± 1.01 -4.10 ± 0.35 3.88 ± 0.73 
800MPa pH6 90.67 ± 0.73 -1.75 ± 0.14 7.13 ± 0.58 
 
A5:  Foam overrun values with one standard deviation error. 
Time (min) 0 5 10 15 30 
Control 1.5 ± 0.1 1.3 ± 0.2 1.3 ± 0.2 1.2 ± 0.2 1.2 ± 0.2 
pH 4.5 2.4 ± 0.1 2.1 ± 0.1 2.0 ± 0.1 2.0 ± 0.1 1.9 ± 0.1 
pH 6.0 1.1 ± 0.3 0.9 ± 0.3 0.9 ± 0.3 0.9 ± 0.3 0.9 ± 0.3 
600 MPa 1.8 ± 0.2 1.6 ± 0.2 1.5 ± 0.2 1.5 ± 0.2 1.5 ± 0.2 
800 MPa 2.1 ± 0.3 1.8 ± 0.2 1.8 ± 0.2 1.7 ± 0.2 1.7 ± 0.2 
 
A6: Foam stability values with one standard deviation error. 
Time (min) 0 5 10 15 30 
Control 66.0 ± 3.7 46.0 ± 2.8 42.0 ± 3.0 40.0 ± 2.4 36.0 ± 2.8 
pH 4.5 84.2 ± 8.3 60.0 ± 11.2 50.8 ± 11.3 45.0 ± 12.3 35.8 ± 12.0 
pH 6.0 42.0 ± 14.1 28.7 ± 8.0 26.7 ± 5.3 26.0 ± 6.4 23.3 ± 5.3 
600 MPa 48.7 ± 6.1 28.7 ± 4.5 23.3 ± 3.3 21.3 ± 1.8 18.7 ± 3.0 
800 MPa 64.0 ± 10.9 32.0 ± 5.1 29.3 ± 2.8 26.0 ± 2.8 22.7 ± 2.8 
 
 
 
